12451000	11450	Okamoto Y	Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2002	156
15599400	11450	Furukawa S	Increased oxidative stress in obesity and its impact on metabolic syndrome.	The Journal of clinical investigation	2004	783
16374858	11450	Schattenberg JM	JNK1 but not JNK2 promotes the development of steatohepatitis in mice.	Hepatology	2006	109
16374859	11450	Ding X	Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.	Hepatology	2006	87
17476695	11450	Yamaguchi K	Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.	Hepatology	2007	180
17569885	11450	Itoh M	Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects.	Arteriosclerosis, thrombosis, and vascular biology	2007	59
17717599	11450	Kim JY	Obesity-associated improvements in metabolic profile through expansion of adipose tissue.	The Journal of clinical investigation	2007	371
19168697	11450	Medoff BD	Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling.	American journal of respiratory cell and molecular biology	2009	59
19211925	11450	González-Périz A	Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.	FASEB journal 	2009	136
19447867	11450	Landskroner-Eiger S	Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.	Clinical cancer research 	2009	54
20007851	11450	Shen Z	Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.	American journal of physiology. Gastrointestinal and liver physiology	2010	56
20858684	11450	Duval C	Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice.	Diabetes	2010	51
21041950	11450	Denzel MS	T-cadherin is critical for adiponectin-mediated cardioprotection in mice.	The Journal of clinical investigation	2010	71
21256905	11450	Xu J	Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK.	Journal of hepatology	2011	45
21462320	11450	Kobori M	Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice.	Molecular nutrition and food research	2011	41
21723971	11450	Krings A	Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes.	Bone	2012	57
21921143	11450	Declèves AE	AMPK mediates the initiation of kidney disease induced by a high-fat diet.	Journal of the American Society of Nephrology 	2011	52
22156343	11450	Konter JM	Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation.	Journal of immunology	2012	32
22457829	11450	Lam YY	Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice.	PloS one	2012	74
22863618	11450	Schipper HS	Natural killer T cells in adipose tissue prevent insulin resistance.	The Journal of clinical investigation	2012	48
23334396	11450	Rutkowski JM	Adiponectin promotes functional recovery after podocyte ablation.	Journal of the American Society of Nephrology 	2013	30
23524376	11450	Guo R	Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy.	Biochimica et biophysica acta	2013	31
23562077	11450	Mansuy-Aubert V	Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure.	Cell metabolism	2013	31
23832548	11450	Wan J	M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.	Hepatology	2014	63
23963681	11450	Seldin MM	Metabolic function of the CTRP family of hormones.	Reviews in endocrine and metabolic disorders	2014	24
24998914	11450	Cawthorn WP	Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction.	Cell metabolism	2014	64
25331877	11450	Yau SY	Physical exercise-induced hippocampal neurogenesis and antidepressant effects are mediated by the adipocyte hormone adiponectin.	Proceedings of the National Academy of Sciences of the United States of America	2014	26
25339419	11450	Ye R	Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes β-cell regeneration.	eLife	2014	21
25504959	11450	Marangoni RG	Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.	Arthritis and rheumatology	2015	26
25794851	11450	Lin Z	Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.	Circulation	2015	16
26581599	11450	Gavin KM	De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissue.	FASEB journal 	2016	10
10375497	11475	Hellström M	Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse.	Development	1999	334
15389867	11475	Magness ST	A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.	Hepatology	2004	71
17106243	11475	Sugimoto H	Identification of fibroblast heterogeneity in the tumor microenvironment.	Cancer biology and therapy	2006	150
19085956	11475	Asahina K	Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development.	Hepatology	2009	55
19640900	11475	Pang M	Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.	American journal of physiology. Renal physiology	2009	57
20395557	11475	Pandit KV	Inhibition and role of let-7d in idiopathic pulmonary fibrosis.	American journal of respiratory and critical care medicine	2010	142
21316604	11475	Quante M	Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.	Cancer cell	2011	211
21520179	11475	Chu AS	Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis.	Hepatology	2011	63
21798245	11475	Sekiya Y	Suppression of hepatic stellate cell activation by microRNA-29b.	Biochemical and biophysical research communications	2011	46
21984612	11475	Mihira H	TGF-β-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A.	Journal of biochemistry	2012	31
22266908	11475	Elliott CG	Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair.	Journal of cell science	2012	31
22302193	11475	Ding H	Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis.	Journal of the American Society of Nephrology 	2012	50
22362908	11475	Liu N	Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.	Journal of the American Society of Nephrology 	2012	37
23342059	11475	Liu N	Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.	PloS one	2013	38
23817022	11475	LeBleu VS	Origin and function of myofibroblasts in kidney fibrosis.	Nature medicine	2013	199
23833260	11475	Yang J	Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis.	Journal of the American Society of Nephrology 	2013	26
24706986	11475	Haak AJ	Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.	The Journal of pharmacology and experimental therapeutics	2014	21
25356754	11475	Wang J	microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.	Oncotarget	2015	25
28079129	11475	Tang CM	CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts.	Scientific reports	2017	7
9308963	11545	Wang ZQ	PARP is important for genomic stability but dispensable in apoptosis.	Genes and development	1997	117
9334719	11545	Eliasson MJ	Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia.	Nature medicine	1997	169
14523042	11545	Du X	Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.	The Journal of clinical investigation	2003	146
15689952	11545	McCullough LD	Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection.	Journal of cerebral blood flow and metabolism 	2005	115
15829966	11545	Bryant HE	Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.	Nature	2005	911
16267234	11545	Culmsee C	Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia.	The Journal of neuroscience 	2005	85
16627622	11545	Kauppinen TM	Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2.	Proceedings of the National Academy of Sciences of the United States of America	2006	68
17919258	11545	Pacher P	Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.	Cardiovascular drug reviews	2007	64
18971340	11545	Rottenberg S	High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs.	Proceedings of the National Academy of Sciences of the United States of America	2008	190
19268668	11545	Yuan M	Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke.	Experimental neurology	2009	56
19969072	11545	Mukhopadhyay P	Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.	Free radical biology and medicine	2010	52
20460994	11545	Liang G	Isoflurane causes greater neurodegeneration than an equivalent exposure of sevoflurane in the developing brain of neonatal mice.	Anesthesiology	2010	44
20493163	11545	Hwang JW	Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD.	Archives of biochemistry and biophysics	2010	48
20590569	11545	Mukhopadhyay P	CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.	British journal of pharmacology	2010	41
20924112	11545	Chan N	Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment.	Cancer research	2010	41
21681448	11545	Speyer CL	Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.	Breast cancer research and treatment	2012	35
22158865	11545	Patel AG	Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.	The Journal of biological chemistry	2012	32
22287547	11545	Brenner JC	PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma.	Cancer research	2012	56
22923475	11545	Li G	Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice.	Diabetes	2012	31
23582862	11545	Xu W	Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.	Biomaterials	2013	30
23974709	11545	Lee Y	Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss.	Nature neuroscience	2013	26
24854277	11545	Ying Y	Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury.	Journal of the American Society of Nephrology 	2014	20
24885920	11545	Zhang L	microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer.	Molecular cancer	2014	22
25440059	11545	Scheibye-Knudsen M	A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome.	Cell metabolism	2014	39
25642963	11545	Ceccaldi R	Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.	Nature	2015	79
25995442	11545	Liu G	Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.	Journal of the National Cancer Institute	2015	18
12671045	11596	Sakaguchi T	Central role of RAGE-dependent neointimal expansion in arterial restenosis.	The Journal of clinical investigation	2003	87
15457210	11596	Arancio O	RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice.	The EMBO journal	2004	90
18079965	11596	Harja E	Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.	The Journal of clinical investigation	2008	120
18208974	11596	Gebhardt C	RAGE signaling sustains inflammation and promotes tumor development.	The Journal of experimental medicine	2008	107
18245812	11596	Englert JM	A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis.	The American journal of pathology	2008	70
18511846	11596	Soro-Paavonen A	Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.	Diabetes	2008	95
18689872	11596	Turovskaya O	RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis.	Carcinogenesis	2008	80
18701698	11596	Hickman SE	Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.	The Journal of neuroscience 	2008	236
19218854	11596	van Zoelen MA	Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.	Shock	2009	84
19890065	11596	Qin YH	HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.	Journal of immunology	2009	46
19906677	11596	Fang F	RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.	FASEB journal 	2010	52
20627935	11596	Reiniger N	Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse.	Diabetes	2010	44
21270403	11596	Yamamoto Y	Septic shock is associated with receptor for advanced glycation end products ligation of LPS.	Journal of immunology	2011	37
22406537	11596	Deane R	A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.	The Journal of clinical investigation	2012	83
22470535	11596	Källberg E	S100A9 interaction with TLR4 promotes tumor growth.	PloS one	2012	34
22615109	11596	Carnevale D	Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.	Hypertension	2012	32
22915134	11596	Okuma Y	Anti-high mobility group box-1 antibody therapy for traumatic brain injury.	Annals of neurology	2012	36
24506934	11596	Ullah MA	Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.	The Journal of allergy and clinical immunology	2014	25
12361603	11600	Gale NW	Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.	Developmental cell	2002	222
17615264	11600	Wu Y	Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.	Stem cells	2007	308
18213733	11600	Xu J	Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice.	The Journal of pathology	2008	64
18316578	11600	Fernando NT	Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.	Clinical cancer research 	2008	53
18823985	11600	Taura K	Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.	Gastroenterology	2008	62
21606590	11600	Jeansson M	Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.	The Journal of clinical investigation	2011	97
24009238	11600	Dessapt-Baradez C	Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.	Journal of the American Society of Nephrology 	2014	21
11606482	11606	Massiéra F	Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.	FASEB journal 	2001	89
12855482	11606	Saraff K	Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2003	110
15192025	11606	Zimmerman MC	Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.	Circulation research	2004	149
17977949	11606	Brezniceanu ML	Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells.	Diabetes	2008	54
18025412	11606	Santos SH	Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism.	Diabetes	2008	52
18495795	11606	Crowley SD	Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension.	American journal of physiology. Renal physiology	2008	55
18579707	11606	Gonzalez-Villalobos RA	Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice.	American journal of physiology. Renal physiology	2008	55
19608970	11606	Police SB	Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation.	Arteriosclerosis, thrombosis, and vascular biology	2009	60
20088827	11606	Daugherty A	Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.	Clinical science	2010	56
20147609	11606	Crowley SD	Lymphocyte responses exacerbate angiotensin II-dependent hypertension.	American journal of physiology. Regulatory, integrative and comparative physiology	2010	60
20488188	11606	Haudek SB	Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.	Journal of molecular and cellular cardiology	2010	55
20676904	11606	Marsh SA	Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.	Amino acids	2011	38
21785215	11606	Swaminathan PD	Oxidized CaMKII causes cardiac sinus node dysfunction in mice.	The Journal of clinical investigation	2011	74
22269326	11606	Maegdefessel L	Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development.	The Journal of clinical investigation	2012	68
22518004	11606	Matsusaka T	Liver angiotensinogen is the primary source of renal angiotensin II.	Journal of the American Society of Nephrology 	2012	62
23064361	11606	Young CN	ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension.	The Journal of clinical investigation	2012	57
23333075	11606	Cortez-Retamozo V	Angiotensin II drives the production of tumor-promoting macrophages.	Immunity	2013	32
23942363	11606	Toth P	Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension.	Journal of cerebral blood flow and metabolism 	2013	38
24718617	11606	Li L	Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.	PloS one	2014	20
25664851	11606	Saleh MA	Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation.	The Journal of clinical investigation	2015	31
25898844	11606	Lorenzen JM	Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis.	European heart journal	2015	17
25920959	11606	Faraco G	Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP.	Journal of cerebral blood flow and metabolism 	2016	12
7732381	11622	Fernandez-Salguero P	Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor.	Science	1995	196
8692887	11622	Schmidt JV	Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development.	Proceedings of the National Academy of Sciences of the United States of America	1996	202
8806883	11622	Fernandez-Salguero PM	Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity.	Toxicology and applied pharmacology	1996	121
10639156	11622	Shimizu Y	Benzoapyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor.	Proceedings of the National Academy of Sciences of the United States of America	2000	94
17322371	11622	Thatcher TH	Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB.	The American journal of pathology	2007	72
18362914	11622	Veldhoen M	The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins.	Nature	2008	398
18560532	11622	Arsenescu V	Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis.	Environmental health perspectives	2008	77
19651607	11622	Kawajiri K	Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands.	Proceedings of the National Academy of Sciences of the United States of America	2009	53
20174617	11622	Kerkvliet NI	Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.	Immunotherapy	2009	48
20706985	11622	Ramirez JM	Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells.	European journal of immunology	2010	46
20855496	11622	Simonian PL	γδ T cells protect against lung fibrosis via IL-22.	The Journal of experimental medicine	2010	71
21600206	11622	Monteleone I	Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.	Gastroenterology	2011	75
21858153	11622	Singh NP	Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis.	PloS one	2011	58
22101730	11622	Lee JS	AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch.	Nature immunology	2011	149
22177117	11622	Qiu J	The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells.	Immunity	2012	135
23200827	11622	Basu R	Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria.	Immunity	2012	95
23954130	11622	Qiu J	Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora.	Immunity	2013	80
24154488	11622	Pierre S	Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin.	Toxicological sciences 	2014	23
24244565	11622	Duarte JH	Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo.	PloS one	2013	28
24302727	11622	Vogel CF	Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-κB.	The Journal of biological chemistry	2014	35
24909886	11622	Di Meglio P	Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions.	Immunity	2014	36
27158904	11622	Lamas B	CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands.	Nature medicine	2016	37
10673259	11651	Fujio Y	Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart.	Circulation	2000	192
11485901	11651	Sun M	AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells.	The American journal of pathology	2001	102
11544177	11651	Chen WS	Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.	Genes and development	2001	253
11733558	11651	Bernal-Mizrachi E	Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia.	The Journal of clinical investigation	2001	127
11909972	11651	Shioi T	Akt/protein kinase B promotes organ growth in transgenic mice.	Molecular and cellular biology	2002	124
11943770	11651	Matsui T	Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart.	The Journal of biological chemistry	2002	128
12086888	11651	Orsulic S	Induction of ovarian cancer by defined multiple genetic changes in a mouse model system.	Cancer cell	2002	102
12097282	11651	Lokker NA	Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.	Cancer research	2002	82
12237475	11651	Condorelli G	Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	122
12782654	11651	Peng XD	Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.	Genes and development	2003	243
12799464	11651	Majumder PK	Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model.	Proceedings of the National Academy of Sciences of the United States of America	2003	99
14656927	11651	Wilkins BJ	Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.	Circulation research	2004	234
14760102	11651	Ciardiello F	Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.	Clinical cancer research 	2004	72
14981233	11651	Schubert M	Role for neuronal insulin resistance in neurodegenerative diseases.	Proceedings of the National Academy of Sciences of the United States of America	2004	139
15029198	11651	Wendel HG	Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.	Nature	2004	273
15033922	11651	Ho L	Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.	FASEB journal 	2004	144
15126356	11651	Hutchinson JN	Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.	Cancer research	2004	77
15485899	11651	Lai KM	Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy.	Molecular and cellular biology	2004	108
15817707	11651	Wesche DE	Leukocyte apoptosis and its significance in sepsis and shock.	Journal of leukocyte biology	2005	80
16007214	11651	Xu Q	Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.	Oncogene	2005	139
16075055	11651	Shiojima I	Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.	The Journal of clinical investigation	2005	257
16075056	11651	Ackah E	Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis.	The Journal of clinical investigation	2005	140
16288295	11651	Cheng JQ	The Akt/PKB pathway: molecular target for cancer drug discovery.	Oncogene	2005	125
16453021	11651	Anitha M	GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway.	The Journal of clinical investigation	2006	73
16636172	11651	DeBosch B	Akt1 is required for physiological cardiac growth.	Circulation	2006	143
16778075	11651	Chen ML	The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice.	Genes and development	2006	95
16877357	11651	Adhami F	Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy.	The American journal of pathology	2006	87
16965940	11651	Noiseux N	Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.	Molecular therapy 	2006	117
16966610	11651	Hiroi Y	Rapid nongenomic actions of thyroid hormone.	Proceedings of the National Academy of Sciences of the United States of America	2006	78
17045205	11651	Skeen JE	Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner.	Cancer cell	2006	83
17082322	11651	Sin SH	Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.	Blood	2007	65
17210696	11651	Maroulakou IG	Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.	Cancer research	2007	103
17258729	11651	Yan F	Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth.	Gastroenterology	2007	159
17460049	11651	Ju X	Akt1 governs breast cancer progression in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2007	80
17504973	11651	Aarabi S	Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis.	FASEB journal 	2007	68
17891174	11651	Ma S	CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.	Oncogene	2008	198
17965779	11651	Li HH	Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.	The Journal of clinical investigation	2007	88
17974583	11651	Spangenburg EE	A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy.	The Journal of physiology	2008	67
18054314	11651	Fernández-Hernando C	Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease.	Cell metabolism	2007	94
18182616	11651	Baba M	Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.	Journal of the National Cancer Institute	2008	76
18292230	11651	Dickey CA	Akt and CHIP coregulate tau degradation through coordinated interactions.	Proceedings of the National Academy of Sciences of the United States of America	2008	64
18583310	11651	Yung HW	Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction.	The American journal of pathology	2008	89
18617895	11651	Yuan M	Yes-associated protein (YAP) functions as a tumor suppressor in breast.	Cell death and differentiation	2008	70
18718903	11651	Ouchi N	Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism.	The Journal of biological chemistry	2008	76
19151200	11651	Noyan-Ashraf MH	GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.	Diabetes	2009	109
19491266	11651	Dillon RL	Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.	Cancer research	2009	53
19759331	11651	Morissette MR	Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt.	American journal of physiology. Cell physiology	2009	47
19850877	11651	Hasumi Y	Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2.	Proceedings of the National Academy of Sciences of the United States of America	2009	78
19965668	11651	Peng C	PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice.	Blood	2010	43
20007913	11651	Durgan DJ	Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock.	Circulation research	2010	49
20008787	11651	Kharas MG	Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice.	Blood	2010	81
20068149	11651	Novosyadlyy R	Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.	Cancer research	2010	89
20198336	11651	Zhang J	miR-221/222 promote malignant progression of glioma through activation of the Akt pathway.	International journal of oncology	2010	44
20424120	11651	Dillon RL	Distinct biological roles for the akt family in mammary tumor progression.	Cancer research	2010	57
20530718	11651	Fritz V	Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.	Molecular cancer therapeutics	2010	43
20708588	11651	Ashton GH	Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling.	Developmental cell	2010	54
20709750	11651	Wijesekara N	Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion.	The Journal of biological chemistry	2010	40
20951698	11651	Lombardo Y	Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.	Gastroenterology	2011	46
20980833	11651	Vucicevic L	Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway.	Autophagy	2011	37
21350002	11651	Boreddy SR	Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.	Clinical cancer research 	2011	44
21387290	11651	Urakawa H	Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.	International journal of cancer	2012	32
21460223	11651	Jimenez S	Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model.	The Journal of biological chemistry	2011	37
21709230	11651	Soltani N	GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2011	53
21744257	11651	Ogunwobi OO	Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways.	Clinical and experimental metastasis	2011	39
21775285	11651	Sundaresan NR	The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy.	Science signaling	2011	75
21901288	11651	Hua Y	Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy.	Basic research in cardiology	2011	49
21993994	11651	Ho C	AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.	Hepatology	2012	49
22237406	11651	Odusanwo O	Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation.	American journal of physiology. Cell physiology	2012	30
22308314	11651	Conley SJ	Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.	Proceedings of the National Academy of Sciences of the United States of America	2012	142
22446186	11651	Selvaraj S	Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.	The Journal of clinical investigation	2012	32
22505453	11651	Nacerddine K	Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer.	The Journal of clinical investigation	2012	41
22622501	11651	Zhou D	Tubule-specific ablation of endogenous β-catenin aggravates acute kidney injury in mice.	Kidney international	2012	33
22689977	11651	Jo H	Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death.	Proceedings of the National Academy of Sciences of the United States of America	2012	36
22797301	11651	Fan B	Cholangiocarcinomas can originate from hepatocytes in mice.	The Journal of clinical investigation	2012	79
22826565	11651	Zeng Z	Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment.	Blood	2012	35
22927428	11651	El Kebir D	Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2012	52
23085755	11651	Huang WH	Mesenchymal stem cells promote growth and angiogenesis of tumors in mice.	Oncogene	2013	37
23125220	11651	Zhang LY	MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.	Carcinogenesis	2013	47
23335250	11651	Osuka S	IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells.	Stem cells	2013	29
23513069	11651	Wei Y	The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis.	Circulation	2013	40
23686362	11651	Sandri M	Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway.	Biogerontology	2013	47
23901824	11651	Andres AM	Mitophagy is required for acute cardioprotection by simvastatin.	Antioxidants and redox signaling	2014	33
23926267	11651	Zhu Z	Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance.	The Journal of neuroscience 	2013	35
24056770	11651	Canaud G	AKT2 is essential to maintain podocyte viability and function during chronic kidney disease.	Nature medicine	2013	41
24067903	11651	Shukla S	Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.	Carcinogenesis	2014	21
24335962	11651	Chin YR	Targeting Akt3 signaling in triple-negative breast cancer.	Cancer research	2014	21
24488013	11651	Miao H	EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.	Oncogene	2015	26
24490809	11651	Zeng Y	The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms.	Cardiovascular diabetology	2014	22
24587182	11651	Di Martino MT	In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma.	PloS one	2014	22
24667640	11651	Koga T	CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.	The Journal of clinical investigation	2014	28
24670654	11651	Liu P	Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus.	Nature	2014	64
24825302	11651	Chang RM	MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.	Hepatology	2014	31
24957076	11651	Fuentes-Mattei E	Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer.	Journal of the National Cancer Institute	2014	28
25428912	11651	Chen H	Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A.	Oncotarget	2014	30
25432172	11651	Crompton JG	Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.	Cancer research	2015	38
25617127	11651	Chen CL	Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.	Biomaterials	2015	35
25788687	11651	Sun J	Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.	The Journal of neuroscience 	2015	16
25826666	11651	Zhao C	miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.	RNA biology	2015	16
25913858	11651	Mukai J	Molecular substrates of altered axonal growth and brain connectivity in a mouse model of schizophrenia.	Neuron	2015	16
26107252	11651	Wilson JE	Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt.	Nature medicine	2015	26
26194913	11651	Yang WJ	Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis.	EMBO molecular medicine	2015	21
26224873	11651	Arqués O	Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.	Clinical cancer research 	2016	12
26476289	11651	Li L	Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.	Journal of hepatology	2016	11
26589417	11651	Li WF	Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.	Tumour biology 	2016	11
26857837	11651	Hu J	Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.	Scientific reports	2016	11
26921108	11651	Larson-Casey JL	Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis.	Immunity	2016	14
27524110	11651	Ratsimandresy RA	The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway.	Cellular and molecular immunology	2017	11
12414638	11747	Ran S	Increased exposure of anionic phospholipids on the surface of tumor blood vessels.	Cancer research	2002	85
19401262	11747	Lima LG	Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner.	Cancer letters	2009	49
24525732	11747	Kang SU	Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species.	Cell death and disease	2014	29
9506519	11789	Takaku K	Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.	Cell	1998	118
12119409	11789	Kucherlapati M	Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression.	Proceedings of the National Academy of Sciences of the United States of America	2002	87
14758356	11789	Gupta RA	Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.	Nature medicine	2004	72
15563600	11789	Colnot S	Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.	Proceedings of the National Academy of Sciences of the United States of America	2004	75
16174748	11789	Yamada Y	Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2005	74
16880406	11789	Myung SJ	15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2006	87
16959882	11789	Sansom OJ	Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2006	62
17047044	11789	Muñoz NM	Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.	Cancer research	2006	65
17377531	11789	Sansom OJ	Myc deletion rescues Apc deficiency in the small intestine.	Nature	2007	201
17671182	11789	Ghaleb AM	Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.	Cancer research	2007	59
17942902	11789	Hinoi T	Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.	Cancer research	2007	99
18055444	11789	May R	Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice.	Stem cells	2008	108
18538487	11789	McCart AE	Apc mice: models, modifiers and mutants.	Pathology, research and practice	2008	57
20696900	11789	Poulogiannis G	PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
21876161	11789	Goodwin AC	Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2011	46
21889923	11789	Sato T	Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.	Gastroenterology	2011	285
24264992	11789	Vermeulen L	Defining stem cell dynamics in models of intestinal tumor initiation.	Science	2013	78
16625204	11793	Hara T	Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice.	Nature	2006	1006
17450150	11793	Nakai A	The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress.	Nature medicine	2007	380
18188005	11793	Miller BC	The autophagy gene ATG5 plays an essential role in B lymphocyte development.	Autophagy	2008	110
18591426	11793	Hashimoto D	Involvement of autophagy in trypsinogen activation within the pancreatic acinar cells.	The Journal of cell biology	2008	65
18849966	11793	Cadwell K	A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells.	Nature	2008	408
18996346	11793	Zhao Z	Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens.	Cell host and microbe	2008	154
19115482	11793	Rodríguez-Hernández A	Coenzyme Q deficiency triggers mitochondria degradation by mitophagy.	Autophagy	2009	60
19139628	11793	Cadwell K	A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn disease.	Autophagy	2009	52
19182537	11793	Aguib Y	Autophagy induction by trehalose counteracts cellular prion infection.	Autophagy	2009	52
20075199	11793	Jiang M	Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury.	The American journal of pathology	2010	95
20171125	11793	Lee HK	In vivo requirement for Atg5 in antigen presentation by dendritic cells.	Immunity	2010	148
20200449	11793	Hartleben B	Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice.	The Journal of clinical investigation	2010	159
20431347	11793	Taneike M	Inhibition of autophagy in the heart induces age-related cardiomyopathy.	Autophagy	2010	76
21493778	11793	Kimura T	Autophagy protects the proximal tubule from degeneration and acute ischemic injury.	Journal of the American Society of Nephrology 	2011	89
21746920	11793	Parkhitko A	Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent.	Proceedings of the National Academy of Sciences of the United States of America	2011	73
21810913	11793	Noman MZ	Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression.	Cancer research	2011	38
22240484	11793	Hernández-Gea V	Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.	Gastroenterology	2012	95
22440612	11793	Razani B	Autophagy links inflammasomes to atherosclerotic progression.	Cell metabolism	2012	89
22445600	11793	Liao X	Macrophage autophagy plays a protective role in advanced atherosclerosis.	Cell metabolism	2012	109
22491424	11793	Ni HM	Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury.	Toxicological sciences 	2012	43
22520467	11793	Hwang S	Nondegradative role of Atg5-Atg12/ Atg16L1 autophagy protein complex in antiviral activity of interferon gamma.	Cell host and microbe	2012	63
22617445	11793	Liu S	Autophagy plays a critical role in kidney tubule maintenance, aging and ischemia-reperfusion injury.	Autophagy	2012	49
22863802	11793	Chong A	Cytosolic clearance of replication-deficient mutants reveals Francisella tularensis interactions with the autophagic pathway.	Autophagy	2012	34
23327930	11793	Conway KL	ATG5 regulates plasma cell differentiation.	Autophagy	2013	33
23461901	11793	Selvakumaran M	Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy.	Clinical cancer research 	2013	35
23800795	11793	Zhang X	Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance.	Autophagy	2013	51
23851366	11793	Castillo K	Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons.	Autophagy	2013	56
24092929	11793	Yamahara K	Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions.	Journal of the American Society of Nephrology 	2013	36
24305049	11793	Rosenfeldt MT	p53 status determines the role of autophagy in pancreatic tumour development.	Nature	2013	132
24445999	11793	Rao S	A dual role for autophagy in a murine model of lung cancer.	Nature communications	2014	77
24815875	11793	Ni HM	Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy.	Journal of hepatology	2014	28
25406339	11793	Kawakami T	Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.	Journal of the American Society of Nephrology 	2015	23
25497209	11793	Diakopoulos KN	Impaired autophagy induces chronic atrophic pancreatitis in mice via sex- and nutrition-dependent processes.	Gastroenterology	2015	17
25526090	11793	Tian Y	Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis.	Cell death and differentiation	2015	18
25550510	11793	López-Vicario C	Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.	Proceedings of the National Academy of Sciences of the United States of America	2015	16
25789971	11793	Ghavami S	Autophagy is a regulator of TGF-β1-induced fibrogenesis in primary human atrial myofibroblasts.	Cell death and disease	2015	20
26061908	11793	Lodder J	Macrophage autophagy protects against liver fibrosis in mice.	Autophagy	2015	16
26325539	11793	Ilyas G	Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1β.	Journal of hepatology	2016	10
26649827	11793	Kimmey JM	Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection.	Nature	2015	33
26982722	11793	Ravindran R	The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation.	Nature	2016	17
27096368	11793	Martinez J	Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells.	Nature	2016	26
17804712	11799	Nakahara T	YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.	Cancer research	2007	113
18593936	11799	Chadalapaka G	Curcumin decreases specificity protein expression in bladder cancer cells.	Cancer research	2008	57
24440709	11799	Rauch A	Survivin and YM155: how faithful is the liaison?	Biochimica et biophysica acta	2014	34
26148234	11799	Hagenbuchner J	BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma.	Oncogene	2016	10
1411543	11816	Zhang SH	Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.	Science	1992	440
1423598	11816	Plump AS	Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.	Cell	1992	419
1584779	11816	Piedrahita JA	Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	1992	200
7667279	11816	Smith JD	Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.	Proceedings of the National Academy of Sciences of the United States of America	1995	131
8274468	11816	Nakashima Y	ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.	Arteriosclerosis and thrombosis 	1994	358
8274470	11816	Reddick RL	Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.	Arteriosclerosis and thrombosis 	1994	138
8656070	11816	Tangirala RK	Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.	Journal of lipid research	1995	117
9069289	11816	Suzuki H	A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection.	Nature	1997	214
9218423	11816	Sullivan PM	Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis.	The Journal of biological chemistry	1997	137
9598845	11816	Nakashima Y	Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.	Arteriosclerosis, thrombosis, and vascular biology	1998	152
9732872	11816	Boring L	Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.	Nature	1998	335
10190883	11816	Moulton KS	Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.	Circulation	1999	98
10430941	11816	Trigatti B	Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.	Proceedings of the National Academy of Sciences of the United States of America	1999	112
10521365	11816	Huber SA	Interleukin-6 exacerbates early atherosclerosis in mice.	Arteriosclerosis, thrombosis, and vascular biology	1999	98
10611368	11816	Bales KR	Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	1999	96
10694577	11816	Holtzman DM	Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2000	191
10841519	11816	Daugherty A	Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.	The Journal of clinical investigation	2000	292
10862788	11816	Shaw PX	Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.	The Journal of clinical investigation	2000	160
11113040	11816	Zhou X	Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice.	Circulation	2000	110
11120756	11816	Shibata M	Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.	The Journal of clinical investigation	2000	266
11282909	11816	von Hundelshausen P	RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.	Circulation	2001	86
11468208	11816	Kuhlencordt PJ	Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice.	Circulation	2001	126
11701621	11816	Mallat Z	Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.	Circulation research	2001	102
11714743	11816	Barry-Lane PA	p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice.	The Journal of clinical investigation	2001	117
11748108	11816	Xu XH	Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.	Circulation	2001	131
11839631	11816	Weis M	Statins have biphasic effects on angiogenesis.	Circulation	2002	113
11854128	11816	Li L	Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model.	Circulation	2002	83
12057992	11816	Chen J	In vivo imaging of proteolytic activity in atherosclerosis.	Circulation	2002	82
12147534	11816	Ballinger SW	Mitochondrial integrity and function in atherogenesis.	Circulation	2002	92
12370251	11816	Massberg S	A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation.	The Journal of experimental medicine	2002	120
12431986	11816	Yamauchi T	Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.	The Journal of biological chemistry	2003	169
12451010	11816	Bucciarelli LG	RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.	Circulation	2002	111
12483207	11816	Huo Y	Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.	Nature medicine	2003	180
12569158	11816	Lesnik P	Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.	The Journal of clinical investigation	2003	105
12600915	11816	Combadière C	Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.	Circulation	2003	116
12615675	11816	Kirii H	Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2003	131
12682294	11816	Moulton KS	Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2003	125
12860902	11816	Rauscher FM	Aging, progenitor cell exhaustion, and atherosclerosis.	Circulation	2003	134
12937153	11816	Davenport P	The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.	The American journal of pathology	2003	89
14744975	11816	Paul A	C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2004	71
15084661	11816	Kawarabayashi T	Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.	The Journal of neuroscience 	2004	90
15087308	11816	Meir KS	Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.	Arteriosclerosis, thrombosis, and vascular biology	2004	87
15124016	11816	Hu Y	Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice.	The Journal of clinical investigation	2004	128
15131116	11816	Lund G	DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E.	The Journal of biological chemistry	2004	74
15249654	11816	Michelsen KS	Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.	Proceedings of the National Academy of Sciences of the United States of America	2004	257
15345516	11816	Brånén L	Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice.	Arteriosclerosis, thrombosis, and vascular biology	2004	97
15372102	11816	Kobayashi T	Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.	The Journal of clinical investigation	2004	88
15567863	11816	Ricci R	Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.	Science	2004	80
15590644	11816	Hojjati MR	Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.	The Journal of biological chemistry	2005	66
15653572	11816	Kelly KA	Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.	Circulation research	2005	111
15761195	11816	Zernecke A	SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells.	Circulation research	2005	81
15772340	11816	Fryer JD	Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.	The Journal of neuroscience 	2005	95
15788759	11816	Lim GP	A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.	The Journal of neuroscience 	2005	124
15809369	11816	Zhou J	Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice.	Circulation	2005	92
15815632	11816	Steffens S	Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.	Nature	2005	99
16075060	11816	Moore KJ	Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.	The Journal of clinical investigation	2005	118
16079201	11816	Malek G	Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2005	80
16221765	11816	Johnson JL	Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.	Proceedings of the National Academy of Sciences of the United States of America	2005	90
16374516	11816	Gough PJ	Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice.	The Journal of clinical investigation	2006	99
16414948	11816	Sun Q	Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model.	JAMA	2005	183
16682495	11816	Galkina E	Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent.	The Journal of experimental medicine	2006	141
16741184	11816	Stoll G	Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.	Stroke	2006	89
16801460	11816	Deguchi JO	Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.	Circulation	2006	96
16801531	11816	Swirski FK	Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease.	Proceedings of the National Academy of Sciences of the United States of America	2006	102
16840715	11816	Bennett BJ	Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.	Arteriosclerosis, thrombosis, and vascular biology	2006	67
16862155	11816	Wong CW	Connexin37 protects against atherosclerosis by regulating monocyte adhesion.	Nature medicine	2006	70
16892061	11816	Clarke MC	Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis.	Nature medicine	2006	135
17215360	11816	Amirbekian V	Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.	Proceedings of the National Academy of Sciences of the United States of America	2007	112
17224478	11816	Aikawa E	Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease.	Circulation	2007	111
17272749	11816	Mor A	Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2007	63
17322176	11816	Stoneman V	Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques.	Circulation research	2007	72
17420349	11816	Lewis P	Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.	Circulation	2007	67
17420353	11816	Jaffer FA	Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.	Circulation	2007	71
17431486	11816	Li Z	Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes.	Environmental health perspectives	2007	56
17470698	11816	Bot I	Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice.	Circulation	2007	63
17657314	11816	Bradley MN	Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.	The Journal of clinical investigation	2007	83
17916769	11816	Sukhanov S	IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2007	58
17942401	11816	Cao D	Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease.	The Journal of biological chemistry	2007	83
17991882	11816	Zernecke A	Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis.	Circulation research	2008	82
18040026	11816	Aikawa E	Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo.	Circulation	2007	133
18155324	11816	Vitek MP	APOE genotype-specific differences in the innate immune response.	Neurobiology of aging	2009	79
18158358	11816	Nahrendorf M	Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis.	Circulation	2008	152
18165355	11816	Saederup N	Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis.	Circulation	2008	64
18202315	11816	Araujo JA	Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress.	Circulation research	2008	121
18212290	11816	Ohman MK	Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2008	51
18268038	11816	Miller AM	IL-33 reduces the development of atherosclerosis.	The Journal of experimental medicine	2008	149
18309100	11816	Ryoo S	Endothelial arginase II: a novel target for the treatment of atherosclerosis.	Circulation research	2008	73
18541740	11816	Briley-Saebo KC	Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.	Circulation	2008	55
18549781	11816	Jiang Q	ApoE promotes the proteolytic degradation of Abeta.	Neuron	2008	240
18689793	11816	Zhang QJ	Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice.	Cardiovascular research	2008	89
18948635	11816	Manning-Tobin JJ	Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice.	Arteriosclerosis, thrombosis, and vascular biology	2009	79
18988885	11816	Wang Y	Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.	Arteriosclerosis, thrombosis, and vascular biology	2009	60
19015167	11816	States JC	Arsenic and cardiovascular disease.	Toxicological sciences 	2009	71
19046569	11816	Gareus R	Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.	Cell metabolism	2008	95
19416717	11816	Thorp E	Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP.	Cell metabolism	2009	114
19430489	11816	Satoh K	Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms.	Nature medicine	2009	69
19433759	11816	Wu H	Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia.	Circulation	2009	80
19487682	11816	Peters D	Targeting atherosclerosis by using modular, multifunctional micelles.	Proceedings of the National Academy of Sciences of the United States of America	2009	59
19620505	11816	Croce K	Myeloid-related protein-8/14 is critical for the biological response to vascular injury.	Circulation	2009	62
19667236	11816	Norata GD	Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis.	Circulation	2009	67
19836260	11816	Xie JJ	The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice.	Cytokine	2010	46
19837950	11816	Judkins CP	Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice.	American journal of physiology. Heart and circulatory physiology	2010	87
19897196	11816	Jun J	Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice.	Atherosclerosis	2010	51
19951691	11816	Li G	GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice.	Cell stem cell	2009	57
20068138	11816	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	96
20100871	11816	Lutgens E	Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.	The Journal of experimental medicine	2010	57
20111605	11816	Khallou-Laschet J	Macrophage plasticity in experimental atherosclerosis.	PloS one	2010	139
20651282	11816	Tsukano H	The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques.	Arteriosclerosis, thrombosis, and vascular biology	2010	48
20668118	11816	Cormode DP	Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles.	Radiology	2010	78
20817865	11816	Kyaw T	Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.	Journal of immunology	2010	62
20947824	11816	Skoura A	Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2011	39
20947826	11816	Barajas B	NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection.	Arteriosclerosis, thrombosis, and vascular biology	2011	35
21041949	11816	Feig JE	LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression.	The Journal of clinical investigation	2010	47
21118811	11816	Chen HK	Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease.	The Journal of biological chemistry	2011	36
21356305	11816	Drake C	Brain inflammation is induced by co-morbidities and risk factors for stroke.	Brain, behavior, and immunity	2011	53
21451572	11816	Menu P	Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome.	Cell death and disease	2011	45
21471207	11816	Nishitsuji K	Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.	The Journal of biological chemistry	2011	46
21474820	11816	Madhur MS	Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2011	59
21482781	11816	Feig JE	HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	86
21484785	11816	Freigang S	Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.	European journal of immunology	2011	48
21505265	11816	Potteaux S	Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.	The Journal of clinical investigation	2011	93
21699799	11816	Long G	Mouse hepatic cells support assembly of infectious hepatitis C virus particles.	Gastroenterology	2011	46
21715678	11816	Castellano JM	Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.	Science translational medicine	2011	229
21763672	11816	Rateri DL	Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm.	The American journal of pathology	2011	42
21868694	11816	Kyaw T	B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.	Circulation research	2011	68
22007077	11816	Shah Z	Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.	Circulation	2011	72
22116098	11816	Danzaki K	Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2012	39
22159114	11816	Kim J	Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-β amyloidosis.	The Journal of neuroscience 	2011	59
22194622	11816	Hanna RN	NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis.	Circulation research	2012	84
22210379	11816	Mercer JR	The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.	Free radical biology and medicine	2012	30
22302786	11816	Butcher MJ	The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment.	Circulation research	2012	41
22394519	11816	Döring Y	Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice.	Circulation research	2012	39
22469977	11816	Alikhani N	Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model.	Oncogene	2013	28
22622580	11816	Bell RD	Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.	Nature	2012	216
22763456	11816	Dutta P	Myocardial infarction accelerates atherosclerosis.	Nature	2012	163
22886300	11816	Koltsova EK	Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis.	The Journal of clinical investigation	2012	59
23041630	11816	Nazari-Jahantigh M	MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.	The Journal of clinical investigation	2012	82
23060451	11816	Youmans KL	APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease.	The Journal of biological chemistry	2012	53
23103162	11816	Kothapalli D	Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening.	Cell reports	2012	38
23224247	11816	Gorenne I	Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis.	Circulation	2013	38
23300273	11816	Majmudar MD	Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques.	Circulation research	2013	38
23337530	11816	Ervinna N	Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice.	Endocrinology	2013	30
23349247	11816	Riwanto M	Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.	Circulation	2013	50
23417922	11816	Soehnlein O	Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes.	EMBO molecular medicine	2013	26
23524964	11816	Martel C	Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice.	The Journal of clinical investigation	2013	52
23564668	11816	Gray SP	NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.	Circulation	2013	76
23620513	11816	Verghese PB	ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions.	Proceedings of the National Academy of Sciences of the United States of America	2013	82
23704552	11816	Fitz NF	Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".	Science	2013	55
24084690	11816	Sun X	Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice.	Circulation research	2014	50
24425713	11816	Knight JS	Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.	Circulation research	2014	40
24445279	11816	Duivenvoorden R	A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.	Nature communications	2014	47
24504735	11816	Du F	MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2014	29
24948358	11816	Rodriguez GA	Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.	Journal of neuroinflammation	2014	22
24990232	11816	Di Gregoli K	MicroRNA-24 regulates macrophage behavior and retards atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2014	20
25070003	11816	Feil S	Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis.	Circulation research	2014	53
25381879	11816	Butovsky O	Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.	Annals of neurology	2015	33
25552357	11816	Clement M	Control of the T follicular helper-germinal center B-cell axis by CD8⁺ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development.	Circulation	2015	16
25619653	11816	Chakrabarty P	IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.	Neuron	2015	51
25675483	11816	Han BH	Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.	Proceedings of the National Academy of Sciences of the United States of America	2015	24
25705917	11816	Yin Y	Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway.	Arteriosclerosis, thrombosis, and vascular biology	2015	20
25757756	11816	Halliday MR	Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.	Journal of cerebral blood flow and metabolism 	2016	35
25800955	11816	Dutta P	Macrophages retain hematopoietic stem cells in the spleen via VCAM-1.	The Journal of experimental medicine	2015	17
25801675	11816	Zhang Y	MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis.	Scientific reports	2015	18
26084025	11816	Hu D	Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin β Receptors.	Immunity	2015	23
26358260	11816	Sager HB	Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction.	Circulation	2015	17
26517696	11816	Chen PY	Endothelial-to-mesenchymal transition drives atherosclerosis progression.	The Journal of clinical investigation	2015	22
26686669	11816	Cacciottolo M	The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice.	Neurobiology of aging	2016	11
26699388	11816	Organ CL	Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure.	Circulation. Heart failure	2016	16
26715682	11816	Gray SP	Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.	Arteriosclerosis, thrombosis, and vascular biology	2016	15
26956647	11816	Ma S	E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis.	Scientific reports	2016	11
7845465	11820	Games D	Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.	Nature	1995	309
8816718	11820	Paresce DM	Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.	Neuron	1996	135
9037091	11820	Johnson-Wood K	Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	1997	170
9117892	11820	Borchelt DR	A vector for expressing foreign genes in the brains and hearts of transgenic mice.	Genetic analysis 	1996	119
9291938	11820	Irizarry MC	APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.	Journal of neuropathology and experimental neurology	1997	130
9354339	11820	Borchelt DR	Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.	Neuron	1997	224
9371838	11820	Sturchler-Pierrat C	Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.	Proceedings of the National Academy of Sciences of the United States of America	1997	259
9422548	11820	Frautschy SA	Microglial response to amyloid plaques in APPsw transgenic mice.	The American journal of pathology	1998	120
9427614	11820	Holcomb L	Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.	Nature medicine	1998	259
10037741	11820	Moechars D	Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain.	The Journal of biological chemistry	1999	135
10077666	11820	Hsia AY	Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.	Proceedings of the National Academy of Sciences of the United States of America	1999	271
10408445	11820	Schenk D	Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.	Nature	1999	574
10804202	11820	Kane MD	Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.	The Journal of neuroscience 	2000	97
11140684	11820	Chen G	A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.	Nature	2000	135
11140685	11820	Janus C	A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.	Nature	2000	300
11140686	11820	Morgan D	A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.	Nature	2000	335
11160418	11820	Kawarabayashi T	Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.	The Journal of neuroscience 	2001	299
11438712	11820	DeMattos RB	Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2001	272
11520987	11820	Lewis J	Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.	Science	2001	280
11700559	11820	Weggen S	A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.	Nature	2001	294
11880515	11820	Westerman MA	The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.	The Journal of neuroscience 	2002	183
12415125	11820	Selkoe DJ	Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics.	Annual review of pharmacology and toxicology	2003	170
12736345	11820	Wilcock DM	Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.	The Journal of neuroscience 	2003	86
12925731	11820	Gong Y	Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.	Proceedings of the National Academy of Sciences of the United States of America	2003	237
12930788	11820	Yan Q	Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.	The Journal of neuroscience 	2003	117
14523085	11820	Cirrito JR	In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.	The Journal of neuroscience 	2003	161
14687544	11820	Leissring MA	Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.	Neuron	2003	191
14985348	11820	Davis J	Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor.	The Journal of biological chemistry	2004	113
15115763	11820	Reddy PH	Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.	Human molecular genetics	2004	78
15174014	11820	Trinchese F	Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.	Annals of neurology	2004	77
15272267	11820	Ross CA	Protein aggregation and neurodegenerative disease.	Nature medicine	2004	529
15311281	11820	Herzig MC	Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.	Nature neuroscience	2004	102
15475691	11820	Moolman DL	Dendrite and dendritic spine alterations in Alzheimer models.	Journal of neurocytology	2004	74
15766532	11820	Lazarov O	Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice.	Cell	2005	177
15862213	11820	Song SK	Demyelination increases radial diffusivity in corpus callosum of mouse brain.	NeuroImage	2005	417
15917461	11820	Jankowsky JL	Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2005	94
16136043	11820	Singer O	Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.	Nature neuroscience	2005	109
16141783	11820	Morgan D	Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics.	Journal of neuropathology and experimental neurology	2005	65
16210396	11820	Caspersen C	Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.	FASEB journal 	2005	195
16282321	11820	Oddo S	Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology.	The Journal of biological chemistry	2006	116
16291932	11820	Klunk WE	Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.	The Journal of neuroscience 	2005	85
16298135	11820	Kim JH	Detecting axon damage in spinal cord from a mouse model of multiple sclerosis.	Neurobiology of disease	2006	68
16344143	11820	Wearne SL	New techniques for imaging, digitization and analysis of three-dimensional neural morphology on multiple scales.	Neuroscience	2005	102
16354928	11820	Laird FM	BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions.	The Journal of neuroscience 	2005	165
16365303	11820	Yue X	Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model.	Proceedings of the National Academy of Sciences of the United States of America	2005	80
16551656	11820	Manczak M	Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.	Human molecular genetics	2006	253
16554819	11820	Pastorino L	The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.	Nature	2006	130
16641106	11820	Galvan V	Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664.	Proceedings of the National Academy of Sciences of the United States of America	2006	97
16767098	11820	McLaurin J	Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model.	Nature medicine	2006	81
16806094	11820	Wolf SA	Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease.	Biological psychiatry	2006	67
16815330	11820	Salehi A	Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.	Neuron	2006	161
16864778	11820	Butovsky O	Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.	Proceedings of the National Academy of Sciences of the United States of America	2006	85
16943563	11820	Green KN	Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2006	126
17021169	11820	Oakley H	Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.	The Journal of neuroscience 	2006	418
17029828	11820	Garcia-Alloza M	Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.	Neurobiology of disease	2006	146
17056594	11820	Oddo S	Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles.	The Journal of biological chemistry	2006	104
17116235	11820	Lambert MP	Monoclonal antibodies that target pathological assemblies of Abeta.	Journal of neurochemistry	2007	104
17197420	11820	Shen J	The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2007	134
17368446	11820	Mac Donald CL	Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of traumatic brain injury.	Experimental neurology	2007	85
17549256	11820	Shaftel SS	Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology.	The Journal of clinical investigation	2007	115
17551515	11820	LaFerla FM	Intracellular amyloid-beta in Alzheimer's disease.	Nature reviews. Neuroscience	2007	386
17634375	11820	Ring S	The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice.	The Journal of neuroscience 	2007	115
17965777	11820	Wang J	Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.	The Journal of clinical investigation	2007	63
18055549	11820	Bolmont T	Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.	The American journal of pathology	2007	63
18218341	11820	Reddy PH	Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.	Trends in molecular medicine	2008	170
18410513	11820	Thirumangalakudi L	High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice.	Journal of neurochemistry	2008	62
18480253	11820	Muhammad A	Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation.	Proceedings of the National Academy of Sciences of the United States of America	2008	70
18486110	11820	Hirata-Fukae C	Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.	Brain research	2008	63
18497889	11820	Pickford F	The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.	The Journal of clinical investigation	2008	253
18562603	11820	Maier M	Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.	The Journal of neuroscience 	2008	83
18759972	11820	Lee JW	Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation.	Journal of neuroinflammation	2008	79
18955571	11820	Qing H	Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models.	The Journal of experimental medicine	2008	59
19151372	11820	Boissonneault V	Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.	Brain 	2009	72
19553447	11820	Puzzo D	Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model.	The Journal of neuroscience 	2009	52
19625751	11820	Francis YI	Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease.	Journal of Alzheimer's disease 	2009	53
19805389	11820	Smith DL	Reversal of long-term dendritic spine alterations in Alzheimer disease models.	Proceedings of the National Academy of Sciences of the United States of America	2009	70
19837693	11820	Ghosal K	Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
20071513	11820	Wesson DW	Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model.	The Journal of neuroscience 	2010	66
20164348	11820	Wu HY	Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation.	The Journal of neuroscience 	2010	127
20217279	11820	Eckert A	Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.	Molecular neurobiology	2010	40
20308787	11820	Li Y	GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.	Journal of Alzheimer's disease 	2010	61
20371804	11820	Tomiyama T	A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.	The Journal of neuroscience 	2010	113
20434528	11820	Dawson HN	Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.	Neuroscience	2010	49
20463404	11820	Dragicevic N	Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.	Journal of Alzheimer's disease 	2010	47
20471717	11820	Lee HJ	Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation.	Neurobiology of aging	2012	41
20547128	11820	Cortes-Canteli M	Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.	Neuron	2010	56
20632020	11820	Boche D	Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.	Acta neuropathologica	2010	41
20846376	11820	Lee DC	LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice.	Journal of neuroinflammation	2010	65
21040845	11820	Harris JA	Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.	Neuron	2010	89
21307267	11820	Yao J	Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2011	39
21436112	11820	Fodero-Tavoletti MT	18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.	Brain 	2011	63
21472769	11820	Puzzo D	Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory.	Annals of neurology	2011	59
21488093	11820	Umeda T	Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo.	Journal of neuroscience research	2011	53
21747957	11820	Yao J	2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.	PloS one	2011	36
21873260	11820	Calkins MJ	Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.	Human molecular genetics	2011	100
22037588	11820	Reddy PH	Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.	Biochimica et biophysica acta	2012	62
22047170	11820	Zhao J	The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.	Journal of neuroinflammation	2011	51
22492996	11820	Mao P	Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.	Human molecular genetics	2012	35
22539346	11820	Xiao Q	Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.	The Journal of biological chemistry	2012	35
22584394	11820	Biscaro B	Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease.	Neuro-degenerative diseases	2012	30
22642825	11820	Tweedie D	Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.	Journal of neuroinflammation	2012	43
22747753	11820	Krstic D	Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice.	Journal of neuroinflammation	2012	58
22884903	11820	Tyan SH	Amyloid precursor protein (APP) regulates synaptic structure and function.	Molecular and cellular neurosciences	2012	34
22915123	11820	Oulès B	Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.	The Journal of neuroscience 	2012	37
23365075	11820	Browne TC	IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.	Journal of immunology	2013	28
23820808	11820	Kandalepas PC	The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques.	Acta neuropathologica	2013	50
23973293	11820	McClean PL	Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.	Neuropharmacology	2014	31
24305823	11820	Kanekiyo T	Neuronal clearance of amyloid-β by endocytic receptor LRP1.	The Journal of neuroscience 	2013	43
24501359	11820	Vargas JY	In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer's disease model.	The Journal of neuroscience 	2014	24
24623762	11820	Born HA	Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease.	The Journal of neuroscience 	2014	29
24728269	11820	Saito T	Single App knock-in mouse models of Alzheimer's disease.	Nature neuroscience	2014	44
24899710	11820	Fowler SW	Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2014	24
25422493	11820	Roh JH	Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease.	The Journal of experimental medicine	2014	22
25619654	11820	Guillot-Sestier MV	Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.	Neuron	2015	41
25707991	11820	Kaufman AC	Fyn inhibition rescues established memory and synapse loss in Alzheimer mice.	Annals of neurology	2015	24
25853174	11820	Pooler AM	Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease.	Acta neuropathologica communications	2015	16
26549211	11820	Zhang Z	Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.	Nature communications	2015	15
15695511	11829	Papadopoulos MC	Aquaporin-4 gene disruption in mice reduces brain swelling and mortality in pneumococcal meningitis.	The Journal of biological chemistry	2005	71
16303850	11829	Saadoun S	Involvement of aquaporin-4 in astroglial cell migration and glial scar formation.	Journal of cell science	2005	115
16564496	11829	Verkman AS	Three distinct roles of aquaporin-4 in brain function revealed by knockout mice.	Biochimica et biophysica acta	2006	74
17347837	11829	Papadopoulos MC	Aquaporin-4 and brain edema.	Pediatric nephrology	2007	65
17928579	11829	Hinson SR	Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.	Neurology	2007	110
21298100	11829	Li SY	Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury.	PloS one	2011	37
21525279	11829	Skucas VA	Impairment of select forms of spatial memory and neurotrophin-dependent synaptic plasticity by deletion of glial aquaporin-4.	The Journal of neuroscience 	2011	36
22069219	11829	Zhang H	Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.	Annals of neurology	2011	49
22374891	11829	Saadoun S	Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.	Annals of neurology	2012	51
22378467	11829	Binder DK	Aquaporin-4 and epilepsy.	Glia	2012	33
22526022	11829	Ratelade J	Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.	Acta neuropathologica	2012	34
23055279	11829	Tradtrantip L	Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.	Annals of neurology	2013	26
23443171	11829	Ren Z	'Hit &amp;amp; Run' model of closed-skull traumatic brain injury (TBI) reveals complex patterns of post-traumatic AQP4 dysregulation.	Journal of cerebral blood flow and metabolism 	2013	38
23563310	11829	Zhang H	Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica.	The Journal of clinical investigation	2013	32
25204284	11829	Kress BT	Impairment of paravascular clearance pathways in the aging brain.	Annals of neurology	2014	76
7724580	11835	Greenberg NM	Prostate cancer in a transgenic mouse.	Proceedings of the National Academy of Sciences of the United States of America	1995	332
12370412	11835	Yeh S	Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues.	Proceedings of the National Academy of Sciences of the United States of America	2002	136
12372280	11835	Katsuno M	Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.	Neuron	2002	112
12692788	11835	Kaplan-Lefko PJ	Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.	The Prostate	2003	138
15107499	11835	Chang C	Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells.	Proceedings of the National Academy of Sciences of the United States of America	2004	101
15152038	11835	Chevalier-Larsen ES	Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy.	The Journal of neuroscience 	2004	71
16140970	11835	Zhou HJ	SRC-3 is required for prostate cancer cell proliferation and survival.	Cancer research	2005	77
16155577	11835	Waza M	17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.	Nature medicine	2005	115
17334372	11835	Yang Z	ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor.	Nature medicine	2007	56
17406000	11835	Miyamoto H	Promotion of bladder cancer development and progression by androgen receptor signals.	Journal of the National Cancer Institute	2007	96
17652515	11835	Wu CT	Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor.	Proceedings of the National Academy of Sciences of the United States of America	2007	71
18639551	11835	Ma WL	Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.	Gastroenterology	2008	55
19176467	11835	Wang RS	Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice.	Endocrine reviews	2009	63
22438320	11835	Germann M	Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.	Stem cells	2012	32
23499463	11835	Hsu JW	Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.	The American journal of pathology	2013	25
23817021	11835	Chen Y	ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.	Nature medicine	2013	80
23873027	11835	Chang C	Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver.	Oncogene	2014	37
23878190	11835	Fang LY	Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.	Cancer research	2013	28
24297183	11835	Sun F	Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors.	The Journal of biological chemistry	2014	30
25822367	11835	Malik R	Targeting the MLL complex in castration-resistant prostate cancer.	Nature medicine	2015	29
27232975	11835	DeRita RM	c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.	Journal of cellular biochemistry	2017	5
28059767	11835	Ku SY	Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.	Science	2017	11
11714822	11846	Hesse M	Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.	Journal of immunology	2001	198
15313928	11846	Rodriguez PC	Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.	Cancer research	2004	215
17200717	11846	Lumeng CN	Obesity induces a phenotypic switch in adipose tissue macrophage polarization.	The Journal of clinical investigation	2007	974
19228260	11846	Troidl C	Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction.	Journal of cellular and molecular medicine	2009	47
19360123	11846	Pesce JT	Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis.	PLoS pathogens	2009	219
20804550	11846	Veltman JD	COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.	BMC cancer	2010	52
21289217	11846	Lee S	Distinct macrophage phenotypes contribute to kidney injury and repair.	Journal of the American Society of Nephrology 	2011	195
22369693	11846	Guerrero AR	Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice.	Journal of neuroinflammation	2012	35
23023971	11846	Ionescu L	Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action.	American journal of physiology. Lung cellular and molecular physiology	2012	59
24492801	11846	Filbey KJ	Innate and adaptive type 2 immune cell responses in genetically controlled resistance to intestinal helminth infection.	Immunology and cell biology	2014	23
25201986	11846	Duque-Correa MA	Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
18083785	11848	Kolavennu V	Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.	Diabetes	2008	52
18794355	11848	Kong W	MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA.	Molecular and cellular biology	2008	217
21209320	11848	Jackson B	RhoA is dispensable for skin development, but crucial for contraction and directed migration of keratinocytes.	Molecular biology of the cell	2011	39
21266354	11848	Timpson P	Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53.	Cancer research	2011	40
22019888	11848	Negishi-Koga T	Suppression of bone formation by osteoclastic expression of semaphorin 4D.	Nature medicine	2011	66
22034008	11848	McDonald DA	Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.	Stroke	2012	32
22045984	11848	Pleines I	Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis.	Blood	2012	38
22278020	11848	Wang L	Mechanisms of the proteinuria induced by Rho GTPases.	Kidney international	2012	35
22397316	11848	Bowerman M	Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy.	BMC medicine	2012	32
26446958	11848	Le Gal K	Antioxidants can increase melanoma metastasis in mice.	Science translational medicine	2015	53
26661165	11848	Han X	Inhibition of prostaglandin E2 receptor EP3 mitigates thrombin-induced brain injury.	Journal of cerebral blood flow and metabolism 	2016	14
26690702	11848	Yu J	Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.	The Journal of clinical investigation	2016	12
8843194	11920	Xu Y	Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.	Genes and development	1996	224
8917548	11920	Elson A	Pleiotropic defects in ataxia-telangiectasia protein-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	1996	132
17136093	11920	Bartkova J	Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.	Nature	2006	560
18097482	11920	Maclean KH	Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.	The Journal of clinical investigation	2008	108
21368836	11920	Deriano L	The RAG2 C terminus suppresses genomic instability and lymphomagenesis.	Nature	2011	38
22797809	11920	Okuno Y	Pathological neoangiogenesis depends on oxidative stress regulation by ATM.	Nature medicine	2012	40
24162653	11920	Li J	EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia.	Nature neuroscience	2013	28
24366691	11920	Gil del Alcazar CR	Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma.	Clinical cancer research 	2014	27
25079327	11920	Santos MA	DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier.	Nature	2014	33
25818648	11920	Jiang W	Differential phosphorylation of DNA-PKcs regulates the interplay between end-processing and end-ligation during nonhomologous end-joining.	Molecular cell	2015	16
27732836	11920	Fang EF	NAD&lt;sup&gt;+&lt;/sup&gt; Replenishment Improves Lifespan and Healthspan in Ataxia Telangiectasia Models via Mitophagy and DNA Repair.	Cell metabolism	2016	12
7569956	12028	Knudson CM	Bax-deficient mice with lymphoid hyperplasia and male germ cell death.	Science	1995	257
8183579	12028	Miyashita T	Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.	Oncogene	1994	308
8816704	12028	Deckwerth TL	BAX is required for neuronal death after trophic factor deprivation and during development.	Neuron	1996	144
9108035	12028	Hsu YT	Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis.	Proceedings of the National Academy of Sciences of the United States of America	1997	265
9454852	12028	White FA	Widespread elimination of naturally occurring neuronal death in Bax-deficient mice.	The Journal of neuroscience 	1998	108
11175253	12028	Korsmeyer SJ	Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.	Cell death and differentiation	2000	186
12505984	12028	Abramovitch RB	Pseudomonas type III effector AvrPtoB induces plant disease susceptibility by inhibition of host programmed cell death.	The EMBO journal	2003	93
12750523	12028	Garcia-Barros M	Tumor response to radiotherapy regulated by endothelial cell apoptosis.	Science	2003	285
15574493	12028	Weiner JA	Gamma protocadherins are required for synaptic development in the spinal cord.	Proceedings of the National Academy of Sciences of the United States of America	2005	76
15668244	12028	Das A	Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.	The Journal of biological chemistry	2005	77
16505490	12028	Malhi H	Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis.	The Journal of biological chemistry	2006	163
16831600	12028	Gunawan BK	c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity.	Gastroenterology	2006	133
16862141	12028	Strom E	Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation.	Nature chemical biology	2006	104
17079463	12028	Chen D	Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity.	Cancer research	2006	91
17135272	12028	Wang X	Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation.	The Journal of biological chemistry	2007	57
17410096	12028	Wei Q	The pathological role of Bax in cisplatin nephrotoxicity.	Kidney international	2007	57
17435755	12028	Nagai M	Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.	Nature neuroscience	2007	347
17906064	12028	Bajt ML	Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity.	The Journal of pharmacology and experimental therapeutics	2008	55
18158332	12028	Howell GR	Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma.	The Journal of cell biology	2007	185
18223185	12028	Salloum FN	Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice.	American journal of physiology. Heart and circulatory physiology	2008	63
18295378	12028	Hauptmann S	Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.	Neurobiology of aging	2009	86
18948087	12028	Yi JH	PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.	Brain research	2008	50
19053047	12028	Singh R	Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.	Hepatology	2009	71
21185334	12028	Loor G	Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion.	Biochimica et biophysica acta	2011	43
21415464	12028	Khanna A	Gain of survival signaling by down-regulation of three key miRNAs in brain of calorie-restricted mice.	Aging	2011	40
23090186	12028	Kim MY	Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.	Diabetologia	2013	43
25264893	12028	Wang C	N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway.	PloS one	2014	22
25401748	12028	Yang Y	Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice.	Journal of pineal research	2015	16
25833129	12028	Hill AS	Increasing Adult Hippocampal Neurogenesis is Sufficient to Reduce Anxiety and Depression-Like Behaviors.	Neuropsychopharmacology 	2015	35
25976060	12028	Wang H	MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim.	Brain pathology	2016	11
1871110	12043	Hockenbery DM	BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.	Proceedings of the National Academy of Sciences of the United States of America	1991	165
2649247	12043	McDonnell TJ	bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.	Cell	1989	211
8402909	12043	Veis DJ	Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair.	Cell	1993	266
9215626	12043	Akashi K	Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice.	Cell	1997	135
10027396	12043	Nör JE	Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression.	The American journal of pathology	1999	127
10201940	12043	Hotchkiss RS	Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis.	Journal of immunology	1999	103
10611317	12043	Ogilvy S	Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.	Proceedings of the National Academy of Sciences of the United States of America	1999	107
11299236	12043	Chen Z	Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice.	American journal of physiology. Heart and circulatory physiology	2001	90
11313012	12043	Nash AA	Natural history of murine gamma-herpesvirus infection.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2001	101
11709185	12043	Bouillet P	Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim.	Developmental cell	2001	92
12086865	12043	Schmitt CA	Dissecting p53 tumor suppressor functions in vivo.	Cancer cell	2002	141
15811867	12043	Fisher PW	Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity.	Circulation	2005	86
15934930	12043	Ryu H	Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.	Journal of neurochemistry	2005	80
17440100	12043	Kunnumakkara AB	Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.	Cancer research	2007	139
17632527	12043	Dierks C	Essential role of stromally induced hedgehog signaling in B-cell malignancies.	Nature medicine	2007	99
18000061	12043	Stathopoulos GT	Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2007	61
18509315	12043	Periyasamy-Thandavan S	Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells.	Kidney international	2008	76
18931683	12043	Bonci D	The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.	Nature medicine	2008	289
19137012	12043	Beverly LJ	MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family.	Oncogene	2009	45
20445066	12043	Yin KJ	Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury.	The Journal of neuroscience 	2010	52
20559783	12043	Dorn GW 2nd	Mitochondrial pruning by Nix and BNip3: an essential function for cardiac-expressed death factors.	Journal of cardiovascular translational research	2010	51
21742976	12043	Penaranda C	Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells.	Journal of immunology	2011	40
21768359	12043	Oakes SR	Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.	Proceedings of the National Academy of Sciences of the United States of America	2012	45
22892563	12043	He C	Exercise induces autophagy in peripheral tissues and in the brain.	Autophagy	2012	39
23223177	12043	He C	Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes.	Diabetes	2013	55
23341542	12043	Vandenberg CJ	ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia.	Blood	2013	52
23827971	12043	Salminen A	Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.	Progress in neurobiology	2013	35
24346116	12043	Pan R	Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia.	Cancer discovery	2014	75
24786774	12043	Fresquet V	Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma.	Blood	2014	23
25994220	12043	Shi C	Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer.	Gut	2016	16
26082557	12043	Yang Y	MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction.	Circulation research	2015	18
26299920	12043	Li X	Inhibition of microRNA-497 ameliorates anoxia/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagy.	Oncotarget	2015	15
26366712	12043	Zhang J	Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis.	Nature medicine	2015	26
26657143	12043	Chang J	Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.	Nature medicine	2016	68
8139657	12064	Ernfors P	Mice lacking brain-derived neurotrophic factor develop with sensory deficits.	Nature	1994	163
10716929	12064	Kernie SG	BDNF regulates eating behavior and locomotor activity in mice.	The EMBO journal	2000	165
12589027	12064	Duan W	Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	108
12890780	12064	Gorski JA	Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites.	The Journal of neuroscience 	2003	126
14593183	12064	Chen WG	Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2.	Science	2003	380
14999077	12064	Spires TL	Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.	The Journal of neuroscience 	2004	72
15115821	12064	Baquet ZC	Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor.	The Journal of neuroscience 	2004	104
15342740	12064	Canals JM	Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.	The Journal of neuroscience 	2004	81
16446138	12064	Chang Q	The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.	Neuron	2006	185
16697351	12064	Monteggia LM	Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors.	Biological psychiatry	2007	136
16924103	12064	Govindarajan A	Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects.	Proceedings of the National Academy of Sciences of the United States of America	2006	78
16938843	12064	Ziv Y	Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury.	Proceedings of the National Academy of Sciences of the United States of America	2006	62
17379385	12064	Zuccato C	Role of brain-derived neurotrophic factor in Huntington's disease.	Progress in neurobiology	2007	107
17959817	12064	Strand AD	Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration.	The Journal of neuroscience 	2007	71
18077569	12064	Lipsky RH	Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity.	Annals of the New York Academy of Sciences	2007	68
18086127	12064	Gharami K	Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice.	Journal of neurochemistry	2008	59
18160634	12064	Unger TJ	Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity.	The Journal of neuroscience 	2007	102
18541795	12064	Kassis I	Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.	Archives of neurology	2008	74
19264961	12064	Simmons DA	Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	66
19633196	12064	Blurton-Jones M	Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	2009	164
20004026	12064	Pistell PJ	Cognitive impairment following high fat diet consumption is associated with brain inflammation.	Journal of neuroimmunology	2010	91
20095008	12064	Magariños AM	Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons.	Hippocampus	2011	59
20133810	12064	Jang SW	A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone.	Proceedings of the National Academy of Sciences of the United States of America	2010	130
20162412	12064	Sasaki M	Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes.	Diabetologia	2010	50
20445049	12064	Ubhi K	Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.	The Journal of neuroscience 	2010	46
20592198	12064	Bianchi P	Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome.	The Journal of neuroscience 	2010	43
20850189	12064	Milnerwood AJ	Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease.	Trends in neurosciences	2010	77
20955337	12064	Frielingsdorf H	Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder.	Annals of the New York Academy of Sciences	2010	43
21048129	12064	Xie Y	BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.	The Journal of neuroscience 	2010	61
21123312	12064	Andero R	Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning.	The American journal of psychiatry	2011	64
21176785	12064	Beers DR	Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.	Brain, behavior, and immunity	2011	37
21228172	12064	Hongpaisan J	PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice.	The Journal of neuroscience 	2011	42
21423756	12064	Lopatina T	Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo.	PloS one	2011	42
22332955	12064	Marconi S	Human adipose-derived mesenchymal stem cells systemically injected promote peripheral nerve regeneration in the mouse model of sciatic crush.	Tissue engineering. Part A	2012	37
22426422	12064	Liao GY	Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin.	Nature medicine	2012	46
22442074	12064	Yu H	Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants.	The Journal of neuroscience 	2012	62
22735487	12064	Liao B	Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.	Experimental neurology	2012	73
23128924	12064	Tripp A	Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder.	The American journal of psychiatry	2012	46
24360280	12064	Parkhurst CN	Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.	Cell	2013	209
24509083	12064	Qiu H	ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.	The Journal of clinical investigation	2014	50
24614170	12064	Castello NA	7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss.	PloS one	2014	22
24920623	12064	Fulmer CG	Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.	The Journal of neuroscience 	2014	29
25101683	12064	Mielcarek M	Dysfunction of the CNS-heart axis in mouse models of Huntington's disease.	PLoS genetics	2014	22
25196192	12064	Xuan W	Low-level laser therapy for traumatic brain injury in mice increases brain derived neurotrophic factor (BDNF) and synaptogenesis.	Journal of biophotonics	2015	20
25329343	12064	Wan G	Neurotrophin-3 regulates ribbon synapse density in the cochlea and induces synapse regeneration after acoustic trauma.	eLife	2014	32
25600109	12064	Lin LC	Somatostatin, neuronal vulnerability and behavioral emotionality.	Molecular psychiatry	2015	19
26019015	12064	Kamat PK	Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.	Molecular neurobiology	2016	11
9171368	12189	Ludwig T	Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.	Genes and development	1997	127
10319859	12189	Xu X	Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.	Nature genetics	1999	197
12533509	12189	Cao L	Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.	Genes and development	2003	102
17626182	12189	Liu X	Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	110
17626183	12189	Rottenberg S	Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	67
18230721	12189	Liu S	BRCA1 regulates human mammary stem/progenitor cell fate.	Proceedings of the National Academy of Sciences of the United States of America	2008	154
18375767	12189	Tan-Wong SM	Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene.	Proceedings of the National Academy of Sciences of the United States of America	2008	56
19716796	12189	Cao L	A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency.	Molecular cell	2009	93
20804975	12189	Molyneux G	BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.	Cell stem cell	2010	200
21765473	12189	Regan JL	c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.	Oncogene	2012	34
21901007	12189	Zhu Q	BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.	Nature	2011	124
22172724	12189	Drost R	BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.	Cancer cell	2011	57
22841781	12189	Hua G	Crypt base columnar stem cells in small intestines of mice are radioresistant.	Gastroenterology	2012	61
22915751	12189	Juvekar A	Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer.	Cancer discovery	2012	72
23408054	12189	Titus S	Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans.	Science translational medicine	2013	60
23857982	12189	Gorrini C	BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.	The Journal of experimental medicine	2013	36
24842372	12189	Polato F	CtIP-mediated resection is essential for viability and can operate independently of BRCA1.	The Journal of experimental medicine	2014	20
27241552	12189	Sigl V	RANKL/RANK control Brca1 mutation-driven mammary tumors.	Cell research	2016	11
27322743	12189	Nolan E	RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.	Nature medicine	2016	16
9590289	12259	Botto M	Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.	Nature genetics	1998	324
12244199	12259	Vandivier RW	Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex.	Journal of immunology	2002	111
15269255	12259	Fonseca MI	Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease.	The Journal of neuroscience 	2004	72
15879138	12259	Hart ML	Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q.	Journal of immunology	2005	65
16269622	12259	Biswas SK	A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).	Blood	2006	144
16651386	12259	Mehlhop E	Protective immune responses against West Nile virus are primed by distinct complement activation pathways.	The Journal of experimental medicine	2006	82
19414539	12259	Thorp E	Mechanisms and consequences of efferocytosis in advanced atherosclerosis.	Journal of leukocyte biology	2009	60
19564341	12259	Chen Y	Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis.	Journal of immunology	2009	52
19620499	12259	Lewis MJ	Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.	Circulation	2009	62
20416309	12259	Cohen JI	Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice.	Gastroenterology	2010	42
24191055	12259	Zhang Z	Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy.	Proceedings of the National Academy of Sciences of the United States of America	2013	49
25679762	12259	Bonavita E	PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.	Cell	2015	34
27033548	12259	Hong S	Complement and microglia mediate early synapse loss in Alzheimer mouse models.	Science	2016	106
27114033	12259	Lui H	Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation.	Cell	2016	31
9108112	12346	Schauwecker PE	Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches.	Proceedings of the National Academy of Sciences of the United States of America	1997	114
11746377	12346	Rockenstein E	Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).	Journal of neuroscience research	2001	89
12235359	12346	Bartos M	Fast synaptic inhibition promotes synchronized gamma oscillations in hippocampal interneuron networks.	Proceedings of the National Academy of Sciences of the United States of America	2002	142
15515178	12346	Belichenko PV	Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome.	The Journal of comparative neurology	2004	91
15716631	12346	Hall ED	Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury.	Journal of neurotrauma	2005	99
16291936	12346	Ramsden M	Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).	The Journal of neuroscience 	2005	152
16651626	12346	Spires TL	Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy.	The American journal of pathology	2006	111
16928182	12346	Saatman KE	Differential behavioral and histopathological responses to graded cortical impact injury in mice.	Journal of neurotrauma	2006	63
17951027	12346	Chen J	Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system.	Brain, behavior, and immunity	2008	121
18784294	12346	Avignone E	Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling.	The Journal of neuroscience 	2008	54
19523516	12346	Serenó L	A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.	Neurobiology of disease	2009	66
20619937	12346	Jawhar S	Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.	Neurobiology of aging	2012	65
21069780	12346	Ricobaraza A	Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease.	Hippocampus	2012	47
21240263	12346	Barretto RP	Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy.	Nature medicine	2011	60
21437933	12346	Stowe AM	Repetitive hypoxia extends endogenous neurovascular protection for stroke.	Annals of neurology	2011	38
21727897	12346	Fonken LK	Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology.	Molecular psychiatry	2011	42
21821124	12346	Ginsberg SD	Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.	Neurobiology of disease	2012	37
22293457	12346	Vinet J	Neuroprotective function for ramified microglia in hippocampal excitotoxicity.	Journal of neuroinflammation	2012	54
22485176	12346	Zhang QG	Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury.	PloS one	2012	49
22532069	12346	Van der Jeugd A	Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.	Acta neuropathologica	2012	35
22592800	12346	Busche MA	Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2012	70
22900595	12346	Mouzon B	Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes.	Journal of neurotrauma	2012	34
23254376	12346	Pop AS	Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant.	Psychopharmacology	2014	22
23276384	12346	Kashiwaya Y	A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease.	Neurobiology of aging	2013	48
23407965	12346	Gourley SL	Corticosteroid-induced neural remodeling predicts behavioral vulnerability and resilience.	The Journal of neuroscience 	2013	40
23560052	12346	Wright AL	Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.	PloS one	2013	35
24005292	12346	Peng Z	A reorganized GABAergic circuit in a model of epilepsy: evidence from optogenetic labeling and stimulation of somatostatin interneurons.	The Journal of neuroscience 	2013	27
24476943	12346	Zhong P	Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling.	Neuropsychopharmacology 	2014	20
24656815	12346	Sun Y	Cell-type-specific circuit connectivity of hippocampal CA1 revealed through Cre-dependent rabies tracing.	Cell reports	2014	24
25220759	12346	Peeraer E	Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice.	Neurobiology of disease	2015	17
25456500	12346	Šišková Z	Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of Alzheimer's disease.	Neuron	2014	25
15178682	12359	Ho YS	Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury.	The Journal of biological chemistry	2004	75
15879174	12359	Schriner SE	Extension of murine life span by overexpression of catalase targeted to mitochondria.	Science	2005	443
17034877	12359	Schrader M	Peroxisomes and oxidative stress.	Biochimica et biophysica acta	2006	113
17457822	12359	Zhao X	Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages.	Annals of neurology	2007	87
18772469	12359	Treuting PM	Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria.	The journals of gerontology. Series A, Biological sciences and medical sciences	2008	55
19265038	12359	Collins AR	Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes.	Circulation research	2009	77
20456298	12359	Dai DF	Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria.	Aging cell	2010	66
22012956	12359	Dai DF	Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress.	Cardiovascular research	2012	39
22315314	12359	Hwang I	Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction.	Diabetes	2012	30
23204527	12359	Rindler PM	High dietary fat selectively increases catalase expression within cardiac mitochondria.	The Journal of biological chemistry	2013	25
24297735	12359	Wang Y	Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages.	Circulation research	2014	32
24781012	12359	Bartell SM	FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation.	Nature communications	2014	32
25565653	12359	Cannavino J	The role of alterations in mitochondrial dynamics and PGC-1α over-expression in fast muscle atrophy following hindlimb unloading.	The Journal of physiology	2015	17
10764647	12362	Li M	Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model.	Science	2000	98
11986668	12362	Zhu S	Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.	Nature	2002	204
12393844	12362	Melnikov VY	Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice.	The Journal of clinical investigation	2002	93
15075209	12362	Kahlenberg JM	Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release.	American journal of physiology. Cell physiology	2004	91
16301671	12362	Kahlenberg JM	Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis.	Journal of immunology	2005	69
16407889	12362	Martinon F	Gout-associated uric acid crystals activate the NALP3 inflammasome.	Nature	2006	936
16984919	12362	Amer A	Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf.	The Journal of biological chemistry	2006	170
17099894	12362	Martin LJ	Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.	The Journal of comparative neurology	2007	86
17192486	12362	Vincent JA	Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia.	Diabetes	2007	71
17400889	12362	Faubel S	Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney.	The Journal of pharmacology and experimental therapeutics	2007	59
17641058	12362	Qu Y	Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages.	Journal of immunology	2007	147
17714514	12362	Fink SL	Pyroptosis and host cell death responses during Salmonella infection.	Cellular microbiology	2007	97
18025098	12362	Cheng W	Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection.	Infection and immunity	2008	63
18474815	12362	Abbate A	Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.	Circulation	2008	75
19164858	12362	Imaeda AB	Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome.	The Journal of clinical investigation	2009	175
19362023	12362	Thomas PG	The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1.	Immunity	2009	209
19465481	12362	Talabot-Ayer D	Interleukin-33 is biologically active independently of caspase-1 cleavage.	The Journal of biological chemistry	2009	67
19494813	12362	Guarda G	T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes.	Nature	2009	73
19950258	12362	Guma M	Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation.	Arthritis and rheumatism	2009	77
19950280	12362	Joosten LA	Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta.	Arthritis and rheumatism	2009	80
20226691	12362	Dupaul-Chicoine J	Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases.	Immunity	2010	141
20303296	12362	Zaki MH	The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.	Immunity	2010	203
20368281	12362	Shaw PJ	Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis.	Journal of immunology	2010	43
20385749	12362	Allen IC	The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer.	The Journal of experimental medicine	2010	164
20428172	12362	Duewell P	NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.	Nature	2010	563
20571523	12362	Northington FJ	Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI.	Journal of cerebral blood flow and metabolism 	2011	55
20574004	12362	Gris D	NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses.	Journal of immunology	2010	68
20679532	12362	Ulland TK	Cutting edge: mutation of Francisella tularensis mviN leads to increased macrophage absent in melanoma 2 inflammasome activation and a loss of virulence.	Journal of immunology	2010	42
20808838	12362	McElvania Tekippe E	Granuloma formation and host defense in chronic Mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1.	PloS one	2010	52
21106820	12362	Jha S	The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18.	The Journal of neuroscience 	2010	50
21118981	12362	Hu B	Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4.	Proceedings of the National Academy of Sciences of the United States of America	2010	88
21488066	12362	Csak T	Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.	Hepatology	2011	104
21622588	12362	Pauwels NS	Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD.	The European respiratory journal	2011	45
21622869	12362	Ather JL	Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice.	Journal of immunology	2011	59
21641991	12362	Tsai PY	Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation.	Free radical biology and medicine	2011	41
21681738	12362	van de Veerdonk FL	The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis.	European journal of immunology	2011	37
21731762	12362	Shimada K	Caspase-1 dependent IL-1β secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection.	PloS one	2011	37
21876127	12362	Stienstra R	Inflammasome is a central player in the induction of obesity and insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2011	149
22106299	12362	Mezzaroma E	The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse.	Proceedings of the National Academy of Sciences of the United States of America	2011	79
22234969	12362	Yan W	High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.	Hepatology	2012	56
22411067	12362	Dixon LJ	Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.	Laboratory investigation; a journal of technical methods and pathology	2012	33
22461621	12362	Liu Z	Role of inflammasomes in host defense against Citrobacter rodentium infection.	The Journal of biological chemistry	2012	34
22555457	12362	Pierini R	AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages.	Cell death and differentiation	2012	51
22647887	12362	Zhang C	Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia.	Hypertension	2012	37
22902502	12362	von Moltke J	Rapid induction of inflammatory lipid mediators by the inflammasome in vivo.	Nature	2012	100
22945633	12362	Petrasek J	IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.	The Journal of clinical investigation	2012	127
23254930	12362	Heneka MT	NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice.	Nature	2013	222
23409132	12362	Dixon LJ	Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis.	PloS one	2013	29
24222351	12362	Westwell-Roper CY	Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.	Diabetes	2014	22
24280936	12362	Nordlander S	NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen.	Mucosal immunology	2014	26
24336017	12362	Marchetti C	A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse.	Journal of cardiovascular pharmacology	2014	23
24395802	12362	Cassel SL	Inflammasome-independent IL-1β mediates autoinflammatory disease in Pstpip2-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	2014	22
25075770	12362	Shahzad K	Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy.	Kidney international	2015	35
25136295	12362	Alfonso-Loeches S	Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells.	Frontiers in cellular neuroscience	2014	21
25176060	12362	Kozai TD	Effects of caspase-1 knockout on chronic neural recording quality and longevity: insight into cellular and molecular mechanisms of the reactive tissue response.	Biomaterials	2014	23
25274309	12362	Lukens JR	Dietary modulation of the microbiome affects autoinflammatory disease.	Nature	2014	39
25327779	12362	Kim HY	Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion.	The FEBS journal	2015	16
25574840	12362	Moon JS	UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis.	The Journal of clinical investigation	2015	24
25675528	12362	Nagamatsu K	Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.	Proceedings of the National Academy of Sciences of the United States of America	2015	21
25704009	12362	Karki R	Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against Aspergillus infection.	Cell host and microbe	2015	37
25762200	12362	dos Santos G	Vimentin regulates activation of the NLRP3 inflammasome.	Nature communications	2015	23
25762778	12362	Katsnelson MA	K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling.	Journal of immunology	2015	22
25959047	12362	Ip WK	Macrophages monitor tissue osmolarity and induce inflammatory response through NLRP3 and NLRC4 inflammasome activation.	Nature communications	2015	21
26100631	12362	Antonopoulos C	Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling.	The Journal of biological chemistry	2015	24
26659062	12362	González-Juarbe N	Pore-Forming Toxins Induce Macrophage Necroptosis during Acute Bacterial Pneumonia.	PLoS pathogens	2015	17
8934524	12367	Kuida K	Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice.	Nature	1996	278
10830166	12367	Li K	Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis.	Cell	2000	96
11101871	12367	Hotchkiss RS	Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte.	Nature immunology	2000	144
12011492	12367	Gujral JS	Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?	Toxicological sciences 	2002	91
12031984	12367	Cai L	Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway.	Diabetes	2002	111
12406830	12367	Knapp S	Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia.	American journal of respiratory and critical care medicine	2003	85
12707011	12367	Aoshiba K	Alveolar wall apoptosis causes lung destruction and emphysematous changes.	American journal of respiratory cell and molecular biology	2003	88
15254240	12367	Erster S	In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation.	Molecular and cellular biology	2004	98
15289376	12367	Okada K	Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.	Circulation	2004	140
15326158	12367	Martin PM	Death of retinal neurons in streptozotocin-induced diabetic mice.	Investigative ophthalmology and visual science	2004	120
15486922	12367	Kon K	Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes.	Hepatology	2004	133
15494404	12367	Gardian G	Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.	The Journal of biological chemistry	2005	119
16166336	12367	Conaway CC	Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice.	Cancer research	2005	73
16249509	12367	Feit-Leichman RA	Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.	Investigative ophthalmology and visual science	2005	75
16380497	12367	Susztak K	Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.	Diabetes	2006	261
17045908	12367	Cai L	Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.	Journal of the American College of Cardiology	2006	85
17192305	12367	Samuel MA	Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis.	Journal of virology	2007	69
17911264	12367	Gironella M	Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2007	167
18037988	12367	Suliman HB	The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.	The Journal of clinical investigation	2007	81
18187572	12367	Koike M	Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury.	The American journal of pathology	2008	118
18357341	12367	Breart B	Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice.	The Journal of clinical investigation	2008	86
18434510	12367	Davis TH	Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus.	The Journal of neuroscience 	2008	168
18493258	12367	You Z	Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice.	Journal of cerebral blood flow and metabolism 	2008	78
18695136	12367	Ottewell PD	Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.	Journal of the National Cancer Institute	2008	50
19095836	12367	Loepke AW	The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory.	Anesthesia and analgesia	2009	55
19265047	12367	Liu F	Sex differences in caspase activation after stroke.	Stroke	2009	52
19286953	12367	Mukhopadhyay P	Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.	American journal of physiology. Heart and circulatory physiology	2009	71
19676126	12367	Witek RP	Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.	Hepatology	2009	61
20460993	12367	Lu Y	Anesthetic sevoflurane causes neurotoxicity differently in neonatal naïve and Alzheimer disease transgenic mice.	Anesthesiology	2010	45
21151119	12367	D'Amelio M	Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease.	Nature neuroscience	2011	124
22490516	12367	Sendler M	Tumour necrosis factor α secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice.	Gut	2013	25
22709825	12367	Qin L	Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration.	Journal of neuroinflammation	2012	35
23223278	12367	Simon DJ	A caspase cascade regulating developmental axon degeneration.	The Journal of neuroscience 	2012	51
23226300	12367	Pan Z	miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models.	PloS one	2012	32
23316765	12367	Eimer WA	Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation.	Molecular neurodegeneration	2013	36
23425860	12367	Haubner BJ	Complete cardiac regeneration in a mouse model of myocardial infarction.	Aging	2012	34
23621987	12367	Meier-Abt F	Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.	Breast cancer research 	2013	35
23776240	12367	Talantova M	Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.	Proceedings of the National Academy of Sciences of the United States of America	2013	90
24642486	12367	Lao Y	The natural compound oblongifolin C inhibits autophagic flux and enhances antitumor efficacy of nutrient deprivation.	Autophagy	2014	20
24750664	12367	Barreyro FJ	The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.	Liver international 	2015	23
25417164	12367	Renier N	iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging.	Cell	2014	98
25692960	12367	Hou Z	UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway.	ACS nano	2015	17
25787076	12367	Silva KA	Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.	The Journal of biological chemistry	2015	20
25866249	12367	Liu X	Caspase-3 promotes genetic instability and carcinogenesis.	Molecular cell	2015	26
26000464	12367	Wang Y	Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium.	International journal of cardiology	2015	21
9671767	12387	de La Coste A	Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.	Proceedings of the National Academy of Sciences of the United States of America	1998	212
9734399	12387	Lefebvre AM	Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice.	Nature medicine	1998	138
9790190	12387	Zhang Z	Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis.	Nature	1998	107
9845363	12387	Gat U	De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin.	Cell	1998	297
10545105	12387	Harada N	Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene.	The EMBO journal	1999	418
11593404	12387	Saadi-Kheddouci S	Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene.	Oncogene	2001	87
11983872	12387	Cheon SS	beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds.	Proceedings of the National Academy of Sciences of the United States of America	2002	86
12702582	12387	Howe LR	Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation.	Cancer research	2003	78
14611673	12387	Tanaka T	A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate.	Cancer science	2003	169
14668413	12387	Merrill BJ	Tcf3: a transcriptional regulator of axis induction in the early embryo.	Development	2004	93
15024077	12387	Müller-Tidow C	Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.	Molecular and cellular biology	2004	70
15186480	12387	Okubo T	Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm.	Journal of biology	2004	106
15314234	12387	Emami KH	A small molecule inhibitor of beta-catenin/CREB-binding protein transcription corrected.	Proceedings of the National Academy of Sciences of the United States of America	2004	196
16007074	12387	Nateri AS	Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.	Nature	2005	109
16818445	12387	Später D	Wnt9a signaling is required for joint integrity and regulation of Ihh during chondrogenesis.	Development	2006	62
16885339	12387	Proweller A	Impaired notch signaling promotes de novo squamous cell carcinoma formation.	Cancer research	2006	69
17101329	12387	Tan X	Conditional deletion of beta-catenin reveals its role in liver growth and regeneration.	Gastroenterology	2006	97
17690189	12387	Ye Z	Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination.	The American journal of pathology	2007	71
17897439	12387	Schlange T	Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.	Breast cancer research 	2007	73
17929301	12387	Apte U	Wnt/beta-catenin signaling mediates oval cell response in rodents.	Hepatology	2008	56
18068630	12387	Zhao C	Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.	Cancer cell	2007	184
18077429	12387	Gounaris E	Mast cells are an essential hematopoietic component for polyp development.	Proceedings of the National Academy of Sciences of the United States of America	2007	82
18094333	12387	Edwards CM	Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.	Blood	2008	62
18242220	12387	Siveke JT	Notch signaling is required for exocrine regeneration after acute pancreatitis.	Gastroenterology	2008	59
18393386	12387	Tan X	Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development.	Hepatology	2008	60
18725219	12387	Heiser PW	Stabilization of beta-catenin induces pancreas tumor formation.	Gastroenterology	2008	55
18768809	12387	Fujishita T	Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	55
18806829	12387	Jeong JW	beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus.	Oncogene	2009	54
18818703	12387	Hu Y	beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.	Leukemia	2009	60
19047173	12387	Wang G	Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer.	Cancer research	2008	52
19092805	12387	Zhu L	Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.	Nature	2009	196
19104148	12387	Kim KK	Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis.	The Journal of clinical investigation	2009	146
19297557	12387	He W	Wnt/beta-catenin signaling promotes renal interstitial fibrosis.	Journal of the American Society of Nephrology 	2009	155
19419300	12387	Lin C	Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.	Journal of bone and mineral research 	2009	131
19553286	12387	Westenskow P	Beta-catenin controls differentiation of the retinal pigment epithelium in the mouse optic cup by regulating Mitf and Otx2 expression.	Development	2009	52
19628668	12387	Dai C	Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.	Journal of the American Society of Nephrology 	2009	121
19718050	12387	van Zijl F	Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge.	Oncogene	2009	51
19786028	12387	Sodhi CP	Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis.	Gastroenterology	2010	63
19841737	12387	Davis R	Nicotine promotes tumor growth and metastasis in mouse models of lung cancer.	PloS one	2009	48
20010698	12387	Maes C	Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones.	The EMBO journal	2010	43
20071774	12387	Morris JP 4th	Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.	The Journal of clinical investigation	2010	119
20106872	12387	Berthon A	Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development.	Human molecular genetics	2010	51
20303298	12387	Nava P	Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways.	Immunity	2010	68
20339075	12387	Wang Y	The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.	Science	2010	206
20388854	12387	Li Y	Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.	Clinical cancer research 	2010	112
20404086	12387	Kramer I	Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis.	Molecular and cellular biology	2010	113
20432254	12387	Nejak-Bowen KN	Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin.	Hepatology	2010	52
20580720	12387	Lee G	Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.	Gastroenterology	2010	56
21613219	12387	Kato H	Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival.	The Journal of biological chemistry	2011	52
21685890	12387	Lyashenko N	Differential requirement for the dual functions of β-catenin in embryonic stem cell self-renewal and germ layer formation.	Nature cell biology	2011	91
21858114	12387	Sinnberg T	β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance.	PloS one	2011	36
22722829	12387	Robinson G	Novel mutations target distinct subgroups of medulloblastoma.	Nature	2012	215
22800756	12387	Heaton JH	Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.	The American journal of pathology	2012	36
25964079	12387	Yuan SX	Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1.	Hepatology	2016	36
8208295	12443	Wang TC	Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.	Nature	1994	211
9679152	12443	St Croix B	E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).	The Journal of cell biology	1998	103
10072388	12443	Schreiber M	Control of cell cycle progression by c-Jun is p53 dependent.	Genes and development	1999	138
10611246	12443	Lee RJ	Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.	Molecular and cellular biology	2000	93
10728791	12443	Fausto N	Liver regeneration.	Journal of hepatology	2000	211
11124803	12443	Alt JR	Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation.	Genes and development	2000	151
12502747	12443	Ciemerych MA	Development of mice expressing a single D-type cyclin.	Genes and development	2002	84
15576649	12443	Pasumarthi KB	Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.	Circulation research	2005	90
16413468	12443	Landis MW	Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.	Cancer cell	2006	96
16823799	12443	Cox BD	New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.	Journal of cellular biochemistry	2006	96
17341655	12443	Blanco-Aparicio C	PTEN, more than the AKT pathway.	Carcinogenesis	2007	113
17890319	12443	Cao Y	IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells.	Proceedings of the National Academy of Sciences of the United States of America	2007	65
18239128	12443	Peer D	Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target.	Science	2008	99
18537191	12443	Zhang Y	Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation.	Hepatology	2008	54
18981289	12443	Maran RR	Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.	The Journal of pharmacology and experimental therapeutics	2009	57
19765988	12443	Klein EA	Cell-cycle control by physiological matrix elasticity and in vivo tissue stiffening.	Current biology 	2009	92
19874425	12443	Rattan R	Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.	Journal of cellular and molecular medicine	2011	56
20406885	12443	Bitler BG	MUC1 regulates nuclear localization and function of the epidermal growth factor receptor.	Journal of cell science	2010	46
21532889	12443	Rattan R	Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.	Neoplasia	2011	76
23079655	12443	Choi YJ	The requirement for cyclin D function in tumor maintenance.	Cancer cell	2012	63
23487025	12443	de Bruin AM	Interferon-γ impairs proliferation of hematopoietic stem cells in mice.	Blood	2013	35
24700412	12443	Yang J	β-catenin signaling in murine liver zonation and regeneration: a Wnt-Wnt situation!	Hepatology	2014	22
25122899	12443	Wu J	Spinal cord injury causes brain inflammation associated with cognitive and affective changes: role of cell cycle pathways.	The Journal of neuroscience 	2014	25
25698753	12443	Pucilowska J	The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor proliferation and brain cytoarchitecture linked to the ERK MAPK pathway.	The Journal of neuroscience 	2015	17
26806818	12443	Lua I	Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers.	Journal of hepatology	2016	16
7481803	12477	Waterhouse P	Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.	Science	1995	539
7584144	12477	Tivol EA	Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.	Immunity	1995	504
10430624	12477	van Elsas A	Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.	The Journal of experimental medicine	1999	254
10899917	12477	Takahashi T	Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.	The Journal of experimental medicine	2000	451
11489974	12477	Gregori S	Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.	Journal of immunology	2001	104
12682289	12477	Hodi FS	Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.	Proceedings of the National Academy of Sciences of the United States of America	2003	185
12796776	12477	Watanabe N	BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.	Nature immunology	2003	167
15701862	12477	Demaria S	Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.	Clinical cancer research 	2005	173
15814720	12477	Taylor MD	Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo.	Journal of immunology	2005	91
16116190	12477	McGeachy MJ	Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.	Journal of immunology	2005	131
16186187	12477	Ko K	Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.	The Journal of experimental medicine	2005	112
16710025	12477	Beck KE	Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.	Journal of clinical oncology 	2006	116
17911375	12477	Daniel C	Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.	The Journal of pharmacology and experimental therapeutics	2008	111
18845758	12477	Wing K	CTLA-4 control over Foxp3+ regulatory T cell function.	Science	2008	618
19109158	12477	Schmidt EM	Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity.	Journal of immunology	2009	48
19188497	12477	Friedline RH	CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance.	The Journal of experimental medicine	2009	75
19706802	12477	Dewan MZ	Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.	Clinical cancer research 	2009	177
19717280	12477	Tiegs G	Immune tolerance: what is unique about the liver.	Journal of autoimmunity	2010	78
20156971	12477	Quezada SA	Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.	The Journal of experimental medicine	2010	187
20445343	12477	Mangsbo SM	Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy.	Journal of immunotherapy	2010	43
21170302	12477	Haque A	CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo.	PLoS pathogens	2010	40
21199897	12477	Joller N	Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.	Journal of immunology	2011	59
21559358	12477	Curran MA	Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production.	PloS one	2011	67
22108823	12477	Waitz R	Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy.	Cancer research	2012	38
22319445	12477	Hafalla JC	The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology.	PLoS pathogens	2012	30
22945631	12477	Ruocco MG	Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.	The Journal of clinical investigation	2012	52
23633484	12477	Duraiswamy J	Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.	Cancer research	2013	128
23728179	12477	Marabelle A	Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.	The Journal of clinical investigation	2013	72
23983257	12477	Allard B	Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.	Clinical cancer research 	2013	42
24078774	12477	Akbay EA	Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.	Cancer discovery	2013	151
24676639	12477	Fiorina P	Role of podocyte B7-1 in diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	27
24687957	12477	Fan X	Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy.	The Journal of experimental medicine	2014	29
24691018	12477	Wainwright DA	Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.	Clinical cancer research 	2014	79
24732076	12477	Bulliard Y	OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy.	Immunology and cell biology	2014	36
24829760	12477	Spranger S	Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment.	Journal for immunotherapy of cancer	2014	68
24856586	12477	Özdemir BC	Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.	Cancer cell	2014	242
25082815	12477	Zhu Y	CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.	Cancer research	2014	96
25329329	12477	Schubert D	Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.	Nature medicine	2014	67
25363763	12477	Huang YH	CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.	Nature	2015	51
25428507	12477	Gubin MM	Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.	Nature	2014	240
25526313	12477	Sage PT	The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells.	Immunity	2014	48
25582080	12477	Hannani D	Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.	Cell research	2015	19
25754329	12477	Twyman-Saint Victor C	Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.	Nature	2015	185
25970248	12477	Spranger S	Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.	Nature	2015	161
26321679	12477	Chang CH	Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.	Cell	2015	131
26371185	12477	Paterson AM	Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.	The Journal of experimental medicine	2015	15
26546453	12477	Reardon DA	Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model.	Cancer immunology research	2016	13
26607445	12477	Demaria O	STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.	Proceedings of the National Academy of Sciences of the United States of America	2015	16
26645196	12477	Peng W	Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.	Cancer discovery	2016	46
9133425	12479	Chen YH	Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice.	Immunity	1997	114
11533710	12479	Hong S	The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.	Nature medicine	2001	130
11927628	12479	Pellicci DG	A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.	The Journal of experimental medicine	2002	103
12093876	12479	Crowe NY	A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.	The Journal of experimental medicine	2002	99
14684827	12479	Zhou D	Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.	Science	2004	106
15539565	12479	Zhou D	Lysosomal glycosphingolipid recognition by NKT cells.	Science	2004	270
16138194	12479	Parekh VV	Glycolipid antigen induces long-term natural killer T cell anergy in mice.	The Journal of clinical investigation	2005	136
16675847	12479	Huang D	The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.	FASEB journal 	2006	80
17256743	12479	Erhardt A	IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice.	Hepatology	2007	59
17442974	12479	Li L	NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury.	Journal of immunology	2007	120
17641782	12479	Halder RC	Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease.	The Journal of clinical investigation	2007	84
20512988	12479	Syn WK	Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.	Hepatology	2010	63
20941605	12479	Matsushita T	Identifying regulatory B cells (B10 cells) that produce IL-10 in mice.	Methods in molecular biology	2011	38
22347409	12479	van der Vlugt LE	Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells.	PloS one	2012	36
24717441	12479	Olszak T	Protective mucosal immunity mediated by epithelial CD1d and IL-10.	Nature	2014	38
24813205	12479	Holzapfel KL	Antigen-dependent versus -independent activation of invariant NKT cells during infection.	Journal of immunology	2014	26
26715643	12479	Pylayeva-Gupta Y	IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia.	Cancer discovery	2016	17
7509044	12490	Lapidot T	A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.	Nature	1994	948
9144235	12490	Bhatia M	Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	1997	124
9616148	12490	Möhle R	The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.	Blood	1998	109
10613752	12490	Theise ND	Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation.	Hepatology	2000	140
11021753	12490	Jordan CT	The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.	Leukemia	2000	120
12160838	12490	Noort WA	Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.	Experimental hematology	2002	85
12163453	12490	Iwano M	Evidence that fibroblasts derive from epithelium during tissue fibrosis.	The Journal of clinical investigation	2002	507
12794745	12490	Sroga JM	Rats and mice exhibit distinct inflammatory reactions after spinal cord injury.	The Journal of comparative neurology	2003	87
14568894	12490	Yeh ET	Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo.	Circulation	2003	83
15297308	12490	Kawada H	Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction.	Blood	2004	113
15550692	12490	Kucia M	Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction.	Circulation research	2004	83
16224047	12490	Nakagami H	Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells.	Arteriosclerosis, thrombosis, and vascular biology	2005	93
16778814	12490	Cotsarelis G	Epithelial stem cells: a folliculocentric view.	The Journal of investigative dermatology	2006	121
17078891	12490	Berges BK	HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.	Retrovirology	2006	72
17114286	12490	Haudek SB	Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	129
17389330	12490	Nishimura S	Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels.	Diabetes	2007	123
18207484	12490	Berges BK	Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.	Virology	2008	56
19095944	12490	Colmone A	Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells.	Science	2008	150
19295307	12490	van der Bogt KE	Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart.	Transplantation	2009	50
19524633	12490	Lepus CM	Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.	Human immunology	2009	48
19779618	12490	Davis DR	Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue.	PloS one	2009	89
21118986	12490	Ooi AG	MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets.	Proceedings of the National Academy of Sciences of the United States of America	2010	71
21799532	12490	Denton PW	Humanized mouse models of HIV infection.	AIDS reviews	2011	58
22422991	12490	Kalscheuer H	A model for personalized in vivo analysis of human immune responsiveness.	Science translational medicine	2012	32
24894716	12490	De Francesco EM	GPER mediates activation of HIF1α/VEGF signaling by estrogens.	Cancer research	2014	22
24957147	12490	Gallipoli P	JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.	Blood	2014	22
1351500	12504	Gazzinelli R	Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.	Journal of immunology	1992	168
1634608	12504	Tiegs G	A T cell-dependent experimental liver injury in mice inducible by concanavalin A.	The Journal of clinical investigation	1992	172
1824635	12504	Pearce EJ	Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni.	The Journal of experimental medicine	1991	171
1909350	12504	Graham BS	Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.	The Journal of clinical investigation	1991	156
2125367	12504	Murphy KM	Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.	Science	1990	409
2573841	12504	Pircher H	Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.	Nature	1989	282
7479772	12504	Morrison SJ	The purification and characterization of fetal liver hematopoietic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	1995	126
7541305	12504	Morrison SJ	The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype.	Immunity	1994	228
7600284	12504	Powrie F	Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.	Immunity	1994	264
7816142	12504	Ferrick DA	Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo.	Nature	1995	143
8094901	12504	Qin S	"Infectious" transplantation tolerance.	Science	1993	163
8676088	12504	Powrie F	A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.	The Journal of experimental medicine	1996	167
9570536	12504	Suri-Payer E	CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.	Journal of immunology	1998	185
9784526	12504	Sellon RK	Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.	Infection and immunity	1998	341
10228018	12504	Caruso AM	Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis.	Journal of immunology	1999	139
10934223	12504	Scanga CA	Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2.	The Journal of experimental medicine	2000	99
11157048	12504	Mogues T	The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice.	The Journal of experimental medicine	2001	168
11298351	12504	Stephens LA	Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.	European journal of immunology	2001	94
11313376	12504	Gabrilovich DI	Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells.	Journal of immunology	2001	127
11535634	12504	Huseby ES	A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis.	The Journal of experimental medicine	2001	129
11781372	12504	Campbell DJ	Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues.	The Journal of experimental medicine	2002	144
11937556	12504	Belkaid Y	CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.	Journal of immunology	2002	84
12042807	12504	Teshima T	Acute graft-versus-host disease does not require alloantigen expression on host epithelium.	Nature medicine	2002	114
12466842	12504	Belkaid Y	CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.	Nature	2002	476
12515818	12504	Maloy KJ	CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.	The Journal of experimental medicine	2003	210
12601158	12504	Miller MJ	Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy.	Proceedings of the National Academy of Sciences of the United States of America	2003	138
12682220	12504	Mottet C	Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.	Journal of immunology	2003	230
12907617	12504	Kusmartsev S	All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.	Cancer research	2003	121
12925844	12504	Edinger M	CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.	Nature medicine	2003	304
12949259	12504	Green EA	CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2003	96
14597485	12504	Johnson JR	Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling.	American journal of respiratory and critical care medicine	2004	103
14660744	12504	Trenado A	Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.	The Journal of clinical investigation	2003	115
14709552	12504	Wong GT	Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation.	The Journal of biological chemistry	2004	158
14734610	12504	Zhang X	IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.	International immunology	2004	80
14962796	12504	Ogawa A	Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice.	Clinical immunology	2004	124
15034024	12504	Suvas S	CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions.	Journal of immunology	2004	126
15128783	12504	Cobbold SP	Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants.	Journal of immunology	2004	111
15184500	12504	Tarbell KV	CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.	The Journal of experimental medicine	2004	182
15263027	12504	Mendez S	Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity.	The Journal of experimental medicine	2004	91
15286798	12504	Shivakumar P	Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia.	The Journal of clinical investigation	2004	71
15292057	12504	Taylor PA	L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.	Blood	2004	102
15585848	12504	Curotto de Lafaille MA	CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.	Journal of immunology	2004	112
15668741	12504	Doganci A	The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.	The Journal of clinical investigation	2005	89
15692785	12504	Araki A	MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.	Journal of gastroenterology	2005	75
15728465	12504	Antony PA	CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.	Journal of immunology	2005	233
15735653	12504	Greter M	Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.	Nature medicine	2005	209
15753207	12504	Fahlén L	T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells.	The Journal of experimental medicine	2005	143
15753211	12504	Yu P	Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.	The Journal of experimental medicine	2005	100
15766662	12504	Drake CG	Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.	Cancer cell	2005	86
15790359	12504	Coombes JL	Regulatory T cells and intestinal homeostasis.	Immunological reviews	2005	81
15855328	12504	You S	Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells.	Diabetes	2005	75
15879097	12504	Min B	Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms.	Journal of immunology	2005	67
15924144	12504	Shakhar G	Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo.	Nature immunology	2005	90
16251406	12504	Duffield JS	Conditional ablation of macrophages halts progression of crescentic glomerulonephritis.	The American journal of pathology	2005	79
16275765	12504	Crowe NY	Differential antitumor immunity mediated by NKT cell subsets in vivo.	The Journal of experimental medicine	2005	115
16314437	12504	Lewkowich IP	CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function.	The Journal of experimental medicine	2005	113
16462800	12504	Ait-Oufella H	Natural regulatory T cells control the development of atherosclerosis in mice.	Nature medicine	2006	213
16493070	12504	Day YJ	Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma.	Journal of immunology	2006	81
16547229	12504	Niederkorn JY	Desiccating stress induces T cell-mediated Sjögren's Syndrome-like lacrimal keratoconjunctivitis.	Journal of immunology	2006	85
16628206	12504	Krutzik PO	Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling.	Nature methods	2006	118
16818744	12504	Jarnicki AG	Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.	Journal of immunology	2006	69
16849474	12504	Oertelt S	Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.	Journal of immunology	2006	88
16950278	12504	Tamachi T	IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice.	The Journal of allergy and clinical immunology	2006	68
17015634	12504	Yurchenko E	CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence.	The Journal of experimental medicine	2006	65
17142730	12504	Battaglia M	Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients.	Journal of immunology	2006	192
17142781	12504	Heimesaat MM	Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii.	Journal of immunology	2006	136
17389241	12504	Sun Z	Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1.	The Journal of experimental medicine	2007	142
17526747	12504	Radosevic K	Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.	Infection and immunity	2007	57
17548625	12504	Evans JG	Novel suppressive function of transitional 2 B cells in experimental arthritis.	Journal of immunology	2007	149
17613255	12504	Yamaguchi T	Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.	Immunity	2007	77
17675459	12504	Dominitzki S	Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.	Journal of immunology	2007	56
17911589	12504	Saxena V	The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse.	Journal of immunology	2007	60
17911645	12504	Roark CL	Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells.	Journal of immunology	2007	101
17932250	12504	Ephrem A	Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.	Blood	2008	55
18496841	12504	Kivisäkk P	Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis.	Annals of neurology	2009	68
18591671	12504	Mills JH	CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis.	Proceedings of the National Academy of Sciences of the United States of America	2008	57
18716618	12504	Atarashi K	ATP drives lamina propria T(H)17 cell differentiation.	Nature	2008	295
18768865	12504	McKinley L	TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice.	Journal of immunology	2008	174
18809917	12504	Beers DR	CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.	Proceedings of the National Academy of Sciences of the United States of America	2008	123
19027740	12504	Su L	Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.	Gastroenterology	2009	103
19104149	12504	Brochard V	Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.	The Journal of clinical investigation	2009	175
19135996	12504	González MA	Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.	Gastroenterology	2009	142
19153229	12504	Ruckwardt TJ	Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities.	Journal of virology	2009	45
19169263	12504	Liesz A	Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke.	Nature medicine	2009	221
19265055	12504	Gelderblom M	Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.	Stroke	2009	186
19265127	12504	Blair PA	Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice.	Journal of immunology	2009	73
19272385	12504	Velin D	Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model.	Gastroenterology	2009	48
19380832	12504	van der Fits L	Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.	Journal of immunology	2009	186
19625990	12504	Gandolfo MT	Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury.	Kidney international	2009	70
19770521	12504	D'Alessio FR	CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.	The Journal of clinical investigation	2009	117
19815530	12504	Niedermeier M	CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes.	Proceedings of the National Academy of Sciences of the United States of America	2009	66
19901080	12504	Brien JD	Key role of T cell defects in age-related vulnerability to West Nile virus.	The Journal of experimental medicine	2009	54
19940103	12504	Singh UP	Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis.	The Journal of pharmacology and experimental therapeutics	2010	45
20171123	12504	Luber CA	Quantitative proteomics reveals subset-specific viral recognition in dendritic cells.	Immunity	2010	126
20432234	12504	Laffont S	Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells.	European journal of immunology	2010	52
20439117	12504	Shima T	Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice.	Journal of reproductive immunology	2010	41
20454651	12504	Cohen AD	Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.	PloS one	2010	65
20547826	12504	Shafiani S	Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis.	The Journal of experimental medicine	2010	101
20640189	12504	Melchior B	Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.	ASN neuro	2010	44
20679530	12504	Yang CW	Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants.	Journal of immunology	2010	47
20696698	12504	Irla M	MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity.	The Journal of experimental medicine	2010	44
20944089	12504	Bertholet S	A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis.	Science translational medicine	2010	77
20956337	12504	Yin B	Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.	Journal of immunology	2010	42
21035406	12504	Rakhra K	CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.	Cancer cell	2010	92
21045153	12504	Kreiter S	Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.	Cancer research	2010	43
21091718	12504	Kavanagh H	Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells.	Allergy	2011	44
21124875	12504	Stephens R	Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria.	PLoS pathogens	2010	42
21304053	12504	Wilke CM	Th17 cells in cancer: help or hindrance?	Carcinogenesis	2011	52
21317389	12504	Michalek RD	Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.	Journal of immunology	2011	272
21347344	12504	Satou Y	HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo.	PLoS pathogens	2011	72
21368026	12504	Dash PK	Loss of neuronal integrity during progressive HIV-1 infection of humanized mice.	The Journal of neuroscience 	2011	45
21441909	12504	Huh JR	Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity.	Nature	2011	129
21494565	12504	Claser C	CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria.	PloS one	2011	60
21596768	12504	Beers DR	Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.	Brain 	2011	68
21709219	12504	Kriegel MA	Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice.	Proceedings of the National Academy of Sciences of the United States of America	2011	132
21911743	12504	Eller K	Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy.	Diabetes	2011	54
22017441	12504	Weinberg AD	Science gone translational: the OX40 agonist story.	Immunological reviews	2011	44
22072556	12504	Srinivasan M	Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.	Blood	2012	58
22080947	12504	Kang TW	Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.	Nature	2011	189
22291184	12504	Baldwin SL	The importance of adjuvant formulation in the development of a tuberculosis vaccine.	Journal of immunology	2012	40
22388323	12504	Hofmann U	Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice.	Circulation	2012	50
22523067	12504	Gomez de Agüero M	Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells.	The Journal of clinical investigation	2012	30
22596049	12504	Bertola A	Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients.	Diabetes	2012	55
22723523	12504	Villegas-Mendez A	IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.	Journal of immunology	2012	49
22750327	12504	Watson MB	Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.	Experimental neurology	2012	36
22802640	12504	Hsiao EY	Modeling an autism risk factor in mice leads to permanent immune dysregulation.	Proceedings of the National Academy of Sciences of the United States of America	2012	68
22855710	12504	Gondek DC	CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract.	Journal of immunology	2012	32
22931926	12504	Honda T	Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis.	The Journal of investigative dermatology	2013	42
23008334	12504	Hirschhorn-Cymerman D	Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype.	The Journal of experimental medicine	2012	42
23020860	12504	Walker PA	Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population.	Journal of neuroinflammation	2012	32
23193171	12504	Avraham T	Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.	FASEB journal 	2013	30
23209328	12504	Teo TH	A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice.	Journal of immunology	2013	40
23233724	12504	Green AM	IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection.	Journal of immunology	2013	56
23250275	12504	Hernández-Santos N	Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections.	Mucosal immunology	2013	45
23335631	12504	Baruch K	CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging.	Proceedings of the National Academy of Sciences of the United States of America	2013	31
23418627	12504	Näslund TI	Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity.	Journal of immunology	2013	30
23467095	12504	Kleinewietfeld M	Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells.	Nature	2013	194
23874682	12504	Poutahidis T	Microbial reprogramming inhibits Western diet-associated obesity.	PloS one	2013	37
23907510	12504	Gigliotti JC	Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway.	Journal of the American Society of Nephrology 	2013	27
24088808	12504	Kunis G	IFN-γ-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair.	Brain 	2013	33
24101376	12504	Mele DA	BET bromodomain inhibition suppresses TH17-mediated pathology.	The Journal of experimental medicine	2013	47
24186967	12504	Ismahil MA	Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis.	Circulation research	2014	51
24197130	12504	Alizadeh D	Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.	Cancer research	2014	56
24226770	12504	Furusawa Y	Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.	Nature	2013	418
24373357	12504	Malmhäll C	MicroRNA-155 is essential for T(H)2-mediated allergen-induced eosinophilic inflammation in the lung.	The Journal of allergy and clinical immunology	2014	24
24574499	12504	Woodworth JS	Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.	Journal of immunology	2014	22
24586709	12504	Guo Z	PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer.	PloS one	2014	29
24607504	12504	Keenan BP	A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.	Gastroenterology	2014	22
24657994	12504	Laroumanie F	CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload.	Circulation	2014	21
24679471	12504	Gold MJ	Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures.	The Journal of allergy and clinical immunology	2014	29
25223704	12504	Yin Y	Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth.	Cell research	2014	23
25259750	12504	Trott DW	Oligoclonal CD8+ T cells play a critical role in the development of hypertension.	Hypertension	2014	29
25312824	12504	Martínez-López M	Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.	European journal of immunology	2015	16
25367577	12504	Ferris ST	A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.	Immunity	2014	31
25412660	12504	Sheng W	STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation.	Cell research	2014	29
25575242	12504	Mackley EC	CCR7-dependent trafficking of RORγ⁺ ILCs creates a unique microenvironment within mucosal draining lymph nodes.	Nature communications	2015	30
25589612	12504	Andrade-Oliveira V	Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion.	Journal of the American Society of Nephrology 	2015	19
25607842	12504	Walsh JT	MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4.	The Journal of clinical investigation	2015	16
25628621	12504	Perez-Mazliah D	CD4 T-cell subsets in malaria: TH1/TH2 revisited.	Frontiers in immunology	2014	27
25700434	12504	Wang X	Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cells.	Blood	2015	19
25716473	12504	Shiao SL	TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy.	Cancer immunology research	2015	24
25869387	12504	Filatenkov A	Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.	Clinical cancer research 	2015	22
25870238	12504	Mastelic Gavillet B	MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life.	Journal of immunology	2015	19
25888258	12504	Lukens JR	The NLRP12 Sensor Negatively Regulates Autoinflammatory Disease by Modulating Interleukin-4 Production in T Cells.	Immunity	2015	15
25924064	12504	Gagliani N	Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation.	Nature	2015	90
25934860	12504	Park HJ	PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.	Journal of immunology	2015	19
26054719	12504	Grajales-Reyes GE	Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.	Nature immunology	2015	33
26063000	12504	Sakala IG	Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.	Journal of immunology	2015	16
26248660	12504	Xiao L	Large adipocytes function as antigen-presenting cells to activate CD4(+) T cells via upregulating MHCII in obesity.	International journal of obesity	2016	10
26321681	12504	Ho PC	Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.	Cell	2015	96
26660519	12504	Niemann CU	Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.	Clinical cancer research 	2016	13
26912858	12504	Delong T	Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion.	Science	2016	29
26950746	12504	Stubbington MJT	T cell fate and clonality inference from single-cell transcriptomes.	Nature methods	2016	24
27424773	12504	Scott P	Cutaneous leishmaniasis: immune responses in protection and pathogenesis.	Nature reviews. Immunology	2016	13
9381175	12505	DeGrendele HC	Requirement for CD44 in activated T cell extravasation into an inflammatory site.	Science	1997	124
9887098	12505	Yu Q	Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.	Genes and development	1999	141
10027409	12505	Wielenga VJ	Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.	The American journal of pathology	1999	137
11825873	12505	Yu WH	CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.	Genes and development	2002	98
11935029	12505	Teder P	Resolution of lung inflammation by CD44.	Science	2002	179
16550188	12505	Hasegawa H	Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.	Nature medicine	2006	95
17507906	12505	Herrera MB	Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury.	Kidney international	2007	76
17548814	12505	Dalerba P	Phenotypic characterization of human colorectal cancer stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2007	571
18250474	12505	Huebener P	CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response.	Journal of immunology	2008	50
18362172	12505	McDonald B	Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids.	The Journal of experimental medicine	2008	68
18563844	12505	Wakabayashi K	Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease.	Hepatology	2008	51
19072981	12505	Chu P	Characterization of a subpopulation of colon cancer cells with stem cell-like properties.	International journal of cancer	2009	49
19164299	12505	Garantziotis S	Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice.	The Journal of biological chemistry	2009	50
19415765	12505	Takaishi S	Identification of gastric cancer stem cells using the cell surface marker CD44.	Stem cells	2009	215
19917779	12505	Smeets B	Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells.	Journal of the American Society of Nephrology 	2009	60
19965872	12505	Takahashi E	Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.	The Journal of biological chemistry	2010	54
20197461	12505	Xu Y	CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.	Cancer research	2010	54
21393860	12505	Brown RL	CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression.	The Journal of clinical investigation	2011	133
21622730	12505	Pramanik D	Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice.	Molecular cancer therapeutics	2011	94
21708929	12505	Li Y	Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44.	The Journal of experimental medicine	2011	79
21864475	12505	Li C	c-Met is a marker of pancreatic cancer stem cells and therapeutic target.	Gastroenterology	2011	109
22359577	12505	Dubrovska A	CXCR4 expression in prostate cancer progenitor cells.	PloS one	2012	34
22499789	12505	Kodama K	Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2012	40
23589310	12505	Khurana SS	The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation.	The Journal of biological chemistry	2013	29
24096479	12505	Bessède E	Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes.	Oncogene	2014	33
24162813	12505	Krause DS	Differential regulation of myeloid leukemias by the bone marrow microenvironment.	Nature medicine	2013	56
24395741	12505	Kinugasa Y	CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment.	Stem cells	2014	23
25053293	12505	Fernando J	A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.	International journal of cancer	2015	17
25181692	12505	Wan S	Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.	Gastroenterology	2014	54
25574084	12505	Zhao Y	Stem cells in gastric cancer.	World journal of gastroenterology	2015	16
25797261	12505	Gao Y	Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition.	Oncotarget	2015	15
25993321	12505	Eng DG	Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis.	Kidney international	2015	18
12576554	12514	Ohmi K	Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.	Proceedings of the National Academy of Sciences of the United States of America	2003	109
18664375	12514	Clark PJ	Intact neurogenesis is required for benefits of exercise on spatial memory but not motor performance or contextual fear conditioning in C57BL/6J mice.	Neuroscience	2008	83
20696988	12514	Venegas-Pont M	Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus.	Hypertension	2010	46
21339485	12514	Feig JE	Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques.	Circulation	2011	74
21791632	12514	Daldrup-Link HE	MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles.	Clinical cancer research 	2011	49
22152337	12514	Perego C	Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice.	Journal of neuroinflammation	2011	94
22281423	12514	Ren J	The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.	Biomaterials	2012	35
23813872	12514	Ishimoto T	High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase.	Hepatology	2013	46
24733756	12514	Cekanaviciute E	Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice.	Glia	2014	21
25863279	12514	Gómez-Gálvez Y	Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.	Progress in neuro-psychopharmacology and biological psychiatry	2016	14
2070412	12550	Vleminckx K	Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.	Cell	1991	315
9269988	12550	Foster BA	Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.	Cancer research	1997	129
9515965	12550	Perl AK	A causal role for E-cadherin in the transition from adenoma to carcinoma.	Nature	1998	344
10655586	12550	Cano A	The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression.	Nature cell biology	2000	907
11387478	12550	Lecuit M	A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier.	Science	2001	155
11689706	12550	Carver EA	The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition.	Molecular and cellular biology	2001	186
16489022	12550	Deckers M	The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.	Cancer research	2006	96
17082242	12550	Tan X	Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.	Journal of the American Society of Nephrology 	2006	70
17097565	12550	Derksen PW	Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.	Cancer cell	2006	160
17611683	12550	Kajiyama H	Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.	International journal of oncology	2007	116
18156212	12550	Chiaverotti T	Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.	The American journal of pathology	2008	74
18171685	12550	Arnold SJ	Pivotal roles for eomesodermin during axis formation, epithelium-to-mesenchyme transition and endoderm specification in the mouse.	Development	2008	58
18996109	12550	Pontoriero GF	Co-operative roles for E-cadherin and N-cadherin during lens vesicle separation and lens epithelial cell survival.	Developmental biology	2009	57
19160489	12550	Li M	The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory.	Nature cell biology	2008	69
19188353	12550	Rhee KJ	Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice.	Infection and immunity	2009	61
19362090	12550	von Burstin J	E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.	Gastroenterology	2009	100
19909744	12550	Zhang B	Antimetastatic role of Smad4 signaling in colorectal cancer.	Gastroenterology	2010	51
20150430	12550	Li L	Autophagy is a component of epithelial cell fate in obstructive uropathy.	The American journal of pathology	2010	51
20452298	12550	Weigelt B	Histological types of breast cancer: how special are they?	Molecular oncology	2010	56
20546735	12550	Scholten D	Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice.	Gastroenterology	2010	75
20548288	12550	Pogribny IP	Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice.	Laboratory investigation; a journal of technical methods and pathology	2010	60
21060868	12550	Lewis-Tuffin LJ	Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype.	PloS one	2010	47
21102519	12550	Roy LD	MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition.	Oncogene	2011	80
21159608	12550	Reka AK	Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.	Molecular cancer therapeutics	2010	44
21237166	12550	Marchiando AM	The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding.	Gastroenterology	2011	56
21330634	12550	Powolny AA	Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer.	Journal of the National Cancer Institute	2011	43
21613543	12550	Wendt MK	Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.	Molecular biology of the cell	2011	40
22273460	12550	Bonde AK	Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.	BMC cancer	2012	44
23013135	12550	Yokobori T	MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.	Cancer science	2013	33
23381389	12550	Cong N	Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.	Oncology reports	2013	27
24590176	12550	Shamir ER	Twist1-induced dissemination preserves epithelial identity and requires E-cadherin.	The Journal of cell biology	2014	38
25230372	12550	Sun Y	MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.	The Journal of pathology	2015	32
25970250	12550	Fernández-Sánchez ME	Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure.	Nature	2015	26
27375020	12550	Zhang Q	Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition.	Oncogene	2017	9
27439973	12550	Fan Y	Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.	Journal of hematology and oncology	2016	12
9707425	12575	Venkatachalam S	Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.	The EMBO journal	1998	100
11507077	12575	Martín-Caballero J	Tumor susceptibility of p21(Waf1/Cip1)-deficient mice.	Cancer research	2001	88
12479224	12575	Gartel AL	The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.	Molecular cancer therapeutics	2002	224
14522949	12575	Aszodi A	Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis.	Genes and development	2003	85
16150936	12575	Wang Y	Total body irradiation selectively induces murine hematopoietic stem cell senescence.	Blood	2006	104
16176927	12575	Rattan R	5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.	The Journal of biological chemistry	2005	104
16912279	12575	Stepniak E	c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity.	Genes and development	2006	62
17143283	12575	Choudhury AR	Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation.	Nature genetics	2007	134
18206965	12575	Lim ST	Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.	Molecular cell	2008	146
19033664	12575	Hui L	Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.	The Journal of clinical investigation	2008	81
19122635	12575	Viale A	Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells.	Nature	2009	92
20110366	12575	Pewzner-Jung Y	A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy.	The Journal of biological chemistry	2010	52
20406979	12575	Wong P	The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.	Cancer research	2010	61
21159648	12575	Siddiqui-Jain A	CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.	Cancer research	2010	82
21816922	12575	Conkrite K	miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma.	Genes and development	2011	67
21885021	12575	Matsumoto A	p57 is required for quiescence and maintenance of adult hematopoietic stem cells.	Cell stem cell	2011	87
21900401	12575	Guan B	ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.	Cancer research	2011	91
22882466	12575	Jurk D	Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response.	Aging cell	2012	52
23699408	12575	Inoue S	Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.	Genes and development	2013	31
24715455	12575	Chakkalakal JV	Early forming label-retaining muscle stem cells require p27kip1 for maintenance of the primitive state.	Development	2014	24
24994713	12575	Colvin TA	Hsp70-Bag3 interactions regulate cancer-related signaling networks.	Cancer research	2014	26
26192438	12575	Lu WY	Hepatic progenitor cells of biliary origin with liver repopulation capacity.	Nature cell biology	2015	49
26843616	12575	Benvenuto M	In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.	Oncotarget	2016	11
10232611	12578	Kamijo T	Tumor spectrum in ARF-deficient mice.	Cancer research	1999	112
10911993	12578	Frank KM	DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway.	Molecular cell	2000	147
11212243	12578	Wetmore C	Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.	Cancer research	2001	93
11485986	12578	Dai C	PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.	Genes and development	2001	186
11544530	12578	Krimpenfort P	Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.	Nature	2001	133
11751631	12578	Fisher GH	Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.	Genes and development	2001	185
12226664	12578	Bardeesy N	Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.	Nature	2002	156
12359767	12578	Uhrbom L	Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.	Cancer research	2002	92
14681207	12578	Aguirre AJ	Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.	Genes and development	2003	325
14991053	12578	Bulavin DV	Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.	Nature genetics	2004	129
15489287	12578	Keller C	Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.	Genes and development	2004	105
15899789	12578	Ackermann J	Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.	Cancer research	2005	68
16199867	12578	Colombo E	Nucleophosmin is required for DNA integrity and p19Arf protein stability.	Molecular and cellular biology	2005	67
16585505	12578	Bardeesy N	Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.	Proceedings of the National Academy of Sciences of the United States of America	2006	191
16618932	12578	Williams RT	Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.	Proceedings of the National Academy of Sciences of the United States of America	2006	83
16957737	12578	Krishnamurthy J	p16INK4a induces an age-dependent decline in islet regenerative potential.	Nature	2006	289
17114584	12578	Bardeesy N	Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.	Genes and development	2006	183
17450133	12578	Sarkisian CJ	Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.	Nature cell biology	2007	149
17637672	12578	Matheu A	Delayed ageing through damage protection by the Arf/p53 pathway.	Nature	2007	166
17713536	12578	Krimpenfort P	p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.	Nature	2007	84
18483220	12578	Terzian T	The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.	Genes and development	2008	116
19246562	12578	Cullion K	Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.	Blood	2009	49
19435898	12578	Mukherjee B	EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma.	Cancer research	2009	63
20173736	12578	Visel A	Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.	Nature	2010	138
20197468	12578	Becher OJ	Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma.	Cancer research	2010	53
20639864	12578	Johnson RA	Cross-species genomics matches driver mutations and cell compartments to model ependymoma.	Nature	2010	115
20708155	12578	Bennecke M	Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis.	Cancer cell	2010	50
20713517	12578	Inda MM	Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.	Genes and development	2010	166
21665147	12578	Guerra C	Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence.	Cancer cell	2011	99
21730286	12578	Mei J	MicroRNA-146a inhibits glioma development by targeting Notch1.	Molecular and cellular biology	2011	44
21975932	12578	Jin X	EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction.	Cancer research	2011	41
22264792	12578	Ling J	KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.	Cancer cell	2012	125
22275380	12578	Zhang H	HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells.	Blood	2012	35
22872574	12578	Roberts PJ	Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models.	Clinical cancer research 	2012	58
23103869	12578	Biankin AV	Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.	Nature	2012	392
23267082	12578	Kowalska E	NONO couples the circadian clock to the cell cycle.	Proceedings of the National Academy of Sciences of the United States of America	2013	44
23376950	12578	Braumüller H	T-helper-1-cell cytokines drive cancer into senescence.	Nature	2013	128
24622326	12578	Shao L	Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner.	Blood	2014	28
26044703	12578	Tabibian JH	Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.	Hepatology	2016	12
26840489	12578	Baker DJ	Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan.	Nature	2016	122
10951241	12765	Devalaraja RM	Delayed wound healing in CXCR2 knockout mice.	The Journal of investigative dermatology	2000	90
12464676	12765	Belperio JA	Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury.	The Journal of clinical investigation	2002	124
14978086	12765	Keane MP	Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.	Journal of immunology	2004	80
16237115	12765	Numasaki M	IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.	Journal of immunology	2005	114
16474398	12765	Weathington NM	A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation.	Nature medicine	2006	154
16485040	12765	Reutershan J	Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung.	The Journal of clinical investigation	2006	110
16618742	12765	Wislez M	High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras.	Cancer research	2006	63
17202320	12765	Yu JJ	An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals.	Blood	2007	82
18347102	12765	Carlson T	The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease.	The Journal of experimental medicine	2008	86
19109198	12765	Shin K	Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes.	Journal of immunology	2009	56
19904283	12765	Semple BD	Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.	Journal of cerebral blood flow and metabolism 	2010	93
20154684	12765	Liu L	CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.	Nature neuroscience	2010	59
20727790	12765	Chou RC	Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis.	Immunity	2010	85
20818377	12765	Marcos V	CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation.	Nature medicine	2010	68
22532075	12765	Marques PE	Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure.	Hepatology	2012	41
22922255	12765	Jamieson T	Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis.	The Journal of clinical investigation	2012	76
23272179	12765	Shang K	Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice.	PloS one	2012	33
24084739	12765	Dorhoi A	MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment.	The Journal of clinical investigation	2013	37
24229710	12765	Katoh H	CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis.	Cancer cell	2013	74
24509076	12765	Nouailles G	CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis.	The Journal of clinical investigation	2014	39
24848257	12765	Highfill SL	Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.	Science translational medicine	2014	76
25156255	12765	Di Mitri D	Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.	Nature	2014	30
27265504	12765	Steele CW	CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.	Cancer cell	2016	20
15254596	12766	Jiang D	Regulation of pulmonary fibrosis by chemokine receptor CXCR3.	The Journal of clinical investigation	2004	70
17442962	12766	Hansen DS	NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria.	Journal of immunology	2007	59
17709491	12766	Müller M	CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system.	Journal of immunology	2007	60
18250476	12766	Zhang B	CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis.	Journal of immunology	2008	63
18347328	12766	Campanella GS	Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.	Proceedings of the National Academy of Sciences of the United States of America	2008	89
18485912	12766	Lammers KM	Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.	Gastroenterology	2008	82
19433855	12766	Wallace KL	NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines.	Blood	2009	46
20484822	12766	Jiang D	Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4.	The Journal of clinical investigation	2010	48
21948969	12766	Hong M	Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control.	Cancer research	2011	52
22116822	12766	Cekic C	Adenosine A2B receptor blockade slows growth of bladder and breast tumors.	Journal of immunology	2012	37
22815789	12766	Srivastava MK	Myeloid suppressor cell depletion augments antitumor activity in lung cancer.	PloS one	2012	53
23318994	12766	Chaturvedi P	Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis.	The Journal of clinical investigation	2013	70
24523323	12766	Rashighi M	CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.	Science translational medicine	2014	27
25769612	12766	Hickman HD	CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells.	Immunity	2015	25
9689100	12767	Ma Q	Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	1998	363
10229189	12767	Ma Q	The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment.	Immunity	1999	156
11983855	12767	Lu M	Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor.	Proceedings of the National Academy of Sciences of the United States of America	2002	118
11994419	12767	Wright DE	Hematopoietic stem cells are uniquely selective in their migratory response to chemokines.	The Journal of experimental medicine	2002	105
12832536	12767	Stumm RK	CXCR4 regulates interneuron migration in the developing neocortex.	The Journal of neuroscience 	2003	124
14722616	12767	Hashimoto N	Bone marrow-derived progenitor cells in pulmonary fibrosis.	The Journal of clinical investigation	2004	223
15087398	12767	Tavor S	CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.	Cancer research	2004	72
15533866	12767	Abbott JD	Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.	Circulation	2004	202
15574767	12767	Smith MC	CXCR4 regulates growth of both primary and metastatic breast cancer.	Cancer research	2004	206
15647826	12767	Sun YX	Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.	Journal of bone and mineral research 	2005	101
15840024	12767	Tögel F	Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury.	Kidney international	2005	90
17646584	12767	Hu X	Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis.	Circulation	2007	84
18427137	12767	Saxena A	Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction.	Circulation	2008	59
19050309	12767	Nervi B	Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.	Blood	2009	136
19248097	12767	Kitaori T	Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.	Arthritis and rheumatism	2009	135
19332720	12767	Kamoun WS	Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.	Journal of clinical oncology 	2009	90
19407239	12767	Tang YL	Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.	Circulation research	2009	116
19433312	12767	Mehrad B	Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis.	The international journal of biochemistry and cell biology	2009	56
19996457	12767	Zernecke A	Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection.	Science signaling	2009	279
20179352	12767	Kioi M	Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.	The Journal of clinical investigation	2010	185
20237412	12767	Jablonska J	Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model.	The Journal of clinical investigation	2010	81
20392955	12767	Wang Y	Dlx5 and Dlx6 regulate the development of parvalbumin-expressing cortical interneurons.	The Journal of neuroscience 	2010	51
20437584	12767	Fan Y	Endothelial progenitor cell transplantation improves long-term stroke outcome in mice.	Annals of neurology	2010	81
20534485	12767	Patel JR	CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination.	Proceedings of the National Academy of Sciences of the United States of America	2010	57
21618540	12767	Ping YF	The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.	The Journal of pathology	2011	48
21742774	12767	Righi E	CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.	Cancer research	2011	43
22294553	12767	Eberl M	Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells.	EMBO molecular medicine	2012	50
22685115	12767	Dong F	Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.	Circulation	2012	39
22815651	12767	Campbell JP	Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice.	PLoS biology	2012	45
23091025	12767	Meechan DW	Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2012	31
23213054	12767	Kuhne MR	BMS-936564/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies.	Clinical cancer research 	2013	49
23509246	12767	Gil M	Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases.	Proceedings of the National Academy of Sciences of the United States of America	2013	37
23813475	12767	Bertran E	Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells.	Hepatology	2013	27
24242874	12767	Chen Y	Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.	Hepatology	2014	26
24256728	12767	Ding BS	Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.	Nature	2014	88
25422496	12767	Nakai A	Control of lymphocyte egress from lymph nodes through β2-adrenergic receptors.	The Journal of experimental medicine	2014	31
25662009	12767	McDermott DH	Chromothriptic cure of WHIM syndrome.	Cell	2015	20
25736399	12767	Philipp-Abbrederis K	In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.	EMBO molecular medicine	2015	19
26058075	12767	Pitt LA	CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance.	Cancer cell	2015	29
26374999	12767	Zhang D	Neutrophil ageing is regulated by the microbiome.	Nature	2015	44
9342361	12772	Kuziel WA	Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2.	Proceedings of the National Academy of Sciences of the United States of America	1997	182
9362535	12772	Kurihara T	Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor.	The Journal of experimental medicine	1997	150
10854218	12772	Dawson TC	Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus.	The American journal of pathology	2000	108
10993920	12772	Fife BT	CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis.	The Journal of experimental medicine	2000	124
11015448	12772	Izikson L	Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.	The Journal of experimental medicine	2000	132
12415265	12772	Merad M	Langerhans cells renew in the skin throughout life under steady-state conditions.	Nature immunology	2002	207
14566334	12772	Ambati J	An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice.	Nature medicine	2003	204
15928200	12772	Robben PM	Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis.	The Journal of experimental medicine	2005	97
16543609	12772	Moore BB	The role of CCL12 in the recruitment of fibrocytes and lung fibrosis.	American journal of respiratory cell and molecular biology	2006	110
17191078	12772	Yan YP	Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia.	Journal of cerebral blood flow and metabolism 	2007	71
17332467	12772	Dimitrijevic OB	Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice.	Stroke	2007	84
17989304	12772	Zhang J	Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain.	The Journal of neuroscience 	2007	113
18089798	12772	Klopp AH	Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment.	Cancer research	2007	78
18250467	12772	Lin KL	CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality.	Journal of immunology	2008	163
18375791	12772	Sawanobori Y	Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.	Blood	2008	99
18522849	12772	Belema-Bedada F	Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2.	Cell stem cell	2008	68
18691912	12772	Dunay IR	Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii.	Immunity	2008	162
18713872	12772	Holt MP	Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury.	Journal of leukocyte biology	2008	82
18835047	12772	El Khoury J	Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.	Trends in pharmacological sciences	2008	62
19359521	12772	Mitchell C	Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice.	The American journal of pathology	2009	47
19720836	12772	Lu X	Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.	The Journal of biological chemistry	2009	64
19920349	12772	Tieu BC	An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice.	The Journal of clinical investigation	2009	120
19933856	12772	Osterholzer JJ	Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes.	Journal of immunology	2009	51
20103702	12772	Obstfeld AE	C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.	Diabetes	2010	65
20145099	12772	Dunay IR	Inflammatory monocytes but not neutrophils are necessary to control infection with Toxoplasma gondii in mice.	Infection and immunity	2010	69
20206286	12772	Ramkumar HL	Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).	Progress in retinal and eye research	2010	47
20234092	12772	Si Y	CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice.	The Journal of clinical investigation	2010	63
20354174	12772	Yao H	Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration.	Blood	2010	54
20889618	12772	Lu H	Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury.	FASEB journal 	2011	46
21131395	12772	Sun L	New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis.	American journal of physiology. Lung cellular and molecular physiology	2011	54
21131425	12772	Lim JK	Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis.	Journal of immunology	2011	59
21217759	12772	Islam SA	Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells.	Nature immunology	2011	54
21508244	12772	Naert G	CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.	The Journal of neuroscience 	2011	49
21654748	12772	Qian BZ	CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.	Nature	2011	432
21813474	12772	Baeck C	Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.	Gut	2012	83
21813677	12772	Mildner A	Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease.	The Journal of neuroscience 	2011	84
21825019	12772	Tagliani E	Coordinate regulation of tissue macrophage and dendritic cell population dynamics by CSF-1.	The Journal of experimental medicine	2011	43
21913218	12772	Gibon E	Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles.	Journal of orthopaedic research 	2012	32
22190370	12772	Terrando N	Resolving postoperative neuroinflammation and cognitive decline.	Annals of neurology	2011	74
22190646	12772	Oh DY	Increased macrophage migration into adipose tissue in obese mice.	Diabetes	2012	83
22516258	12772	Nakasone ES	Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance.	Cancer cell	2012	101
22718543	12772	Gliem M	Macrophages prevent hemorrhagic infarct transformation in murine stroke models.	Annals of neurology	2012	52
22789541	12772	Wolf MJ	Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway.	Cancer cell	2012	49
22848538	12772	Craven M	Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease.	PloS one	2012	42
22863620	12772	Butovsky O	Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.	The Journal of clinical investigation	2012	97
23081697	12772	Zhao L	Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis.	Hepatology	2013	38
23168163	12772	Ren G	CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα.	Cell stem cell	2012	57
23185004	12772	Miller RE	CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis.	Proceedings of the National Academy of Sciences of the United States of America	2012	44
23434060	12772	Egawa M	Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4.	Immunity	2013	50
23438822	12772	Norris BA	Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity.	Immunity	2013	33
23467934	12772	Osterholzer JJ	Implicating exudate macrophages and Ly-6C(high) monocytes in CCR2-dependent lung fibrosis following gene-targeted alveolar injury.	Journal of immunology	2013	25
23533946	12772	Cruz-Guilloty F	Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration.	International journal of inflammation	2013	28
23616627	12772	Majmudar MD	Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice.	Circulation	2013	47
23653148	12772	Sanford DE	Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.	Clinical cancer research 	2013	81
23928703	12772	Lin TH	Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling.	Cell death and disease	2013	34
23966702	12772	Wohleb ES	Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior.	The Journal of neuroscience 	2013	85
24184057	12772	Tamoutounour S	Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin.	Immunity	2013	107
24623768	12772	Hammond MD	CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage.	The Journal of neuroscience 	2014	30
24695541	12772	Morganti JM	Cranial irradiation alters the brain's microenvironment and permits CCR2+ macrophage infiltration.	PloS one	2014	21
24696480	12772	Poo YS	CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis.	Journal of virology	2014	21
24806994	12772	Hsieh CL	CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury.	Journal of neurotrauma	2014	22
24890723	12772	Zigmond E	Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury.	Journal of immunology	2014	41
24904083	12772	Zhou X	Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation.	Journal of the American Society of Nephrology 	2015	18
25315009	12772	Morinaga H	Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice.	Diabetes	2015	15
25337873	12772	Bonapace L	Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.	Nature	2014	70
25384670	12772	Spaan AN	The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors.	Nature communications	2014	26
25779633	12772	Lampron A	Inefficient clearance of myelin debris by microglia impairs remyelinating processes.	The Journal of experimental medicine	2015	27
25800956	12772	Dal-Secco D	A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury.	The Journal of experimental medicine	2015	39
26452628	12772	Li X	Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.	Gut	2017	24
27444755	12772	Sager HB	Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure.	Circulation research	2016	18
2188141	12977	Yoshida H	The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene.	Nature	1990	292
2191302	12977	Wiktor-Jedrzejczak W	Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.	Proceedings of the National Academy of Sciences of the United States of America	1990	180
10804170	12977	Gouon-Evans V	Postnatal mammary gland development requires macrophages and eosinophils.	Development	2000	105
11257139	12977	Lin EY	Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.	The Journal of experimental medicine	2001	424
14675042	12977	Chow F	Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.	Kidney international	2004	86
14742270	12977	Dewald O	Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction.	The American journal of pathology	2004	101
15034056	12977	Sunderkötter C	Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response.	Journal of immunology	2004	323
17314396	12977	Majumdar A	Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils.	Molecular biology of the cell	2007	63
19109434	12977	Wang S	Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.	Proceedings of the National Academy of Sciences of the United States of America	2009	47
19398755	12977	Kubota Y	M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.	The Journal of experimental medicine	2009	95
19435787	12977	Joly S	Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions.	The American journal of pathology	2009	47
19587445	12977	Menke J	CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice.	The Journal of clinical investigation	2009	48
20018620	12977	Ojalvo LS	Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors.	Journal of immunology	2010	59
21536742	12977	Hashimoto D	Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.	The Journal of experimental medicine	2011	41
21762674	12977	Alikhan MA	Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses.	The American journal of pathology	2011	40
21822305	12977	Pyonteck SM	Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development.	Oncogene	2012	30
22039576	12977	DeNardo DG	Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.	Cancer discovery	2011	353
22046273	12977	Erblich B	Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits.	PloS one	2011	74
22078798	12977	Choi JH	Flt3 signaling-dependent dendritic cells protect against atherosclerosis.	Immunity	2011	58
22294205	12977	Coniglio SJ	Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.	Molecular medicine	2012	58
23296467	12977	Luo J	Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival.	The Journal of experimental medicine	2013	34
23372702	12977	Ryder M	Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression.	PloS one	2013	28
7958674	12981	Dieleman LA	Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.	Gastroenterology	1994	166
8171324	12981	Dranoff G	Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.	Science	1994	160
8202532	12981	Stanley E	Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.	Proceedings of the National Academy of Sciences of the United States of America	1994	158
10562301	12981	Gracie JA	A proinflammatory role for IL-18 in rheumatoid arthritis.	The Journal of clinical investigation	1999	99
11160337	12981	Fischer HG	Brain dendritic cells and macrophages/microglia in central nervous system inflammation.	Journal of immunology	2001	105
15891110	12981	Rojas M	Bone marrow-derived mesenchymal stem cells in repair of the injured lung.	American journal of respiratory cell and molecular biology	2005	214
17557120	12981	Jinushi M	MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF.	The Journal of clinical investigation	2007	63
18192401	12981	Ohnishi N	Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse.	Proceedings of the National Academy of Sciences of the United States of America	2008	163
19223554	12981	Eubank TD	Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages.	Cancer research	2009	50
19752185	12981	Zhu SN	GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions.	The Journal of experimental medicine	2009	50
21917794	12981	Yamada K	In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice.	The Journal of neuroscience 	2011	68
21954284	12981	Youn JI	Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.	Journal of leukocyte biology	2012	88
21969559	12981	Meyer C	Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.	Proceedings of the National Academy of Sciences of the United States of America	2011	69
22698406	12981	Bayne LJ	Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.	Cancer cell	2012	178
22698407	12981	Pylayeva-Gupta Y	Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia.	Cancer cell	2012	143
23775718	12981	Vincent L	Mast cell activation contributes to sickle cell pathobiology and pain in mice.	Blood	2013	37
23796475	12981	Kapanadze T	Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.	Journal of hepatology	2013	29
24091328	12981	Waight JD	Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis.	The Journal of clinical investigation	2013	51
24446489	12981	Sawada H	Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension.	The Journal of experimental medicine	2014	22
25263125	12981	Schneider C	Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages.	Nature immunology	2014	38
25274301	12981	Suzuki T	Pulmonary macrophage transplantation therapy.	Nature	2014	36
25388222	12981	Huen SC	GM-CSF Promotes Macrophage Alternative Activation after Renal Ischemia/Reperfusion Injury.	Journal of the American Society of Nephrology 	2015	15
25866971	12981	Rajavelu P	Airway epithelial SPDEF integrates goblet cell differentiation and pulmonary Th2 inflammation.	The Journal of clinical investigation	2015	15
26458769	12981	Song C	Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation.	The Journal of experimental medicine	2015	21
16732273	13051	Cardona AE	Control of microglial neurotoxicity by the fractalkine receptor.	Nature neuroscience	2006	399
17652758	13051	Tuo J	Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration.	Investigative ophthalmology and visual science	2007	92
17909628	13051	Combadière C	CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.	The Journal of clinical investigation	2007	169
18490516	13051	Soehnlein O	Neutrophil secretion products pave the way for inflammatory monocytes.	Blood	2008	79
18575457	13051	Dénes A	Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse.	Journal of cerebral blood flow and metabolism 	2008	99
18971423	13051	Landsman L	CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival.	Blood	2009	101
19733097	13051	Varol C	Intestinal lamina propria dendritic cell subsets have different origin and functions.	Immunity	2009	229
20089703	13051	Niess JH	Enteric flora expands gut lamina propria CX3CR1+ dendritic cells supporting inflammatory immune responses under normal and inflammatory conditions.	Journal of immunology	2010	69
20305648	13051	Fuhrmann M	Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease.	Nature neuroscience	2010	151
20683935	13051	Aoyama T	CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice.	Hepatology	2010	45
20864679	13051	Lee S	CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.	The American journal of pathology	2010	121
20920788	13051	Bhaskar K	Regulation of tau pathology by the microglial fractalkine receptor.	Neuron	2010	122
21159979	13051	Liu Z	CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis.	The Journal of neuroscience 	2010	88
21734283	13051	Donnelly DJ	Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages.	The Journal of neuroscience 	2011	58
21771791	13051	Cho SH	CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.	The Journal of biological chemistry	2011	69
22045567	13051	Medina-Contreras O	CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice.	The Journal of clinical investigation	2011	80
22072675	13051	Rogers JT	CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.	The Journal of neuroscience 	2011	109
22327225	13051	Gil-Bernabé AM	Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice.	Blood	2012	60
22990622	13051	Bain CC	Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors.	Mucosal immunology	2013	135
23100431	13051	Hoshiko M	Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex.	The Journal of neuroscience 	2012	45
23392842	13051	Jung K	Endoscopic time-lapse imaging of immune cells in infarcted mouse hearts.	Circulation research	2013	30
23424002	13051	Pong WW	Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.	Annals of neurology	2013	30
23440897	13051	Fumagalli S	CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice.	Glia	2013	32
24177428	13051	Lionakis MS	CX3CR1-dependent renal macrophage survival promotes Candida control and host survival.	The Journal of clinical investigation	2013	48
24468477	13051	Evans TA	High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury.	Experimental neurology	2014	39
24487234	13051	Zhan Y	Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior.	Nature neuroscience	2014	132
24490760	13051	Tang Z	CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke.	Journal of neuroinflammation	2014	28
24967715	13051	Girgis NM	Ly6C(high) monocytes become alternatively activated macrophages in schistosome granulomas with help from CD4+ cells.	PLoS pathogens	2014	22
25630253	13051	Condello C	Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques.	Nature communications	2015	28
25833819	13051	Maphis N	Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.	Brain 	2015	29
25902482	13051	Cronk JC	Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli.	Immunity	2015	24
25987130	13051	Feng X	Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.	Oncotarget	2015	15
10899910	13058	Mastroeni P	Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo.	The Journal of experimental medicine	2000	124
15867174	13058	Tojo T	Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia.	Circulation	2005	92
18180403	13058	Looi YH	Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction.	Hypertension	2008	67
18202172	13058	Park L	Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein.	Proceedings of the National Academy of Sciences of the United States of America	2008	107
18583711	13058	Urao N	Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia.	Circulation research	2008	67
19380816	13058	Corzo CA	Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.	Journal of immunology	2009	155
19661248	13058	Carnesecchi S	NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice.	American journal of respiratory and critical care medicine	2009	48
20145655	13058	Brait VH	Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide.	Journal of cerebral blood flow and metabolism 	2010	48
20659322	13058	Dohi K	Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury.	Journal of neuroinflammation	2010	52
20877715	13058	Kleinschnitz C	Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.	PLoS biology	2010	111
20884632	13058	Zhao Y	Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy.	Cancer research	2010	46
21302291	13058	Yuan G	Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia.	Journal of cellular physiology	2011	62
21304882	13058	Vlahos R	Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation.	PLoS pathogens	2011	54
21528437	13058	Murdoch CE	Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction.	Basic research in cardiology	2011	37
22456182	13058	Schröder K	Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.	Circulation research	2012	144
22747566	13058	Zhang M	NADPH oxidases in heart failure: poachers or gamekeepers?	Antioxidants and redox signaling	2013	37
23100220	13058	Nlandu Khodo S	NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury.	Journal of the American Society of Nephrology 	2012	31
23100627	13058	Campbell AM	NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus.	Science translational medicine	2012	53
23348743	13058	Gandhirajan RK	Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation.	The Journal of clinical investigation	2013	46
24206089	13058	Nayernia Z	New insights on NOX enzymes in the central nervous system.	Antioxidants and redox signaling	2014	45
24424382	13058	Yang F	NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke.	Journal of cerebral blood flow and metabolism 	2014	26
24739962	13058	Noubade R	NRROS negatively regulates reactive oxygen species during host defence and autoimmunity.	Nature	2014	35
25028121	13058	Pal R	Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy.	Nature communications	2014	35
25104775	13058	Knight JS	Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.	Annals of the rheumatic diseases	2015	45
25341795	13058	Karbach S	Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.	Arteriosclerosis, thrombosis, and vascular biology	2014	23
1865908	13405	Stedman HH	The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy.	Nature	1991	211
11095710	13405	Wang B	Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model.	Proceedings of the National Academy of Sciences of the United States of America	2000	103
12021255	13405	Qu-Petersen Z	Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration.	The Journal of cell biology	2002	196
12847521	13405	Lu QL	Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.	Nature medicine	2003	93
15351425	13405	Briguet A	Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse.	Neuromuscular disorders 	2004	85
15528244	13405	Yeung EW	Effects of stretch-activated channel blockers on Ca2+i and muscle damage in the mdx mouse.	The Journal of physiology	2005	89
15528407	13405	Goyenvalle A	Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.	Science	2004	110
16444267	13405	Alter J	Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.	Nature medicine	2006	136
16789936	13405	Whitehead NP	Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species.	Clinical and experimental pharmacology and physiology	2006	68
16980968	13405	Minetti GC	Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors.	Nature medicine	2006	96
17162189	13405	Deconinck N	Pathophysiology of duchenne muscular dystrophy: current hypotheses.	Pediatric neurology	2007	105
18545222	13405	Jearawiriyapaisarn N	Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice.	Molecular therapy 	2008	75
19186250	13405	Banks GB	The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.	Current topics in developmental biology	2008	56
19277018	13405	Wu B	Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice.	Molecular therapy 	2009	61
19288467	13405	Yokota T	Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs.	Annals of neurology	2009	110
19528256	13405	Greco S	Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia.	FASEB journal 	2009	93
20170628	13405	Moulton HM	Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy.	Biochimica et biophysica acta	2010	48
20859263	13405	Odom GL	Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6.	Molecular therapy 	2011	41
21768542	13405	Rafael-Fortney JA	Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.	Circulation	2011	35
21933029	13405	Zhang Y	Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma.	Human gene therapy	2012	38
22218699	13405	Kornegay JN	Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.	Mammalian genome 	2012	46
22968479	13405	Vulin A	Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping.	Molecular therapy 	2012	37
23197572	13405	Martin EA	Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.	Science translational medicine	2012	32
23297347	13405	Rayavarapu S	Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.	Molecular and cellular proteomics 	2013	29
23462992	13405	Filareto A	An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells.	Nature communications	2013	39
25123483	13405	Long C	Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA.	Science	2014	116
25740330	13405	McGreevy JW	Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.	Disease models and mechanisms	2015	35
25935000	13405	Godfrey C	How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse.	Human molecular genetics	2015	18
26237517	13405	Chal J	Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy.	Nature biotechnology	2015	34
27479876	13405	Schiaffino S	Regulatory T cells and skeletal muscle regeneration.	The FEBS journal	2017	7
7618085	13649	Sibilia M	Strain-dependent epithelial defects in mice lacking the EGF receptor.	Science	1995	189
7630400	13649	Miettinen PJ	Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor.	Nature	1995	196
8052651	13649	Nishikawa R	A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.	Proceedings of the National Academy of Sciences of the United States of America	1994	231
11684709	13649	Mariotti A	EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion.	The Journal of cell biology	2001	87
11818567	13649	Roberts RB	Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2002	82
12621152	13649	Iwamoto R	Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function.	Proceedings of the National Academy of Sciences of the United States of America	2003	94
12791272	13649	Zenz R	c-Jun regulates eyelid closure and skin tumor development through EGFR signaling.	Developmental cell	2003	89
14603439	13649	Pandita A	Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR.	Genes, chromosomes and cancer	2004	88
16453019	13649	Tyner JW	Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals.	The Journal of clinical investigation	2006	84
16554459	13649	Chen S	Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function.	The Journal of neuroscience 	2006	63
16609043	13649	Sarkaria JN	Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.	Clinical cancer research 	2006	100
16648858	13649	Ferby I	Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation.	Nature medicine	2006	84
16672372	13649	Ji H	Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors.	Proceedings of the National Academy of Sciences of the United States of America	2006	73
16705038	13649	Politi K	Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors.	Genes and development	2006	128
17548515	13649	Curto M	Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.	The Journal of cell biology	2007	116
18454306	13649	Stern DF	ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.	Journal of mammary gland biology and neoplasia	2008	59
18632637	13649	Shimamura T	Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.	Cancer research	2008	57
18664652	13649	Gril B	Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain.	Journal of the National Cancer Institute	2008	76
18800267	13649	Burgess AW	EGFR family: structure physiology signalling and therapeutic targets.	Growth factors	2008	69
19190345	13649	Schnidar H	Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.	Cancer research	2009	71
19234449	13649	Keng VW	A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.	Nature biotechnology	2009	81
19249398	13649	Shi G	Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia.	Gastroenterology	2009	63
19452131	13649	Li T	Skin toxicities associated with epidermal growth factor receptor inhibitors.	Targeted oncology	2009	50
19759520	13649	Regales L	Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer.	The Journal of clinical investigation	2009	112
20009104	13649	Guo D	EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.	Science signaling	2009	72
20159552	13649	Long W	SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration.	Molecular cell	2010	52
20978205	13649	Chou YT	EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.	Cancer research	2010	74
21606592	13649	Yan F	Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism.	The Journal of clinical investigation	2011	75
21946538	13649	Bollée G	Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.	Nature medicine	2011	54
22011930	13649	Taskar KS	Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.	Pharmaceutical research	2012	38
22095949	13649	Chen J	EGFR signaling promotes TGFβ-dependent renal fibrosis.	Journal of the American Society of Nephrology 	2012	62
22131831	13649	Reuveni T	Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study.	International journal of nanomedicine	2011	45
22418982	13649	Chen J	Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury.	Kidney international	2012	32
22891338	13649	Zhu W	EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection.	Proceedings of the National Academy of Sciences of the United States of America	2012	31
23032975	13649	Ohno S	Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.	Molecular therapy 	2013	146
23169551	13649	Yang J	Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.	Stem cells	2013	49
23481268	13649	Kwon MC	Mouse models for lung cancer.	Molecular oncology	2013	27
23684791	13649	Tang J	Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury.	The American journal of pathology	2013	25
23966300	13649	Lichtenberger BM	Epidermal EGFR controls cutaneous host defense and prevents inflammation.	Science translational medicine	2013	28
24705402	13649	Zhang MZ	Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy.	Diabetes	2014	30
24726384	13649	Xie H	Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells.	Cell metabolism	2014	71
25173978	13649	Lanaya H	EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation.	Nature cell biology	2014	24
25596178	13649	Martinelli P	The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.	Gut	2016	12
25696001	13649	Johnson LA	Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma.	Science translational medicine	2015	54
25925741	13649	Dong S	The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.	Journal of hematology and oncology	2015	21
26330166	13649	Liu X	Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice.	Cancer research	2015	36
26387848	13649	Shu D	Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.	ACS nano	2015	19
26595119	13649	Antaris AL	A small-molecule dye for NIR-II imaging.	Nature materials	2016	21
27251290	13649	Jia Y	Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.	Nature	2016	22
27402485	13649	Zhang Y	Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer.	Gut	2017	7
1359541	13866	Guy CT	Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.	Proceedings of the National Academy of Sciences of the United States of America	1992	321
2898299	13866	Muller WJ	Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.	Cell	1988	258
9661897	13866	Baselga J	Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.	Cancer research	1998	122
12498714	13866	Moody SE	Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.	Cancer cell	2002	109
16369543	13866	Bentires-Alj M	A role for the scaffolding adapter GAB2 in breast cancer.	Nature medicine	2006	67
16951186	13866	Campbell MJ	Breast cancer growth prevention by statins.	Cancer research	2006	72
17283148	13866	Tada H	In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice.	Cancer research	2007	84
17875707	13866	Liu JC	Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.	Cancer research	2007	73
18008005	13866	Zuo T	FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.	The Journal of clinical investigation	2007	61
18167340	13866	Hüsemann Y	Systemic spread is an early step in breast cancer.	Cancer cell	2008	268
18794144	13866	Lee YS	The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis.	Cancer research	2008	70
19106626	13866	Vazquez-Martin A	The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells.	Cell cycle	2009	72
19176373	13866	Ogawa M	In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green.	Cancer research	2009	69
19240213	13866	Barros CS	Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system.	Proceedings of the National Academy of Sciences of the United States of America	2009	68
19411449	13866	Sloan EK	Stromal cell expression of caveolin-1 predicts outcome in breast cancer.	The American journal of pathology	2009	82
19818098	13866	Coscia M	Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.	Journal of cellular and molecular medicine	2010	64
20068073	13866	Ahmed N	HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.	Clinical cancer research 	2010	72
20305377	13866	Martin-Castillo B	Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena.	Cell cycle	2010	81
20713705	13866	Huck L	beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression.	Proceedings of the National Academy of Sciences of the United States of America	2010	49
20813035	13866	Prat A	Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.	Breast cancer research 	2010	520
21081567	13866	Hainfeld JF	Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions.	The British journal of radiology	2011	36
21159656	13866	Liu M	The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion.	Cancer research	2010	52
21499296	13866	Rexer BN	Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition.	Oncogene	2011	47
21510863	13866	Barok M	Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo.	Breast cancer research 	2011	41
21666715	13866	Kondratyev M	Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer.	Oncogene	2012	46
21730275	13866	Morrow PK	Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.	Journal of clinical oncology 	2011	63
22397502	13866	Wang B	Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.	Breast cancer research 	2012	30
22819326	13866	Korkaya H	Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population.	Molecular cell	2012	110
23569315	13866	Rimawi MF	Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006.	Journal of clinical oncology 	2013	40
23873688	13866	John LB	Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells.	Clinical cancer research 	2013	96
23940356	13866	Hanker AB	Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies.	Proceedings of the National Academy of Sciences of the United States of America	2013	40
24097864	13866	Phillips GD	Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.	Clinical cancer research 	2014	28
24322659	13866	Zhu P	Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models.	Cancer prevention research	2014	23
24556924	13866	Popovich IG	Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin.	Cancer biology and therapy	2014	22
24845231	13866	Krishnan N	Targeting the disordered C terminus of PTP1B with an allosteric inhibitor.	Nature chemical biology	2014	43
25196138	13866	Orecchioni S	The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.	International journal of cancer	2015	26
25277192	13866	Khan S	MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.	Oncotarget	2014	30
25689852	13866	Hiroshima Y	Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern.	PloS one	2015	19
25739959	13866	Memmi EM	p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling.	Proceedings of the National Academy of Sciences of the United States of America	2015	38
25961456	13866	Abravanel DL	Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.	The Journal of clinical investigation	2015	16
26047477	13866	Hiroshima Y	Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models.	PloS one	2015	21
8248223	13982	Lubahn DB	Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.	Proceedings of the National Academy of Sciences of the United States of America	1993	297
9861029	13982	Krege JH	Generation and reproductive phenotypes of mice lacking estrogen receptor beta.	Proceedings of the National Academy of Sciences of the United States of America	1998	294
11172057	13982	Dubal DB	Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury.	Proceedings of the National Academy of Sciences of the United States of America	2001	140
11581496	13982	Nilsson S	Mechanisms of estrogen action.	Physiological reviews	2001	330
12039798	13982	Pare G	Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury.	Circulation research	2002	82
16356836	13982	Garvin S	Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo.	Cancer letters	2006	63
17332335	13982	Gupta PB	Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers.	Cancer research	2007	56
17491024	13982	Armstrong VJ	Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha.	The Journal of biological chemistry	2007	93
17493263	13982	Herschkowitz JI	Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.	Genome biology	2007	413
17803905	13982	Nakamura T	Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.	Cell	2007	214
18055862	13982	Ricke WA	Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling.	FASEB journal 	2008	54
18063692	13982	Wang C	GPR30 contributes to estrogen-induced thymic atrophy.	Molecular endocrinology	2008	58
19054762	13982	Pedram A	Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse.	The Journal of biological chemistry	2009	46
20577047	13982	Chambliss KL	Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.	The Journal of clinical investigation	2010	77
21555578	13982	Spence RD	Neuroprotection mediated through estrogen receptor-alpha in astrocytes.	Proceedings of the National Academy of Sciences of the United States of America	2011	52
21900603	13982	Ribas V	Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development.	Proceedings of the National Academy of Sciences of the United States of America	2011	47
23345419	13982	Windahl SH	Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice.	Proceedings of the National Academy of Sciences of the United States of America	2013	30
23379261	13982	Li Y	Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.	Molecular cancer	2013	35
23804112	13982	Spence RD	Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons.	The Journal of neuroscience 	2013	27
24038209	13982	Melville KM	Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength.	Journal of bone and mineral research 	2014	22
26599602	13982	Tam A	Sex Differences in Airway Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease.	American journal of respiratory and critical care medicine	2016	11
7533645	14102	Singer GG	The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice.	Immunity	1994	138
8910274	14102	Hahne M	Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.	Science	1996	169
11245480	14102	Jahr S	DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.	Cancer research	2001	248
12579197	14102	Song E	RNA interference targeting Fas protects mice from fulminant hepatitis.	Nature medicine	2003	199
15731075	14102	Eruslanov EB	Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice.	Infection and immunity	2005	74
18328427	14102	Kleber S	Yes and PI3K bind CD95 to signal invasion of glioblastoma.	Cancer cell	2008	82
19955656	14102	Wueest S	Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.	The Journal of clinical investigation	2010	49
20505730	14102	Chen L	CD95 promotes tumour growth.	Nature	2010	103
19092804	14160	Barker N	Crypt stem cells as the cells-of-origin of intestinal cancer.	Nature	2009	558
19136944	14160	Quigley DA	Genetic architecture of mouse skin inflammation and tumour susceptibility.	Nature	2009	66
19324043	14160	Snippert HJ	Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.	Gastroenterology	2009	78
20384634	14160	Uchida H	Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.	Cancer science	2010	45
21383077	14160	Gerbe F	Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium.	The Journal of cell biology	2011	77
22264787	14160	Quante M	Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.	Cancer cell	2012	88
22855427	14160	Schepers AG	Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.	Science	2012	307
22895187	14160	Koo BK	Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.	Nature	2012	119
22955282	14160	Neal MD	Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis.	The Journal of biological chemistry	2012	36
23446353	14160	Buczacki SJ	Intestinal label-retaining cells are secretory precursors expressing Lgr5.	Nature	2013	164
24139758	14160	Fordham RP	Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury.	Cell stem cell	2013	42
24185900	14160	Hahn S	SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition.	The EMBO journal	2013	31
24282287	14160	Hirsch D	LGR5 positivity defines stem-like cells in colorectal cancer.	Carcinogenesis	2014	32
24355609	14160	Snippert HJ	Biased competition between Lgr5 intestinal stem cells driven by oncogenic mutation induces clonal expansion.	EMBO reports	2014	35
25419707	14160	Davis H	Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.	Nature medicine	2015	28
25533785	14160	Huch M	Long-term culture of genome-stable bipotent stem cells from adult human liver.	Cell	2015	78
25725293	14160	Sigal M	Helicobacter pylori Activates and Expands Lgr5(+) Stem Cells Through Direct Colonization of the Gastric Glands.	Gastroenterology	2015	30
26266975	14160	Koren S	PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours.	Nature	2015	41
26503053	14160	Gregorieff A	Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.	Nature	2015	31
11744618	14219	Inoki I	Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.	FASEB journal 	2002	101
12114504	14219	Hashimoto G	Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165.	The Journal of biological chemistry	2002	95
16204060	14219	Yang F	Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis.	Cancer research	2005	95
17554073	14219	Guha M	Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.	FASEB journal 	2007	56
20213804	14219	Sonnylal S	Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.	Arthritis and rheumatism	2010	53
20936632	14219	Liu S	CCN2 is required for bleomycin-induced skin fibrosis in mice.	Arthritis and rheumatism	2011	43
21747166	14219	Kodama T	Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice.	The Journal of clinical investigation	2011	43
22363445	14219	Hall-Glenn F	CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis.	PloS one	2012	36
22542845	14219	Junglas B	Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork.	The American journal of pathology	2012	45
23322166	14219	Sakai N	LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.	FASEB journal 	2013	34
23836645	14219	Neesse A	CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	38
24122827	14219	Chen L	Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells.	Hepatology	2014	32
11689883	14254	Lyden D	Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.	Nature medicine	2001	383
12574630	14254	LeCouter J	Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.	Science	2003	131
12796773	14254	Autiero M	Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.	Nature medicine	2003	151
16226705	14254	Casanovas O	Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.	Cancer cell	2005	406
16341007	14254	Kaplan RN	VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.	Nature	2005	648
16436677	14254	Maharaj AS	Vascular endothelial growth factor localization in the adult.	The American journal of pathology	2006	66
16754748	14254	Li B	VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.	FASEB journal 	2006	77
17389265	14254	Cudmore M	Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.	Circulation	2007	96
19538465	14254	Bergmann A	Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model.	Journal of cellular and molecular medicine	2010	41
20739676	14254	Outtz HH	Notch1 deficiency results in decreased inflammation during wound healing and regulates vascular endothelial growth factor receptor-1 and inflammatory cytokine expression in macrophages.	Journal of immunology	2010	41
21115742	14254	Roybal JD	miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.	Molecular cancer research 	2011	54
22228176	14254	De Falco S	The discovery of placenta growth factor and its biological activity.	Experimental and molecular medicine	2012	42
24332967	14254	Schoors S	Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.	Cell metabolism	2014	53
8033209	14265	-	Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.	Cell	1994	234
9144249	14265	Comery TA	Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.	Proceedings of the National Academy of Sciences of the United States of America	1997	269
11438589	14265	Nimchinsky EA	Abnormal development of dendritic spines in FMR1 knock-out mice.	The Journal of neuroscience 	2001	134
11860268	14265	Li J	Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency.	Molecular and cellular neurosciences	2002	89
12052912	14265	O'Donnell WT	A decade of molecular studies of fragile X syndrome.	Annual review of neuroscience	2002	140
12700164	14265	Willemsen R	The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.	Human molecular genetics	2003	101
15880753	14265	Galvez R	Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome.	American journal of medical genetics. Part A	2005	84
15901791	14265	Qin M	Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse.	The Journal of neuroscience 	2005	91
16076950	14265	Restivo L	Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2005	76
16452252	14265	Nosyreva ED	Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.	Journal of neurophysiology	2006	126
17298186	14265	Westmark CJ	FMRP mediates mGluR5-dependent translation of amyloid precursor protein.	PLoS biology	2007	107
17913902	14265	Lauterborn JC	Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome.	The Journal of neuroscience 	2007	99
18093519	14265	Dölen G	Correction of fragile X syndrome in mice.	Neuron	2007	342
18474609	14265	Narayanan U	S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.	The Journal of biological chemistry	2008	83
18480274	14265	Bureau I	Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knock-out mice.	The Journal of neuroscience 	2008	75
18539120	14265	Dictenberg JB	A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome.	Developmental cell	2008	146
18571098	14265	de Vrij FM	Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.	Neurobiology of disease	2008	134
18784272	14265	Gibson JR	Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome.	Journal of neurophysiology	2008	136
19014369	14265	Brouwer JR	CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome.	Journal of neurochemistry	2008	60
19377084	14265	Hashem V	Ectopic expression of CGG containing mRNA is neurotoxic in mammals.	Human molecular genetics	2009	52
19799873	14265	Yuskaitis CJ	Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.	Biochemical pharmacology	2010	69
19846466	14265	Chen Y	Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration.	Human molecular genetics	2010	72
20071534	14265	Sharma A	Dysregulation of mTOR signaling in fragile X syndrome.	The Journal of neuroscience 	2010	175
20497624	14265	Liu ZH	Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.	The international journal of neuropsychopharmacology	2011	55
20534828	14265	Cruz-Martín A	Delayed stabilization of dendritic spines in fragile X mice.	The Journal of neuroscience 	2010	84
20935171	14265	Cunningham CL	Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development.	Human molecular genetics	2011	35
21084617	14265	Osterweil EK	Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.	The Journal of neuroscience 	2010	118
21220020	14265	Qin M	A mouse model of the fragile X premutation: effects on behavior, dendrite morphology, and regional rates of cerebral protein synthesis.	Neurobiology of disease	2011	44
21262808	14265	Krueger DD	Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2011	47
21516088	14265	Guo W	Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning.	Nature medicine	2011	62
21795546	14265	Deng PY	Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome.	The Journal of neuroscience 	2011	51
21856714	14265	Testa-Silva G	Hyperconnectivity and slow synapses during early development of medial prefrontal cortex in a mouse model for mental retardation and autism.	Cerebral cortex	2012	34
22009360	14265	Hagerman R	Fragile X syndrome and targeted treatment trials.	Results and problems in cell differentiation	2012	39
22048960	14265	Guo W	Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome.	Human molecular genetics	2012	42
22113615	14265	Auerbach BD	Mutations causing syndromic autism define an axis of synaptic pathophysiology.	Nature	2011	181
22267161	14265	Ronesi JA	Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.	Nature neuroscience	2012	63
22466801	14265	Cao Z	Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone.	Human molecular genetics	2012	37
22522472	14265	He CX	The trouble with spines in fragile X syndrome: density, maturity and plasticity.	Neuroscience	2013	38
22993295	14265	Henderson C	Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.	Science translational medicine	2012	63
23235829	14265	Ascano M Jr	FMRP targets distinct mRNA sequence elements to regulate protein expression.	Nature	2012	149
23509247	14265	Dolan BM	Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486.	Proceedings of the National Academy of Sciences of the United States of America	2013	30
24463622	14265	Ludwig AL	CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.	Human molecular genetics	2014	24
25057190	14265	Sidhu H	Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.	The Journal of neuroscience 	2014	38
25383903	14265	Zhang Y	Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(-/y) mice.	Nature neuroscience	2014	25
25561520	14265	Myrick LK	Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.	Proceedings of the National Academy of Sciences of the United States of America	2015	25
25921527	14265	Gross C	Selective role of the catalytic PI3K subunit p110β in impaired higher order cognition in fragile X syndrome.	Cell reports	2015	18
7507904	14580	Smith LE	Oxygen-induced retinopathy in the mouse.	Investigative ophthalmology and visual science	1994	458
9568712	14580	Bush TG	Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice.	Cell	1998	127
10399936	14580	Bush TG	Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice.	Neuron	1999	221
11059815	14580	Eng LF	Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).	Neurochemical research	2000	194
11169793	14580	Nolte C	GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue.	Glia	2001	135
11430801	14580	Cherny RA	Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.	Neuron	2001	201
11606625	14580	Lim GP	The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.	The Journal of neuroscience 	2001	222
15163694	14580	Wilhelmsson U	Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration.	The Journal of neuroscience 	2004	83
15240551	14580	Ferri AL	Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain.	Development	2004	173
15998793	14580	Brambilla R	Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury.	The Journal of experimental medicine	2005	125
18367594	14580	Oberheim NA	Loss of astrocytic domain organization in the epileptic brain.	The Journal of neuroscience 	2008	73
18511600	14580	Yang L	Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers.	Stem cells	2008	69
19293246	14580	Hsuchou H	Obesity induces functional astrocytic leptin receptors in hypothalamus.	Brain 	2009	57
21372007	14580	Park SW	A selective inhibitor of drp1, mdivi-1, increases retinal ganglion cell survival in acute ischemic mouse retina.	Investigative ophthalmology and visual science	2011	37
21451035	14580	Orellana JA	Amyloid β-induced death in neurons involves glial and neuronal hemichannels.	The Journal of neuroscience 	2011	71
22583833	14580	Gallego BI	IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma.	Journal of neuroinflammation	2012	40
22912745	14580	Kamphuis W	GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease.	PloS one	2012	41
22961591	14580	Puche JE	A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice.	Hepatology	2013	28
23047490	14580	Buckman LB	Regional astrogliosis in the mouse hypothalamus in response to obesity.	The Journal of comparative neurology	2013	30
23935246	14580	Biesmans S	Systemic immune activation leads to neuroinflammation and sickness behavior in mice.	Mediators of inflammation	2013	29
24033454	14580	Kane CJ	Effects of ethanol on immune response in the brain: region-specific changes in adolescent versus adult mice.	Alcoholism, clinical and experimental research	2014	29
24357067	14580	Brambilla R	Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination.	Glia	2014	26
24982137	14580	Stöhr J	Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2014	40
25043249	14580	Liu Z	Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke.	Glia	2014	22
15668323	14825	Lappalainen U	Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung.	American journal of respiratory cell and molecular biology	2005	91
16888083	14825	Qualls JE	Suppression of experimental colitis by intestinal mononuclear phagocytes.	Journal of leukocyte biology	2006	75
23645836	14825	De Filippo K	Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation.	Blood	2013	82
24593875	14825	Valencia K	miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization.	Molecular oncology	2014	24
25143000	14825	Wang J	MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.	International journal of cancer	2015	15
25209655	14825	Masterson JC	Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis.	Gut	2015	16
25419628	14825	Schliehe C	The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection.	Nature immunology	2015	21
26019272	14825	Smallie T	Dual-Specificity Phosphatase 1 and Tristetraprolin Cooperate To Regulate Macrophage Responses to Lipopolysaccharide.	Journal of immunology	2015	17
26858343	14825	Wieser V	Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors.	Gut	2017	7
8596934	15111	Forsthuber T	Induction of TH1 and TH2 immunity in neonatal mice.	Science	1996	114
9844047	15111	Dieleman LA	Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.	Clinical and experimental immunology	1998	238
9916129	15111	Hansen G	Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation.	The Journal of clinical investigation	1999	113
12939340	15111	Prass K	Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.	The Journal of experimental medicine	2003	158
12967673	15111	Hunt NH	Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria.	Trends in immunology	2003	153
14500663	15111	Sandler NG	Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair.	Journal of immunology	2003	91
14657217	15111	Schmieg J	Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide.	The Journal of experimental medicine	2003	109
15972667	15111	Stout RD	Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences.	Journal of immunology	2005	213
16086853	15111	Monticelli S	MicroRNA profiling of the murine hematopoietic system.	Genome biology	2005	135
16230473	15111	Tu L	Notch signaling is an important regulator of type 2 immunity.	The Journal of experimental medicine	2005	102
17632526	15111	Idzko M	Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells.	Nature medicine	2007	142
18641328	15111	Stummvoll GH	Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells.	Journal of immunology	2008	53
18942757	15111	Alex P	Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.	Inflammatory bowel diseases	2009	160
19907079	15111	Bedoret D	Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice.	The Journal of clinical investigation	2009	69
20668193	15111	Dénes A	Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice.	The Journal of neuroscience 	2010	41
22277204	15111	Jones CP	Activin A and TGF-β promote T(H)9 cell-mediated pulmonary allergic pathology.	The Journal of allergy and clinical immunology	2012	37
22318520	15111	Josefowicz SZ	Extrathymically generated regulatory T cells control mucosal TH2 inflammation.	Nature	2012	190
22508383	15111	Groβ P	IL-33 attenuates development and perpetuation of chronic intestinal inflammation.	Inflammatory bowel diseases	2012	35
22684102	15111	Masuoka M	Periostin promotes chronic allergic inflammation in response to Th2 cytokines.	The Journal of clinical investigation	2012	53
23235830	15111	Juncadella IJ	Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation.	Nature	2013	53
23293084	15111	Martinez FO	Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences.	Blood	2013	85
23380221	15111	Grotenboer NS	Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology.	The Journal of allergy and clinical immunology	2013	27
25145536	15111	Russell SL	Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases.	The Journal of allergy and clinical immunology	2015	21
25746972	15111	Sehra S	TH9 cells are required for tissue mast cell accumulation during allergic inflammation.	The Journal of allergy and clinical immunology	2015	19
26121748	15111	Raundhal M	High IFN-γ and low SLPI mark severe asthma in mice and humans.	The Journal of clinical investigation	2015	29
7550343	15194	Zeitlin S	Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue.	Nature genetics	1995	153
9267034	15194	Scherzinger E	Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.	Cell	1997	283
9398841	15194	White JK	Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.	Nature genetics	1997	127
9949199	15194	Schilling G	Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.	Human molecular genetics	1999	184
10402204	15194	Hodgson JG	A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.	Neuron	1999	159
10778856	15194	Yamamoto A	Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.	Cell	2000	218
10942430	15194	Jana NR	Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.	Human molecular genetics	2000	91
11062468	15194	Dragatsis I	Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice.	Nature genetics	2000	116
11152661	15194	Lin CH	Neurological abnormalities in a knock-in mouse model of Huntington's disease.	Human molecular genetics	2001	146
11906693	15194	Zeron MM	Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.	Neuron	2002	114
12165554	15194	Luthi-Carter R	Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.	Human molecular genetics	2002	85
12223539	15194	Wellington CL	Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.	The Journal of neuroscience 	2002	83
12812983	15194	Slow EJ	Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.	Human molecular genetics	2003	207
12926013	15194	Menalled LB	Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.	The Journal of comparative neurology	2003	134
14561870	15194	Ferrante RJ	Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.	The Journal of neuroscience 	2003	167
14981075	15194	Gafni J	Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus.	The Journal of biological chemistry	2004	73
15811941	15194	Harper SQ	RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.	Proceedings of the National Academy of Sciences of the United States of America	2005	184
15882643	15194	Gu X	Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.	Neuron	2005	84
15996546	15194	Bae BI	p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.	Neuron	2005	118
16076956	15194	Slow EJ	Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.	Proceedings of the National Academy of Sciences of the United States of America	2005	75
16127709	15194	Stack EC	Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.	The Journal of comparative neurology	2005	79
16251441	15194	Valenza M	Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.	The Journal of neuroscience 	2005	68
16365166	15194	Shin JY	Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity.	The Journal of cell biology	2005	110
16777606	15194	Graham RK	Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.	Cell	2006	204
17352931	15194	Woodman B	The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes.	Brain research bulletin	2007	69
17519223	15194	Kuhn A	Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.	Human molecular genetics	2007	125
17652581	15194	Tang TS	Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.	The Journal of neuroscience 	2007	63
17913701	15194	Settembre C	A block of autophagy in lysosomal storage disorders.	Human molecular genetics	2008	144
17940007	15194	DiFiglia M	Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.	Proceedings of the National Academy of Sciences of the United States of America	2007	125
18337408	15194	Orr AL	N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.	The Journal of neuroscience 	2008	103
18362179	15194	Wang J	Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.	The Journal of cell biology	2008	53
18638556	15194	Heng MY	Rodent genetic models of Huntington disease.	Neurobiology of disease	2008	60
18805465	15194	Hickey MA	Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.	Neuroscience	2008	73
18984744	15194	Martin B	Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.	Diabetes	2009	60
19052220	15194	Tydlacka S	Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.	The Journal of neuroscience 	2008	55
19525941	15194	Morfini GA	Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.	Nature neuroscience	2009	83
19825844	15194	Sathasivam K	Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease.	Human molecular genetics	2010	65
19864571	15194	Southwell AL	Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease.	The Journal of neuroscience 	2009	60
20018729	15194	Bradford J	Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
20145253	15194	Bradford J	Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.	The Journal of biological chemistry	2010	44
20190273	15194	Rose C	Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease.	Human molecular genetics	2010	46
20190739	15194	Bauer PO	Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein.	Nature biotechnology	2010	50
20357106	15194	Li X	Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.	The Journal of neuroscience 	2010	51
20494921	15194	Faideau M	In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.	Human molecular genetics	2010	56
21315254	15194	Crook ZR	Huntington's disease: can mice lead the way to treatment?	Neuron	2011	65
22726834	15194	Kordasiewicz HB	Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.	Neuron	2012	137
23284644	15194	Heikkinen T	Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.	PloS one	2012	44
23372043	15194	Hsiao HY	A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.	Human molecular genetics	2013	34
23872847	15194	Vashishtha M	Targeting H3K4 trimethylation in Huntington disease.	Proceedings of the National Academy of Sciences of the United States of America	2013	26
24302884	15194	Mielcarek M	HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.	PLoS biology	2013	36
24784230	15194	Wang N	Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.	Nature medicine	2014	23
24836077	15194	Yano H	Inhibition of mitochondrial protein import by mutant huntingtin.	Nature neuroscience	2014	25
25038828	15194	Fernández-Nogales M	Huntington's disease is a four-repeat tauopathy with tau nuclear rods.	Nature medicine	2014	34
25556834	15194	Lee JH	Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.	Neuron	2015	16
26900923	15194	Langfelder P	Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice.	Nature neuroscience	2016	25
7854453	15234	Uehara Y	Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor.	Nature	1995	197
15249655	15234	Borowiak M	Met provides essential signals for liver regeneration.	Proceedings of the National Academy of Sciences of the United States of America	2004	128
15856015	15234	Cheng N	Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.	Oncogene	2005	97
16141414	15234	Urbanek K	Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival.	Circulation research	2005	136
16452232	15234	Burgess T	Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.	Cancer research	2006	65
16565519	15234	Yoo MH	Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells.	The Journal of biological chemistry	2006	65
19098908	15234	Stein U	MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.	Nature medicine	2009	105
19470725	15234	Knowles LM	HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.	Clinical cancer research 	2009	51
19920187	15234	Jedeszko C	Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.	Cancer research	2009	45
20842104	15234	Katsha AM	Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model.	Molecular therapy 	2011	39
21199531	15234	Nakamura T	Hepatocyte growth factor twenty years on: Much more than a growth factor.	Journal of gastroenterology and hepatology	2011	80
22095660	15234	Ishikawa T	Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice.	Hepatology	2012	39
24284055	15234	Cañadas I	Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer.	Clinical cancer research 	2014	28
25985180	15234	Finisguerra V	MET is required for the recruitment of anti-tumoural neutrophils.	Nature	2015	27
10861440	15251	Zagzag D	Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression.	Cancer	2000	111
12761491	15251	Unruh A	The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy.	Oncogene	2003	79
12957288	15251	Blouw B	The hypoxic response of tumors is dependent on their microenvironment.	Cancer cell	2003	110
15489957	15251	Karhausen J	Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis.	The Journal of clinical investigation	2004	178
15906272	15251	Greijer AE	Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1).	The Journal of pathology	2005	106
16007254	15251	Peyssonnaux C	HIF-1alpha expression regulates the bactericidal capacity of phagocytes.	The Journal of clinical investigation	2005	176
17234764	15251	Liao D	Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.	Cancer research	2007	115
17549257	15251	Wang Y	The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.	The Journal of clinical investigation	2007	164
17932327	15251	Bosch-Marce M	Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia.	Circulation research	2007	92
18037992	15251	Higgins DF	Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.	The Journal of clinical investigation	2007	217
18184809	15251	Wan C	Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration.	Proceedings of the National Academy of Sciences of the United States of America	2008	102
18397542	15251	Trayhurn P	Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?	The British journal of nutrition	2008	82
18606865	15251	Granger A	Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice.	FASEB journal 	2008	74
18667485	15251	Kimura K	Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis.	American journal of physiology. Renal physiology	2008	61
19136383	15251	Moon JO	Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice.	American journal of physiology. Gastrointestinal and liver physiology	2009	52
19276158	15251	Xie H	LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.	Molecular cancer therapeutics	2009	82
19541609	15251	Shackelford DB	mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2009	67
19584228	15251	Rapisarda A	Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.	Molecular cancer therapeutics	2009	51
20609350	15251	Qi J	Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.	Cancer cell	2010	61
20620956	15251	Lim JH	Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.	Molecular cell	2010	154
20689059	15251	Feinman R	HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury.	American journal of physiology. Gastrointestinal and liver physiology	2010	41
20841473	15251	Doedens AL	Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression.	Cancer research	2010	122
21358671	15251	Bell EL	SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production.	Oncogene	2011	112
21474104	15251	Wang Y	Targeting HIF1α eliminates cancer stem cells in hematological malignancies.	Cell stem cell	2011	97
21592963	15251	Liu Y	Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer.	The Journal of biological chemistry	2011	37
21606594	15251	Jiang X	Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection.	The Journal of clinical investigation	2011	37
21868504	15251	Ciuclan L	A novel murine model of severe pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2011	54
21965273	15251	Wang H	Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α.	Carcinogenesis	2011	42
22225988	15251	Schwab LP	Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.	Breast cancer research 	2012	45
22302938	15251	Krishnan J	Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system.	Genes and development	2012	61
22484816	15251	Maione F	Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice.	The Journal of clinical investigation	2012	32
22589271	15251	Haigis MC	SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis.	Cancer research	2012	44
22615958	15251	Kong J	Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA.	PloS one	2012	31
22925884	15251	Sasaki M	D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function.	Genes and development	2012	69
23249949	15251	Sun K	Selective inhibition of hypoxia-inducible factor 1α ameliorates adipose tissue dysfunction.	Molecular and cellular biology	2013	34
23299930	15251	Liang Y	Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.	Hepatology	2013	46
23316304	15251	Bir SC	Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1α and vascular endothelial growth factor-dependent angiogenesis.	Journal of the American Heart Association	2012	44
23340180	15251	Zhang L	MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma.	Cancer letters	2013	27
23344526	15251	Storti P	Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction.	Leukemia	2013	26
23906982	15251	Eisinger-Mathason TS	Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis.	Cancer discovery	2013	39
24251580	15251	Ball MK	Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.	American journal of respiratory and critical care medicine	2014	33
24336068	15251	Barsoum IB	A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.	Cancer research	2014	48
24931163	15251	Dodd KM	mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3.	Oncogene	2015	18
25040043	15251	Csak T	microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.	Liver international 	2015	16
25063991	15251	Ong SG	HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.	Cardiovascular research	2014	21
25305448	15251	Xu W	Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.	Cancer letters	2015	16
25385028	15251	Zhao T	LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.	Cancer research	2015	17
25535359	15251	Amelio I	TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation.	Proceedings of the National Academy of Sciences of the United States of America	2015	20
26098368	15251	Kimura W	Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart.	Nature	2015	30
26154152	15251	Won C	Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma.	Hepatology	2015	16
26715642	15251	Lee KE	Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia.	Cancer discovery	2016	12
27374498	15251	Lampropoulou V	Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation.	Cell metabolism	2016	16
10391216	15289	Calogero S	The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice.	Nature genetics	1999	136
15374839	15289	Ueno H	Contributions of high mobility group box protein in experimental and clinical acute lung injury.	American journal of respiratory and critical care medicine	2004	89
15640285	15289	Kim JY	HMGB1 contributes to the development of acute lung injury after hemorrhage.	American journal of physiology. Lung cellular and molecular physiology	2005	72
15795240	15289	Tsung A	The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion.	The Journal of experimental medicine	2005	317
16818669	15289	Qin S	Role of HMGB1 in apoptosis-mediated sepsis lethality.	The Journal of experimental medicine	2006	128
17475888	15289	Fan J	Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling.	Journal of immunology	2007	84
17666052	15289	Faraco G	High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.	Journal of neurochemistry	2007	68
18250463	15289	Sha Y	HMGB1 develops enhanced proinflammatory activity by binding to cytokines.	Journal of immunology	2008	117
18574060	15289	Andrassy M	High-mobility group box-1 in ischemia-reperfusion injury of the heart.	Circulation	2008	147
19454652	15289	Davé SH	Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis.	Journal of leukocyte biology	2009	48
19587006	15289	Willingham SB	NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways.	Journal of immunology	2009	91
20700129	15289	Yang QW	HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling.	Journal of cerebral blood flow and metabolism 	2011	45
20811657	15289	Antoine DJ	Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity.	Molecular medicine	2010	43
20847143	15289	Wu H	HMGB1 contributes to kidney ischemia reperfusion injury.	Journal of the American Society of Nephrology 	2010	77
21809356	15289	Li L	Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.	Hepatology	2011	43
22634723	15289	Chavan SS	HMGB1 mediates cognitive impairment in sepsis survivors.	Molecular medicine	2012	35
23954861	15289	Murakami Y	Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration.	Cell death and differentiation	2014	41
24302768	15289	Yanai H	Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection.	Proceedings of the National Academy of Sciences of the United States of America	2013	36
24361123	15289	Kang R	Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice.	Gastroenterology	2014	43
24928512	15289	Ge X	High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD).	The Journal of biological chemistry	2014	27
25164013	15289	Parker KH	HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells.	Cancer research	2014	32
25208916	15289	Koks CA	Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.	International journal of cancer	2015	34
25562324	15289	Huebener P	The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.	The Journal of clinical investigation	2015	48
25623334	15289	Wu H	PGE2 receptor agonist misoprostol protects brain against intracerebral hemorrhage in mice.	Neurobiology of aging	2015	22
25642769	15289	Zhu X	Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation.	The Journal of clinical investigation	2015	17
25681553	15289	Liu Y	Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9.	Journal of hepatology	2015	21
26037082	15289	Zhang W	Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo.	Journal of the American Heart Association	2015	15
26551681	15289	Vogel S	Platelet-derived HMGB1 is a critical mediator of thrombosis.	The Journal of clinical investigation	2015	15
26759232	15289	Tohme S	Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress.	Cancer research	2016	20
26818617	15289	Arriazu E	Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.	Gut	2017	10
15331427	15368	Kapturczak MH	Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse.	The American journal of pathology	2004	96
16485041	15368	Belcher JD	Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice.	The Journal of clinical investigation	2006	78
17525142	15368	Wang J	Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage.	Brain 	2007	96
18060048	15368	Chung SW	Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice.	The Journal of clinical investigation	2008	79
18566435	15368	Innamorato NG	The transcription factor Nrf2 is a therapeutic target against brain inflammation.	Journal of immunology	2008	91
18926825	15368	Choi KM	Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis.	Gastroenterology	2008	66
19706490	15368	Seixas E	Heme oxygenase-1 affords protection against noncerebral forms of severe malaria.	Proceedings of the National Academy of Sciences of the United States of America	2009	79
20186857	15368	Arumugam TV	Age and energy intake interact to modify cell stress pathways and stroke outcome.	Annals of neurology	2010	68
20404253	15368	Wang G	Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.	Circulation	2010	67
20705711	15368	Bolisetty S	Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury.	Journal of the American Society of Nephrology 	2010	53
20844238	15368	Kovtunovych G	Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution.	Blood	2010	62
20881280	15368	Larsen R	A central role for free heme in the pathogenesis of severe sepsis.	Science translational medicine	2010	107
21088618	15368	Radhakrishnan N	Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia.	Journal of pediatric hematology/oncology	2011	37
21289052	15368	Wu QQ	Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.	American journal of physiology. Renal physiology	2011	45
21437926	15368	Carchman EH	Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice.	Hepatology	2011	57
21444764	15368	Sheikh SZ	An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis.	Journal of immunology	2011	38
21518986	15368	Vergadi E	Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.	Circulation	2011	43
23630967	15368	Silva-Gomes S	Heme catabolism by heme oxygenase-1 confers host resistance to Mycobacterium infection.	Infection and immunity	2013	27
24366077	15368	Linzke N	Carbon monoxide promotes proliferation of uterine natural killer cells and remodeling of spiral arteries in pregnant hypertensive heme oxygenase-1 mutant mice.	Hypertension	2014	20
25241054	15368	Naito Y	Heme oxygenase-1 and anti-inflammatory M2 macrophages.	Archives of biochemistry and biophysics	2014	25
25593219	15368	Sun C	Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2.	Journal of applied physiology	2015	18
25790743	15368	Sala E	Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.	Gastroenterology	2015	21
26363199	15368	Jiang W	The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state.	Chemico-biological interactions	2016	10
26765329	15368	Chen X	Overexpression of Heme Oxygenase-1 Prevents Renal Interstitial Inflammation and Fibrosis Induced by Unilateral Ureter Obstruction.	PloS one	2016	10
8613529	15894	Kelly KJ	Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury.	The Journal of clinical investigation	1996	139
9108078	15894	Dustin ML	Antigen receptor engagement delivers a stop signal to migrating T lymphocytes.	Proceedings of the National Academy of Sciences of the United States of America	1997	109
10779797	15894	Yamamoto M	IL-6 is required for the development of Th1 cell-mediated murine colitis.	Journal of immunology	2000	101
11375415	15894	Cybulsky MI	A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.	The Journal of clinical investigation	2001	209
15231732	15894	Joussen AM	A central role for inflammation in the pathogenesis of diabetic retinopathy.	FASEB journal 	2004	278
17116732	15894	Johnson LA	An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium.	The Journal of experimental medicine	2006	84
17143330	15894	Zarbock A	Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation.	The Journal of clinical investigation	2006	140
18202748	15894	Nishimura S	In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue.	The Journal of clinical investigation	2008	72
18246079	15894	Bartlett NW	Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation.	Nature medicine	2008	92
19614983	15894	Dvoriantchikova G	Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury.	The European journal of neuroscience	2009	47
21926464	15894	Fisher DT	IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.	The Journal of clinical investigation	2011	47
23261767	15894	Rolland WB	Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage.	Experimental neurology	2013	33
24067647	15894	Du Y	Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina.	Proceedings of the National Academy of Sciences of the United States of America	2013	56
25361845	15894	Liou GY	Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions.	Cancer discovery	2015	23
25784952	15894	Elahy M	Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment.	Immunity and ageing 	2015	21
14502282	15930	Uyttenhove C	Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.	Nature medicine	2003	382
15254595	15930	Munn DH	Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.	The Journal of clinical investigation	2004	206
16272121	15930	Platten M	Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite.	Science	2005	94
18317452	15930	Prendergast GC	Immune escape as a fundamental trait of cancer: focus on IDO.	Oncogene	2008	70
18477398	15930	Henry CJ	Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.	Journal of neuroinflammation	2008	129
18568076	15930	Reddy P	Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.	The Journal of clinical investigation	2008	95
18952840	15930	Muller AJ	Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.	Proceedings of the National Academy of Sciences of the United States of America	2008	75
19339614	15930	O'Connor JC	Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin.	The Journal of neuroscience 	2009	110
19366986	15930	Sharma MD	Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.	Blood	2009	132
19635913	15930	Baban B	IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.	Journal of immunology	2009	143
20064452	15930	Desvignes L	Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis.	Immunity	2009	79
20124451	15930	Koblish HK	Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors.	Molecular cancer therapeutics	2010	40
20190767	15930	Wang Y	Kynurenine is an endothelium-derived relaxing factor produced during inflammation.	Nature medicine	2010	76
22355111	15930	Ravishankar B	Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase.	Proceedings of the National Academy of Sciences of the United States of America	2012	41
22822050	15930	Smith C	IDO is a nodal pathogenic driver of lung cancer and metastasis development.	Cancer discovery	2012	65
23752227	15930	Holmgaard RB	Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.	The Journal of experimental medicine	2013	96
23986400	15930	Spranger S	Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.	Science translational medicine	2013	233
24402311	15930	Metz R	IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.	International immunology	2014	31
15302901	15975	O'Connell RM	Type I interferon production enhances susceptibility to Listeria monocytogenes infection.	The Journal of experimental medicine	2004	176
16868248	15975	Kamphuis E	Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia.	Blood	2006	61
19812195	15975	Agrawal H	Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease.	Journal of immunology	2009	52
20637658	15975	Kohlmeier JE	Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge.	Immunity	2010	70
21383977	15975	Seo SU	Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice.	PLoS pathogens	2011	49
22911155	15975	Majer O	Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections.	PLoS pathogens	2012	42
25896511	15975	Goldmann T	USP18 lack in microglia causes destructive interferonopathy of the mouse brain.	The EMBO journal	2015	18
26755706	15975	Madera S	Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide.	The Journal of experimental medicine	2016	13
27066744	15975	Lazear HM	A Mouse Model of Zika Virus Pathogenesis.	Cell host and microbe	2016	134
27180225	15975	Miner JJ	Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise.	Cell	2016	136
2104918	15978	Sadick MD	Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.	The Journal of experimental medicine	1990	154
7504064	15978	Flynn JL	An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.	The Journal of experimental medicine	1993	696
7561678	15978	Orange JS	Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.	The Journal of experimental medicine	1995	115
8097322	15978	Tripp CS	Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.	Proceedings of the National Academy of Sciences of the United States of America	1993	198
8245795	15978	Cooper AM	Disseminated tuberculosis in interferon gamma gene-disrupted mice.	The Journal of experimental medicine	1993	642
8752931	15978	Gazzinelli RT	In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.	Journal of immunology	1996	249
8871615	15978	Willenborg DO	IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.	Journal of immunology	1996	162
9104813	15978	Scharton-Kersten TM	Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii.	The Journal of experimental medicine	1997	135
9120292	15978	Perry LL	Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways.	Journal of immunology	1997	129
9362523	15978	Chu RS	CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.	The Journal of experimental medicine	1997	164
9636188	15978	Kaplan DH	Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.	Proceedings of the National Academy of Sciences of the United States of America	1998	289
10521249	15978	Mallat Z	Protective role of interleukin-10 in atherosclerosis.	Circulation research	1999	135
10878379	15978	Smythies LE	Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice.	Journal of immunology	2000	100
10899912	15978	Ashkar AA	Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy.	The Journal of experimental medicine	2000	119
11009425	15978	Guttridge DC	NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.	Science	2000	194
11104801	15978	Wang Z	Interferon gamma induction of pulmonary emphysema in the adult murine lung.	The Journal of experimental medicine	2000	91
11257133	15978	Smyth MJ	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.	The Journal of experimental medicine	2001	86
11323675	15978	Shankaran V	IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.	Nature	2001	495
12122110	15978	Dummer W	T cell homeostatic proliferation elicits effective antitumor autoimmunity.	The Journal of clinical investigation	2002	114
12244183	15978	Seki E	Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice.	Journal of immunology	2002	90
12506197	15978	Shi L	Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence.	Proceedings of the National Academy of Sciences of the United States of America	2003	108
14579280	15978	Rodig N	Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis.	European journal of immunology	2003	101
14614852	15978	Villarino A	The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection.	Immunity	2003	142
14712275	15978	Mempel TR	T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.	Nature	2004	452
15879135	15978	Arora S	Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis.	Journal of immunology	2005	69
15905186	15978	Zappia E	Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.	Blood	2005	316
15944250	15978	Lugade AA	Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.	Journal of immunology	2005	166
16148138	15978	Rutitzky LI	Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17.	Journal of immunology	2005	70
16365150	15978	Bafica A	TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.	The Journal of experimental medicine	2005	171
16680149	15978	Uno T	Eradication of established tumors in mice by a combination antibody-based therapy.	Nature medicine	2006	62
16785554	15978	Komiyama Y	IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.	Journal of immunology	2006	453
16849446	15978	Cruz A	Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection.	Journal of immunology	2006	93
17034586	15978	Ito R	Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.	Clinical and experimental immunology	2006	67
17082625	15978	Feng CG	NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis.	Journal of immunology	2006	61
17227914	15978	Hirota K	T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.	The Journal of experimental medicine	2007	124
17255335	15978	Yamamoto M	Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.	The American journal of pathology	2007	86
17376993	15978	Mount MP	Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.	The Journal of neuroscience 	2007	59
17392692	15978	Hurn PD	T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation.	Journal of cerebral blood flow and metabolism 	2007	102
17393396	15978	Chu CQ	Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.	Arthritis and rheumatism	2007	63
17393408	15978	Young DA	Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.	Arthritis and rheumatism	2007	67
17525184	15978	De Paiva CS	Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma.	Investigative ophthalmology and visual science	2007	72
17546038	15978	Sun J	Mast cells promote atherosclerosis by releasing proinflammatory cytokines.	Nature medicine	2007	96
17559174	15978	Purtha WE	Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.	European journal of immunology	2007	69
17932568	15978	Sun J	Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice.	The Journal of clinical investigation	2007	77
18166357	15978	Jeong WI	Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.	Gastroenterology	2008	68
18202187	15978	Henderson NC	Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis.	The American journal of pathology	2008	82
18268213	15978	Rashid S	Topical omega-3 and omega-6 fatty acids for treatment of dry eye.	Archives of ophthalmology	2008	54
18292536	15978	Lugade AA	Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity.	Journal of immunology	2008	79
18317595	15978	Zhang B	IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.	The Journal of clinical investigation	2008	51
18322463	15978	Harrington LE	Memory CD4 T cells emerge from effector T-cell progenitors.	Nature	2008	89
18568027	15978	Haworth O	Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation.	Nature immunology	2008	116
18791161	15978	Dai R	Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation.	Blood	2008	57
18852291	15978	Lees JR	Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis.	The Journal of experimental medicine	2008	62
18941232	15978	Marques CP	Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis.	Journal of immunology	2008	51
18948106	15978	DeLyria ES	Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent.	Gastroenterology	2009	51
18957685	15978	Carlson MJ	In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.	Blood	2009	81
18958172	15978	Croyle MA	Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.	PloS one	2008	64
18972444	15978	Wang YD	Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.	Hepatology	2008	95
19130584	15978	Martin-Orozco N	Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells.	European journal of immunology	2009	115
19242409	15978	De Paiva CS	IL-17 disrupts corneal barrier following desiccating stress.	Mucosal immunology	2009	107
19297619	15978	Franklin BS	Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function.	Proceedings of the National Academy of Sciences of the United States of America	2009	58
19336265	15978	Le HK	Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.	International immunopharmacology	2009	88
19565166	15978	Henn A	The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation.	ALTEX	2009	93
20138983	15978	Murphy AC	Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.	Brain, behavior, and immunity	2010	88
20173021	15978	Karlsson EA	Diet-induced obesity impairs the T cell memory response to influenza virus infection.	Journal of immunology	2010	50
20368278	15978	Chakrabarty P	IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice.	Journal of immunology	2010	57
20378858	15978	Baldeviano GC	Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.	Circulation research	2010	59
20581149	15978	Yang H	Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance.	Journal of immunology	2010	92
20624892	15978	Scapini P	Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice.	The Journal of experimental medicine	2010	46
23135404	15978	Ouyang W	Novel Foxo1-dependent transcriptional programs control T(reg) cell function.	Nature	2012	84
7744859	16000	Coleman ME	Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice.	The Journal of biological chemistry	1995	117
11466439	16000	Carro E	Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy.	The Journal of neuroscience 	2001	87
11927606	16000	Barton ER	Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice.	The Journal of cell biology	2002	122
12215457	16000	Zhang M	Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization.	The Journal of biological chemistry	2002	208
12907804	16000	Kaspar BK	Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.	Science	2003	196
15210967	16000	Lopez-Lopez C	Insulin-like growth factor I is required for vessel remodeling in the adult brain.	Proceedings of the National Academy of Sciences of the United States of America	2004	70
15650772	16000	Song YH	Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.	The Journal of clinical investigation	2005	93
15657392	16000	Dobrowolny G	Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model.	The Journal of cell biology	2005	115
15924568	16000	Miller RA	Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance.	Aging cell	2005	168
16530517	16000	Horváth VJ	Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis.	Gastroenterology	2006	63
16877542	16000	Wu DC	The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	79
17416680	16000	Okada T	Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2007	92
17942965	16000	Imberti B	Insulin-like growth factor-1 sustains stem cell mediated renal repair.	Journal of the American Society of Nephrology 	2007	64
18177265	16000	Kuro-o M	Klotho as a regulator of oxidative stress and senescence.	Biological chemistry	2008	56
18612045	16000	Waddell DS	The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.	American journal of physiology. Endocrinology and metabolism	2008	95
18728386	16000	Anisimov VN	Metformin slows down aging and extends life span of female SHR mice.	Cell cycle	2008	77
19679072	16000	Palazzolo I	Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy.	Neuron	2009	65
20056750	16000	Zhang L	Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy.	Journal of the American Society of Nephrology 	2010	53
20145127	16000	Lee C	Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index.	Cancer research	2010	59
21048967	16000	Penna F	Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.	PloS one	2010	44
21386129	16000	Anisimov VN	If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice.	Aging	2011	67
21949739	16000	White JP	The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.	PloS one	2011	40
22729283	16000	Xian L	Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.	Nature medicine	2012	91
23771523	16000	Quinn BJ	Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.	Cancer prevention research	2013	26
25003234	16000	Carlson SW	Conditional overexpression of insulin-like growth factor-1 enhances hippocampal neurogenesis and restores immature neuron dendritic processes after traumatic brain injury.	Journal of neuropathology and experimental neurology	2014	20
25619689	16000	Hofmann JW	Reduced expression of MYC increases longevity and enhances healthspan.	Cell	2015	30
25896247	16000	Tonkin J	Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization.	Molecular therapy 	2015	17
26094889	16000	Brandhorst S	A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan.	Cell metabolism	2015	53
26290229	16000	Gontier G	Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance.	The Journal of neuroscience 	2015	17
10229185	16150	Tanaka M	Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice.	Immunity	1999	131
10359587	16150	Li ZW	The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.	The Journal of experimental medicine	1999	238
12075355	16150	Pasparakis M	TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2.	Nature	2002	115
12540784	16150	Li Z	Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.	Hepatology	2003	157
14614859	16150	Maeda S	IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha.	Immunity	2003	103
15479644	16150	Cai D	IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.	Cell	2004	323
15685173	16150	Cai D	Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.	Nature medicine	2005	490
15989949	16150	Maeda S	IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.	Cell	2005	313
16807293	16150	Sakurai T	Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.	Proceedings of the National Academy of Sciences of the United States of America	2006	124
16916935	16150	Reynaert NL	Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.	Proceedings of the National Academy of Sciences of the United States of America	2006	124
17080195	16150	Mourkioti F	Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration.	The Journal of clinical investigation	2006	90
17380205	16150	Acharyya S	Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.	The Journal of clinical investigation	2007	139
17475880	16150	Cheng DS	Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway.	Journal of immunology	2007	73
17803913	16150	Greten FR	NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta.	Cell	2007	178
17982104	16150	Nicholas C	Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation.	Journal of immunology	2007	58
18166353	16150	Cummins EP	The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis.	Gastroenterology	2008	111
18577694	16150	Bradley RL	Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice.	American journal of physiology. Endocrinology and metabolism	2008	67
20808781	16150	Ropelle ER	IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition.	PLoS biology	2010	58
21784844	16150	Meng Q	Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)/NF-kappaB pathway.	The Journal of biological chemistry	2011	52
22327365	16150	Xia Y	Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.	Nature cell biology	2012	31
22828956	16150	Carvalho BM	Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice.	Diabetologia	2012	46
22893683	16150	Shaked H	Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation.	Proceedings of the National Academy of Sciences of the United States of America	2012	36
23041324	16150	Huang H	Activation of nuclear factor-κB in acinar cells increases the severity of pancreatitis in mice.	Gastroenterology	2013	44
23437127	16150	Zhu T	Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB.	PloS one	2013	31
1385868	16153	Hsieh CS	Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system.	Proceedings of the National Academy of Sciences of the United States of America	1992	154
8402911	16153	Kühn R	Interleukin-10-deficient mice develop chronic enterocolitis.	Cell	1993	941
8770874	16153	Berg DJ	Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.	The Journal of clinical investigation	1996	281
10220502	16153	Madsen KL	Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.	Gastroenterology	1999	120
10843696	16153	Hoffmann KF	IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis.	Journal of immunology	2000	111
10958782	16153	Steidler L	Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.	Science	2000	213
11722634	16153	Singh B	Control of intestinal inflammation by regulatory T cells.	Immunological reviews	2001	127
11869683	16153	Mizoguchi A	Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.	Immunity	2002	210
12444141	16153	Turner J	In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice.	Journal of immunology	2002	83
12642601	16153	Chiaramonte MG	Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response.	The Journal of experimental medicine	2003	86
14500760	16153	Froicu M	A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases.	Molecular endocrinology	2003	100
14978122	16153	Hesse M	The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells.	Journal of immunology	2004	111
15187140	16153	van der Sluijs KF	IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.	Journal of immunology	2004	105
15368285	16153	Elliott DE	Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice.	European journal of immunology	2004	81
15534372	16153	Roers A	T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation.	The Journal of experimental medicine	2004	92
15753208	16153	Miles SA	A role for IgG immune complexes during infection with the intracellular pathogen Leishmania.	The Journal of experimental medicine	2005	80
15825073	16153	Kim SC	Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria.	Gastroenterology	2005	117
15937545	16153	Mucida D	Oral tolerance in the absence of naturally occurring Tregs.	The Journal of clinical investigation	2005	143
16005735	16153	Wilson EH	A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis.	Journal of neuroimmunology	2005	66
16275759	16153	Wilson MS	Suppression of allergic airway inflammation by helminth-induced regulatory T cells.	The Journal of experimental medicine	2005	172
16314435	16153	Kearley J	Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent.	The Journal of experimental medicine	2005	132
16393950	16153	Mizoguchi A	A case for regulatory B cells.	Journal of immunology	2006	137
16543948	16153	Dillon S	Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.	The Journal of clinical investigation	2006	139
16670770	16153	Yen D	IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.	The Journal of clinical investigation	2006	419
16849510	16153	Osuchowski MF	Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.	Journal of immunology	2006	143
16903779	16153	Apte RS	Macrophages inhibit neovascularization in a murine model of age-related macular degeneration.	PLoS medicine	2006	73
16920910	16153	Naganuma M	Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis.	Journal of immunology	2006	83
17056509	16153	Uhlig HH	Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis.	Journal of immunology	2006	151
17226902	16153	Foligne B	Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria.	World journal of gastroenterology	2007	85
17241871	16153	Shkoda A	Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.	Gastroenterology	2007	70
17579604	16153	Meyer U	Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling.	Molecular psychiatry	2008	53
17600128	16153	Amante FH	A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria.	The American journal of pathology	2007	58
17641052	16153	Gupta N	Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice.	Journal of immunology	2007	243
17660506	16153	Mitchell LA	Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes.	Toxicological sciences 	2007	79
17694059	16153	Maynard CL	Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.	Nature immunology	2007	180
17760501	16153	Stecher B	Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota.	PLoS biology	2007	314
17975672	16153	Kelly J	Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice.	The Journal of clinical investigation	2007	62
17994023	16153	Fitzgerald DC	Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells.	Nature immunology	2007	194
18292504	16153	Selvaraj RK	Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance.	Journal of immunology	2008	51
18322239	16153	Schnoeller C	A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages.	Journal of immunology	2008	54
18387831	16153	Rubtsov YP	Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.	Immunity	2008	387
18497886	16153	Shmelkov SV	CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.	The Journal of clinical investigation	2008	263
18523633	16153	Chen H	The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration.	PloS one	2008	51
18613832	16153	O'Garra A	Strategies for use of IL-10 or its antagonists in human disease.	Immunological reviews	2008	108
18829978	16153	Arrieta MC	Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse.	Gut	2009	56
19098906	16153	Németh K	Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.	Nature medicine	2009	460
19570783	16153	Gounaris E	T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis.	Cancer research	2009	57
19587018	16153	Walsh KP	Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses.	Journal of immunology	2009	55
19620304	16153	Madan R	Nonredundant roles for B cell-derived IL-10 in immune counter-regulation.	Journal of immunology	2009	102
19884657	16153	Yang J	Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis.	The Journal of clinical investigation	2009	51
20051628	16153	González-Navajas JM	TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice.	The Journal of clinical investigation	2010	48
20093775	16153	Bamboat ZM	Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion.	The Journal of clinical investigation	2010	62
20299353	16153	Cao Q	IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis.	Journal of the American Society of Nephrology 	2010	51
20518032	16153	Redford PS	Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung.	European journal of immunology	2010	72
20531465	16153	Ochoa-Repáraz J	A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease.	Mucosal immunology	2010	90
20631310	16153	Findlay EG	Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection.	Journal of immunology	2010	42
20641004	16153	Toben D	Fracture healing is accelerated in the absence of the adaptive immune system.	Journal of bone and mineral research 	2011	36
20842630	16153	Ki SH	Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.	Hepatology	2010	105
21118895	16153	Villalta SA	Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype.	Human molecular genetics	2011	60
21149607	16153	Sayi A	TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells.	Journal of immunology	2011	39
21263114	16153	Lai Z	A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice.	Hypertension	2011	35
21317392	16153	Trandem K	Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis.	Journal of immunology	2011	42
21433043	16153	Thomas JA	Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.	Hepatology	2011	58
21511184	16153	Huber S	Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.	Immunity	2011	150
21511185	16153	Chaudhry A	Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.	Immunity	2011	169
21518800	16153	Kamanaka M	Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology.	The Journal of experimental medicine	2011	39
21562046	16153	Hao Y	A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice.	Blood	2011	53
21653859	16153	Ren X	Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke.	The Journal of neuroscience 	2011	56
21817097	16153	Kassan M	Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice.	Arteriosclerosis, thrombosis, and vascular biology	2011	39
21959218	16153	Krishnamurthy P	Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.	Circulation research	2011	39
22101830	16153	Gopal R	IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination.	European journal of immunology	2012	48
22114895	16153	Dénes A	Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size.	Journal of neuroinflammation	2011	40
22123924	16153	Tanikawa T	Interleukin-10 ablation promotes tumor development, growth, and metastasis.	Cancer research	2012	37
22172723	16153	Mumm JB	IL-10 elicits IFNγ-dependent tumor immune surveillance.	Cancer cell	2011	61
22184725	16153	Duell BL	Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection.	Journal of immunology	2012	30
22205023	16153	Freitas do Rosário AP	IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection.	Journal of immunology	2012	65
22308302	16153	Anzai A	Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling.	Circulation	2012	48
22315945	16153	Carter NA	Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis.	Arthritis research and therapy	2012	47
22637701	16153	Anderson P	Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis.	Gut	2013	33
22722865	16153	Devkota S	Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice.	Nature	2012	271
22745325	16153	Parsa R	Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice.	Diabetes	2012	38
22808254	16153	Haag LM	Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling.	PloS one	2012	39
22892938	16153	Zhao J	Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling.	Mucosal immunology	2013	38
22981537	16153	Hall AO	The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology.	Immunity	2012	107
23064231	16153	Yoshizaki A	Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions.	Nature	2012	125
23123183	16153	Hasnain SZ	IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells.	Gastroenterology	2013	28
23125413	16153	Schmitt EG	IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy.	Journal of immunology	2012	32
23484005	16153	Hsiao HM	A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.	PloS one	2013	43
23566632	16153	Ohland CL	Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome.	Psychoneuroendocrinology	2013	32
23640015	16153	Bodhankar S	IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke.	Metabolic brain disease	2013	26
23842501	16153	Atarashi K	Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.	Nature	2013	358
23918988	16153	Maseda D	Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+CD4+ T cell numbers during colitis development in mice.	Journal of immunology	2013	29
23951007	16153	Yang I	Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis.	PloS one	2013	27
23955389	16153	Dennis KL	Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells.	Cancer research	2013	28
24301657	16153	Li B	IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis.	Mucosal immunology	2014	23
24374817	16153	Bodhankar S	Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice.	Metabolic brain disease	2014	20
24487272	16153	Basic M	Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice.	Inflammatory bowel diseases	2014	30
24491821	16153	Sattler S	IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut.	Journal of autoimmunity	2014	23
24507158	16153	Shouval DS	Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.	Advances in immunology	2014	31
24603330	16153	Cauwels A	Extracellular ATP drives systemic inflammation, tissue damage and mortality.	Cell death and disease	2014	28
24713654	16153	Zohar Y	CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis.	The Journal of clinical investigation	2014	21
24721123	16153	Gao X	Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet.	Journal of bioscience and bioengineering	2014	26
24787713	16153	Lokken KL	Malaria parasite infection compromises control of concurrent systemic non-typhoidal Salmonella infection via IL-10-mediated alteration of myeloid cell function.	PLoS pathogens	2014	22
24792913	16153	Zigmond E	Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis.	Immunity	2014	65
24959425	16153	Heimesaat MM	The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice.	Frontiers in cellular and infection microbiology	2014	20
25170116	16153	Beury DW	Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors.	Journal of leukocyte biology	2014	23
25182170	16153	Arthur JC	Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer.	Nature communications	2014	33
25320234	16153	Villalta SA	Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy.	Science translational medicine	2014	26
25614966	16153	Zhu C	An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction.	Nature communications	2015	17
25659581	16153	Takahashi H	MUC1-C activates the TAK1 inflammatory pathway in colon cancer.	Oncogene	2015	22
25710911	16153	Suryawanshi A	Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation.	Journal of immunology	2015	15
26147684	16153	Laidlaw BJ	Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+) T cells.	Nature immunology	2015	23
26446957	16153	Zhang J	ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease.	Science translational medicine	2015	21
26511795	16153	Schuijt TJ	The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia.	Gut	2016	28
9856950	16163	Grünig G	Requirement for IL-13 independently of IL-4 in experimental asthma.	Science	1998	406
10079098	16163	Zhu Z	Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.	The Journal of clinical investigation	1999	342
10491413	16163	Chiaramonte MG	An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.	The Journal of clinical investigation	1999	164
10679097	16163	Fallon PG	Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent.	Journal of immunology	2000	110
11067861	16163	Zheng T	Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema.	The Journal of clinical investigation	2000	158
12091879	16163	Kuperman DA	Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma.	Nature medicine	2002	204
12150887	16163	Fallon PG	IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13.	Immunity	2002	80
15356151	16163	Kaviratne M	IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent.	Journal of immunology	2004	86
15618138	16163	Noverr MC	Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13.	Infection and immunity	2005	70
17623648	16163	Hayakawa H	Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.	The Journal of biological chemistry	2007	111
17881510	16163	Ho LH	IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.	Journal of leukocyte biology	2007	86
17911623	16163	Müller U	IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans.	Journal of immunology	2007	99
18448455	16163	Kondo Y	Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.	International immunology	2008	122
18480254	16163	Munitz A	Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2008	71
18787175	16163	Ryman-Rasmussen JP	Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma.	American journal of respiratory cell and molecular biology	2009	80
19117533	16163	Cihakova D	Pathogenesis of myocarditis and dilated cardiomyopathy.	Advances in immunology	2008	50
19841166	16163	Kurowska-Stolarska M	IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation.	Journal of immunology	2009	159
19893050	16163	Zhang Y	Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99.	The American journal of pathology	2009	55
20042577	16163	Rankin AL	IL-33 induces IL-13-dependent cutaneous fibrosis.	Journal of immunology	2010	47
20052800	16163	Daley JM	The phenotype of murine wound macrophages.	Journal of leukocyte biology	2010	110
20543112	16163	Zuo L	IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway.	Journal of immunology	2010	46
20693421	16163	Stolarski B	IL-33 exacerbates eosinophil-mediated airway inflammation.	Journal of immunology	2010	63
20980995	16163	Meylan F	The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.	Mucosal immunology	2011	45
22017439	16163	Meylan F	TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.	Immunological reviews	2011	35
22425247	16163	Halim TY	Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation.	Immunity	2012	158
23027612	16163	Cardilo-Reis L	Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype.	EMBO molecular medicine	2012	44
23257358	16163	Stanya KJ	Direct control of hepatic glucose production by interleukin-13 in mice.	The Journal of clinical investigation	2013	30
24985397	16163	Li D	IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice.	The Journal of allergy and clinical immunology	2014	45
25659095	16163	Besnard AG	IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells.	PLoS pathogens	2015	23
25981357	16163	Xue J	Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis.	Nature communications	2015	23
27345402	16163	Deng Z	Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis.	Oncogene	2017	6
11441109	16171	Lubberts E	IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis.	Journal of immunology	2001	113
12495931	16171	Hellings PW	Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma.	American journal of respiratory cell and molecular biology	2003	102
12707345	16171	Miyamoto M	Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways.	Journal of immunology	2003	79
14634133	16171	Nakae S	Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice.	Journal of immunology	2003	358
17082599	16171	He D	CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses.	Journal of immunology	2006	64
17339477	16171	Umemura M	IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection.	Journal of immunology	2007	182
17513719	16171	Kryczek I	Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment.	Journal of immunology	2007	135
17967903	16171	Moisan J	Ets-1 is a negative regulator of Th17 differentiation.	The Journal of experimental medicine	2007	61
18185592	16171	Romani L	Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.	Nature	2008	166
18299333	16171	Flierl MA	Adverse functions of IL-17A in experimental sepsis.	FASEB journal 	2008	75
18311793	16171	Nguyen CQ	Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.	Arthritis and rheumatism	2008	73
18395085	16171	Fina D	Regulation of gut inflammation and th17 cell response by interleukin-21.	Gastroenterology	2008	64
18483277	16171	Nam JS	Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.	Cancer research	2008	92
18768886	16171	Da Silva CA	TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation.	Journal of immunology	2008	74
18796297	16171	Ito R	Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.	Biochemical and biophysical research communications	2008	55
18941201	16171	Song C	IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma.	Journal of immunology	2008	84
19075395	16171	Haak S	IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice.	The Journal of clinical investigation	2009	133
19188681	16171	Bending D	Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.	The Journal of clinical investigation	2009	187
19234200	16171	Lopez Kostka S	IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice.	Journal of immunology	2009	55
19289853	16171	Kryczek I	Endogenous IL-17 contributes to reduced tumor growth and metastasis.	Blood	2009	106
19371791	16171	Miossec P	IL-17 and Th17 cells in human inflammatory diseases.	Microbes and infection	2009	51
19564351	16171	Wang L	IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway.	The Journal of experimental medicine	2009	216
19604490	16171	Colonna M	Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.	Immunity	2009	94
19644886	16171	Ito Y	Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.	Arthritis and rheumatism	2009	48
19657089	16171	Zhang Z	The role of IL-23/IL-17 axis in lupus nephritis.	Journal of immunology	2009	72
19808254	16171	Das J	Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation.	The Journal of experimental medicine	2009	62
19818650	16171	Gomez-Rodriguez J	Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase.	Immunity	2009	66
19940258	16171	Huppert J	Cellular mechanisms of IL-17-induced blood-brain barrier disruption.	FASEB journal 	2010	77
20007582	16171	Erbel C	Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.	Journal of immunology	2009	87
20083652	16171	Riol-Blanco L	IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections.	Journal of immunology	2010	41
20083665	16171	Passos ST	IL-6 promotes NK cell production of IL-17 during toxoplasmosis.	Journal of immunology	2010	46
20169058	16171	da Matta Guedes PM	IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis.	PLoS neglected tropical diseases	2010	46
20173024	16171	Pickens SR	IL-17 contributes to angiogenesis in rheumatoid arthritis.	Journal of immunology	2010	48
20212110	16171	Chae WJ	Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2010	67
20303295	16171	Kang Z	Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.	Immunity	2010	90
20351183	16171	Shi Y	Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice.	Journal of immunology	2010	51
20421647	16171	Lo Re S	IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis.	Journal of immunology	2010	42
20498020	16171	Sonnenberg GF	Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A.	The Journal of experimental medicine	2010	98
20624887	16171	Cruz A	Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.	The Journal of experimental medicine	2010	86
20921529	16171	Kagami S	IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans.	Journal of immunology	2010	67
20935201	16171	Chen S	IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice.	Journal of immunology	2010	45
21037091	16171	Zúñiga LA	IL-17 regulates adipogenesis, glucose homeostasis, and obesity.	Journal of immunology	2010	60
21159633	16171	Wang L	IL-17 enhances tumor development in carcinogen-induced skin cancer.	Cancer research	2010	49
21172868	16171	Rizzo HL	IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A.	Journal of immunology	2011	41
21209700	16171	Domingues HS	Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.	PloS one	2010	69
21282514	16171	Liu Y	IL-17A and TNF-α exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro.	Journal of immunology	2011	38
21356362	16171	Li Z	IL-17 and VEGF are necessary for efficient corneal nerve regeneration.	The American journal of pathology	2011	42
21359196	16171	Wozniak KL	Role of IL-17A on resolution of pulmonary C. neoformans infection.	PloS one	2011	39
21531892	16171	Feng T	Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.	Journal of immunology	2011	47
21703407	16171	Mukherjee S	IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.	The American journal of pathology	2011	56
21858022	16171	Gasse P	IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis.	PloS one	2011	39
21982596	16171	Cai Y	Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation.	Immunity	2011	157
21985374	16171	Tang Y	Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.	Clinical and experimental immunology	2011	43
22025253	16171	Li C	IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus.	Cell research	2012	32
22292739	16171	Kumar N	Identification of SR2211: a potent synthetic RORγ-selective modulator.	ACS chemical biology	2012	32
22354874	16171	Hyun YS	Role of IL-17A in the development of colitis-associated cancer.	Carcinogenesis	2012	38
22388091	16171	Kudo M	IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction.	Nature medicine	2012	120
22426030	16171	Pulido J	Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.	Nature biotechnology	2012	39
22461511	16171	Zhang Q	Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models.	Cancer research	2012	33
22546855	16171	Pantelyushin S	Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice.	The Journal of clinical investigation	2012	90
22687286	16171	Meng F	Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.	Gastroenterology	2012	98
23023676	16171	Miossec P	Targeting IL-17 and TH17 cells in chronic inflammation.	Nature reviews. Drug discovery	2012	184
23034169	16171	Yi H	Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.	Journal of immunology	2012	32
23064362	16171	Tortola L	Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk.	The Journal of clinical investigation	2012	56
23108651	16171	Markó L	Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage.	Hypertension	2012	32
23221338	16171	Huber M	IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.	The Journal of clinical investigation	2013	43
23241743	16171	Blatner NR	Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer.	Science translational medicine	2012	54
23555256	16171	Gonzalez-Lombana C	IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection.	PLoS pathogens	2013	32
23624556	16171	Gray EE	Deficiency in IL-17-committed Vγ4(+) γδ T cells in a spontaneous Sox13-mutant CD45.1(+) congenic mouse substrain provides protection from dermatitis.	Nature immunology	2013	38
23671588	16171	Katayama M	Neutrophils are essential as a source of IL-17 in the effector phase of arthritis.	PloS one	2013	26
23842754	16171	Tan Z	IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.	Journal of immunology	2013	39
23853593	16171	Kozakiewicz L	B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response.	PLoS pathogens	2013	30
23995070	16171	Kang Z	Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells.	Nature neuroscience	2013	35
24291066	16171	Marzo E	Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis.	Tuberculosis	2014	26
24362892	16171	Taylor PR	Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2.	Nature immunology	2014	93
24525743	16171	Ma S	IL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinoma.	Cancer research	2014	30
24573745	16171	Lin X	Th17 cells play a critical role in the development of experimental Sjögren's syndrome.	Annals of the rheumatic diseases	2015	17
24586307	16171	Cruz-Guilloty F	T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration.	PloS one	2014	21
24591369	16171	Taylor PR	Aspergillus and Fusarium corneal infections are regulated by Th17 cells and IL-17-producing neutrophils.	Journal of immunology	2014	25
24663215	16171	Fleige H	IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs.	The Journal of experimental medicine	2014	27
24670684	16171	Moutsopoulos NM	Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss.	Science translational medicine	2014	44
24747744	16171	Deshmukh HS	The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice.	Nature medicine	2014	65
24808362	16171	Maekawa T	Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.	Journal of immunology	2014	32
24823639	16171	McAllister F	Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.	Cancer cell	2014	52
25114209	16171	Rei M	Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages.	Proceedings of the National Academy of Sciences of the United States of America	2014	23
25446779	16171	Pascual M	Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2.	Neuropharmacology	2015	20
25533336	16171	Rutkowski MR	Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation.	Cancer cell	2015	34
25642768	16171	Murugaiyan G	MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis.	The Journal of clinical investigation	2015	24
26188072	16171	Conti HR	IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans.	Journal of immunology	2015	17
26214837	16171	Zenaro E	Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin.	Nature medicine	2015	29
26431947	16171	Maxwell JR	Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation.	Immunity	2015	17
26884164	16171	Li J	Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice.	Proceedings of the National Academy of Sciences of the United States of America	2016	14
26983850	16171	Flynn R	Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.	Blood	2016	10
27040495	16171	Xiong H	Innate Lymphocyte/Ly6C(hi) Monocyte Crosstalk Promotes Klebsiella Pneumoniae Clearance.	Cell	2016	12
1279270	16176	Passaniti A	A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.	Laboratory investigation; a journal of technical methods and pathology	1992	141
10908610	16176	Lim GP	Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.	The Journal of neuroscience 	2000	178
11549714	16176	Mason JL	Interleukin-1beta promotes repair of the CNS.	The Journal of neuroscience 	2001	90
11880505	16176	Wu DC	Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.	The Journal of neuroscience 	2002	253
12923200	16176	Marcheselli VL	Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression.	The Journal of biological chemistry	2003	185
15047567	16176	Skerrett SJ	Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin.	American journal of physiology. Lung cellular and molecular physiology	2004	74
15156202	16176	Jimi E	Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.	Nature medicine	2004	119
15692052	16176	Maeda S	Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.	Science	2005	185
15951334	16176	Shvedova AA	Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice.	American journal of physiology. Lung cellular and molecular physiology	2005	236
16207887	16176	Cunningham C	Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration.	The Journal of neuroscience 	2005	171
16239969	16176	Nakao S	Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.	The Journal of clinical investigation	2005	74
17325656	16176	Lin HS	Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.	British journal of pharmacology	2007	58
17635115	16176	Gauldie J	TGF-beta, Smad3 and the process of progressive fibrosis.	Biochemical Society transactions	2007	60
17942936	16176	Bunt SK	Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.	Cancer research	2007	171
18407066	16176	Master SS	Mycobacterium tuberculosis prevents inflammasome activation.	Cell host and microbe	2008	106
18417733	16176	Begum AN	Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease.	The Journal of pharmacology and experimental therapeutics	2008	92
18802069	16176	Sinha P	Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.	Journal of immunology	2008	180
18931327	16176	Churg A	The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling.	American journal of respiratory cell and molecular biology	2009	51
18977329	16176	Tu S	Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.	Cancer cell	2008	198
19208854	16176	Jeong HW	Berberine suppresses proinflammatory responses through AMPK activation in macrophages.	American journal of physiology. Endocrinology and metabolism	2009	96
19752225	16176	Carmi Y	The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis.	Journal of immunology	2009	59
19883649	16176	Waghray M	Interleukin-1beta promotes gastric atrophy through suppression of Sonic Hedgehog.	Gastroenterology	2010	40
20616033	16176	Meissner F	Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2010	48
20818791	16176	Cibelli M	Role of interleukin-1beta in postoperative cognitive dysfunction.	Annals of neurology	2010	125
21110318	16176	Elkabets M	IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.	European journal of immunology	2010	54
21239716	16176	Pazár B	Basic calcium phosphate crystals induce monocyte/macrophage IL-1β secretion through the NLRP3 inflammasome in vitro.	Journal of immunology	2011	37
21512143	16176	Tu SP	IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis.	Cancer research	2011	35
21543214	16176	Ashino NG	Maternal high-fat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver.	The Journal of nutritional biochemistry	2012	31
21646297	16176	Witzenrath M	The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia.	Journal of immunology	2011	58
21796662	16176	Favrais G	Systemic inflammation disrupts the developmental program of white matter.	Annals of neurology	2011	64
21864548	16176	Lin D	Isoflurane induces hippocampal cell injury and cognitive impairments in adult rats.	Neuropharmacology	2011	40
21911941	16176	Lu T	Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice.	The Journal of clinical investigation	2011	81
22213805	16176	Leuschner F	Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis.	The Journal of experimental medicine	2012	106
22291094	16176	Shaw MH	Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine.	The Journal of experimental medicine	2012	95
22392631	16176	Pham LD	Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury.	Glia	2012	33
22484733	16176	Franchi L	NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense.	Nature immunology	2012	81
22547706	16176	Cai S	NLRC4 inflammasome-mediated production of IL-1β modulates mucosal immunity in the lung against gram-negative bacterial infection.	Journal of immunology	2012	39
22738332	16176	Püntener U	Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia.	Journal of neuroinflammation	2012	35
22848083	16176	Bracey NA	The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β.	Experimental physiology	2013	29
22888139	16176	Hasegawa M	Protective role of commensals against Clostridium difficile infection via an IL-1β-mediated positive-feedback loop.	Journal of immunology	2012	32
22999935	16176	Wang DS	Memory deficits induced by inflammation are regulated by α5-subunit-containing GABAA receptors.	Cell reports	2012	31
23110665	16176	Bohr S	Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model.	Wound repair and regeneration 	2013	28
23225887	16176	He Y	TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.	Journal of immunology	2013	42
23341960	16176	Nov O	Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability.	PloS one	2013	27
23361394	16176	Sudduth TL	Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation.	Journal of cerebral blood flow and metabolism 	2013	27
23486975	16176	Ghosh S	Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.	The Journal of neuroscience 	2013	56
23526221	16176	Aumiller V	WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis.	American journal of respiratory cell and molecular biology	2013	27
24225053	16176	Hamilton RF Jr	Effect of MWCNT size, carboxylation, and purification on in vitro and in vivo toxicity, inflammation and lung pathology.	Particle and fibre toxicology	2013	29
24478069	16176	Peters BM	Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis.	Infection and immunity	2014	25
24501200	16176	Rinaldi SF	Decidual neutrophil infiltration is not required for preterm birth in a mouse model of infection-induced preterm labor.	Journal of immunology	2014	22
25060788	16176	Emanuel R	Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae.	Arteriosclerosis, thrombosis, and vascular biology	2014	29
25232870	16176	Brown AO	Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function.	PLoS pathogens	2014	25
25326801	16176	Rosser EC	Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production.	Nature medicine	2014	33
25375146	16176	Moretti S	IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis.	PLoS pathogens	2014	21
25450328	16176	Chang AL	Redox regulation of mitophagy in the lung during murine Staphylococcus aureus sepsis.	Free radical biology and medicine	2015	15
25568099	16176	Moyon S	Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration.	The Journal of neuroscience 	2015	21
25900651	16176	Bruno VM	Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.	mBio	2015	18
26764184	16176	Hirsova P	Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.	Gastroenterology	2016	21
27011353	16176	Sanman LE	Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death.	eLife	2016	13
2551036	16409	Kishimoto TK	Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors.	Science	1989	181
8986723	16409	Coxon A	A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.	Immunity	1996	164
12960339	16409	Gonzalez-Juarrero M	Dynamics of macrophage cell populations during murine pulmonary tuberculosis.	Journal of immunology	2003	75
15630444	16409	Duffield JS	Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.	The Journal of clinical investigation	2005	392
15665833	16409	Heppner FL	Experimental autoimmune encephalomyelitis repressed by microglial paralysis.	Nature medicine	2005	177
16051744	16409	Courret N	CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain.	Blood	2006	95
16476660	16409	Simard AR	Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.	Neuron	2006	289
16751424	16409	Sudres M	Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice.	Journal of immunology	2006	88
17151265	16409	Nakazawa T	Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma.	The Journal of neuroscience 	2006	114
17339406	16409	Adams RA	The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.	The Journal of experimental medicine	2007	87
18674538	16409	Haile LA	Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.	Gastroenterology	2008	88
19245367	16409	Schintu N	PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.	The European journal of neuroscience	2009	50
19714652	16409	Guo R	Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis.	Arthritis and rheumatism	2009	49
19838177	16409	Grathwohl SA	Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia.	Nature neuroscience	2009	122
20404138	16409	Ahn GO	Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment.	Proceedings of the National Academy of Sciences of the United States of America	2010	89
20577213	16409	Iannacone M	Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus.	Nature	2010	91
20823155	16409	Sloan EK	The sympathetic nervous system induces a metastatic switch in primary breast cancer.	Cancer research	2010	132
21063074	16409	Lionakis MS	Organ-specific innate immune responses in a mouse model of invasive candidiasis.	Journal of innate immunity	2011	68
21215831	16409	Calabro S	Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.	Vaccine	2011	64
21268007	16409	Schif-Zuck S	Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids.	European journal of immunology	2011	61
21666057	16409	Denning TL	Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization.	Journal of immunology	2011	107
21949025	16409	Turnquist HR	IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.	Journal of immunology	2011	57
22056381	16409	Kerkar SP	IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.	The Journal of clinical investigation	2011	90
22120756	16409	Filipazzi P	Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients.	Cancer immunology, immunotherapy 	2012	74
22215137	16409	Porembka MR	Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.	Cancer immunology, immunotherapy 	2012	57
22751463	16409	Sceneay J	Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.	Cancer research	2012	59
22965162	16409	Piao Y	Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.	Neuro-oncology	2012	43
23311642	16409	Morrison HW	A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion.	Journal of neuroinflammation	2013	47
23352232	16409	Plantinga M	Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen.	Immunity	2013	164
23997102	16409	Kong P	Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis.	American journal of physiology. Heart and circulatory physiology	2013	45
24292363	16409	Watchmaker PB	Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice.	Nature immunology	2014	47
24440789	16409	Williams CD	Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans.	Toxicology and applied pharmacology	2014	35
24778162	16409	Ortiz ML	Myeloid-derived suppressor cells in the development of lung cancer.	Cancer immunology research	2014	20
24786973	16409	Heidt T	Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction.	Circulation research	2014	59
24907113	16409	Mao Y	Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.	Clinical cancer research 	2014	35
25902531	16409	Rashidian M	Noninvasive imaging of immune responses.	Proceedings of the National Academy of Sciences of the United States of America	2015	27
27120577	16409	Zhang Y	IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.	Molecular carcinogenesis	2017	8
9363890	16591	Kuro-o M	Mutation of the mouse klotho gene leads to a syndrome resembling ageing.	Nature	1997	595
14528024	16591	Tsujikawa H	Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system.	Molecular endocrinology	2003	114
15135068	16591	Imura A	Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane.	FEBS letters	2004	132
16123266	16591	Kurosu H	Suppression of aging in mice by the hormone Klotho.	Science	2005	370
16186101	16591	Yamamoto M	Regulation of oxidative stress by the anti-aging hormone klotho.	The Journal of biological chemistry	2005	123
16436388	16591	Kurosu H	Regulation of fibroblast growth factor-23 signaling by klotho.	The Journal of biological chemistry	2006	310
16775459	16591	Kuro-o M	Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.	Current opinion in nephrology and hypertension	2006	61
17569864	16591	Imura A	alpha-Klotho as a regulator of calcium homeostasis.	Science	2007	89
18606998	16591	Cha SK	Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1.	Proceedings of the National Academy of Sciences of the United States of America	2008	121
19230844	16591	Kuro-o M	Klotho and aging.	Biochimica et biophysica acta	2009	52
19635988	16591	Wang Y	Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage.	Hypertension	2009	57
19730882	16591	Kuro-o M	Klotho.	Pflugers Archiv 	2010	41
20080590	16591	Tomiyama K	Relevant use of Klotho in FGF19 subfamily signaling system in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2010	45
20418498	16591	Ohnishi M	Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging.	FASEB journal 	2010	51
21209102	16591	Doi S	Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice.	The Journal of biological chemistry	2011	103
21593200	16591	Zhao Y	Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation.	Diabetes	2011	39
22338084	16591	Sugiura H	Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis.	American journal of physiology. Renal physiology	2012	31
22660551	16591	Kuro-o M	Klotho in health and disease.	Current opinion in nephrology and hypertension	2012	30
23559584	16591	Zhou L	Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling.	Journal of the American Society of Nephrology 	2013	53
24854271	16591	Lindberg K	The kidney is the principal organ mediating klotho effects.	Journal of the American Society of Nephrology 	2014	33
25326585	16591	Hu MC	Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.	Journal of the American Society of Nephrology 	2015	31
25475745	16591	Xie J	Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.	Journal of the American Society of Nephrology 	2015	18
8465203	16653	Shirasawa S	Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.	Science	1993	177
11323676	16653	Johnson L	Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.	Nature	2001	354
11751630	16653	Jackson EL	Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.	Genes and development	2001	557
12957286	16653	Guerra C	Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context.	Cancer cell	2003	166
14699048	16653	Braun BS	Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.	Proceedings of the National Academy of Sciences of the United States of America	2004	109
14706336	16653	Hingorani SR	Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.	Cancer cell	2003	632
15093544	16653	Tuveson DA	Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.	Cancer cell	2004	278
15619626	16653	Dinulescu DM	Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.	Nature medicine	2005	163
15894267	16653	Hingorani SR	Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.	Cancer cell	2005	504
16288016	16653	Jackson EL	The differential effects of mutant p53 alleles on advanced murine lung cancer.	Cancer research	2005	176
16288213	16653	Ji H	K-ras activation generates an inflammatory response in lung tumors.	Oncogene	2006	84
16702406	16653	Lu SL	Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.	Genes and development	2006	77
17030180	16653	Janssen KP	APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.	Gastroenterology	2006	86
17114585	16653	Ijichi H	Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.	Genes and development	2006	106
17217625	16653	Shih AH	Notch signaling enhances nestin expression in gliomas.	Neoplasia	2006	66
17349585	16653	Guerra C	Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.	Cancer cell	2007	297
17360542	16653	Carrière C	The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia.	Proceedings of the National Academy of Sciences of the United States of America	2007	63
17591971	16653	Zhu L	Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia.	The American journal of pathology	2007	95
17676035	16653	Ji H	LKB1 modulates lung cancer differentiation and metastasis.	Nature	2007	306
17804720	16653	Kissil JL	Requirement for Rac1 in a K-ras induced lung cancer in the mouse.	Cancer research	2007	60
18658273	16653	Shvedova AA	Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis.	American journal of physiology. Lung cellular and molecular physiology	2008	148
18755941	16653	Podsypanina K	Seeding and propagation of untransformed mouse mammary cells in the lung.	Science	2008	110
19028870	16653	Habbe N	Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	118
19028876	16653	De La O JP	Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia.	Proceedings of the National Academy of Sciences of the United States of America	2008	131
19029981	16653	Engelman JA	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.	Nature medicine	2008	467
19147554	16653	Seeley ES	Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia.	Cancer research	2009	74
19292977	16653	Carrière C	Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras.	Biochemical and biophysical research communications	2009	65
19351816	16653	Miller KA	Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo.	Cancer research	2009	45
19501586	16653	Ji B	Ras activity levels control the development of pancreatic diseases.	Gastroenterology	2009	71
19789349	16653	Konstantinidou G	Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.	Cancer research	2009	54
19847165	16653	Meylan E	Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma.	Nature	2009	179
20080688	16653	Hung KE	Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.	Proceedings of the National Academy of Sciences of the United States of America	2010	75
20081861	16653	Houghton AM	Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.	Nature medicine	2010	102
20406971	16653	Bassères DS	Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis.	Cancer research	2010	58
20421486	16653	Weinberg F	Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.	Proceedings of the National Academy of Sciences of the United States of America	2010	340
20484026	16653	Hanlon L	Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma.	Cancer research	2010	42
20495549	16653	Singh M	Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models.	Nature biotechnology	2010	91
20541700	16653	Carretero J	Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors.	Cancer cell	2010	100
20675343	16653	Zhao WG	The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.	Carcinogenesis	2010	64
20832755	16653	Hatley ME	Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.	Cancer cell	2010	183
20972333	16653	Vicent S	Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models.	The Journal of clinical investigation	2010	45
21107427	16653	Junttila MR	Selective activation of p53-mediated tumour suppression in high-grade tumours.	Nature	2010	80
21285251	16653	Sureban SM	DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.	Cancer research	2011	64
21311774	16653	Ray KC	Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model.	PloS one	2011	36
21451123	16653	Lyubynska N	A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice.	Science translational medicine	2011	39
21555567	16653	Shaw AT	Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress.	Proceedings of the National Academy of Sciences of the United States of America	2011	50
21710835	16653	Kamp DW	Chronic inflammation and cancer: the role of the mitochondria.	Oncology	2011	49
21847114	16653	Gaglio D	Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.	Molecular systems biology	2011	115
21874163	16653	Xue W	Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma.	Cancer discovery	2011	35
21878506	16653	Deng M	miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.	Journal of cell science	2011	37
21926469	16653	Ijichi H	Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.	The Journal of clinical investigation	2011	74
21984975	16653	Ying H	PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network.	Cancer discovery	2011	56
22232209	16653	Collins MA	Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.	The Journal of clinical investigation	2012	141
22266668	16653	Gier B	Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.	Diabetes	2012	49
22308361	16653	Cortez-Retamozo V	Origins of tumor-associated macrophages and neutrophils.	Proceedings of the National Academy of Sciences of the United States of America	2012	103
22406536	16653	Daniluk J	An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.	The Journal of clinical investigation	2012	75
22411819	16653	Xu X	Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma.	Proceedings of the National Academy of Sciences of the United States of America	2012	57
22430205	16653	Zhou C	The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis.	Oncogene	2013	32
22565310	16653	Hamidi T	Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis.	The Journal of clinical investigation	2012	34
22825584	16653	Julien S	Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.	Clinical cancer research 	2012	64
22952217	16653	Gill BJ	A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model.	Cancer research	2012	30
23226501	16653	Collins MA	Metastatic pancreatic cancer is dependent on oncogenic Kras in mice.	PloS one	2012	35
23352126	16653	Shackelford DB	LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.	Cancer cell	2013	133
23475959	16653	Soucek L	Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.	Genes and development	2013	68
23598351	16653	Flandez M	Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis.	Gut	2014	25
23622131	16653	di Magliano MP	Roles for KRAS in pancreatic tumor development and progression.	Gastroenterology	2013	65
23715154	16653	Liu Y	Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.	Cancer discovery	2013	34
23824538	16653	Guo JY	Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis.	Genes and development	2013	121
23958541	16653	Philip B	A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice.	Gastroenterology	2013	39
24097820	16653	Zhang Y	Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.	Cancer research	2013	38
24163374	16653	Faber AC	mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1.	Cancer discovery	2014	34
24213921	16653	Shvedova AA	Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: one year postexposure comparisons.	American journal of physiology. Lung cellular and molecular physiology	2014	26
24444711	16653	Zhu Z	Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit.	Cancer discovery	2014	36
24491301	16653	Moon BS	Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.	Journal of the National Cancer Institute	2014	25
24499815	16653	Desai TJ	Alveolar progenitor and stem cells in lung development, renewal and cancer.	Nature	2014	123
24586047	16653	Sutherland KD	Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.	Proceedings of the National Academy of Sciences of the United States of America	2014	28
24675361	16653	Hata AN	Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancers.	Cancer research	2014	23
24875857	16653	Karsli-Uzunbas G	Autophagy is required for glucose homeostasis and lung tumor maintenance.	Cancer discovery	2014	69
24875860	16653	Yang A	Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations.	Cancer discovery	2014	68
24954535	16653	Kapoor A	Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.	Cell	2014	86
25119024	16653	Viale A	Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.	Nature	2014	144
25174400	16653	Kasinski AL	A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer.	Oncogene	2015	28
25174708	16653	Schulz MD	High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity.	Nature	2014	47
25261994	16653	Mayers JR	Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.	Nature medicine	2014	67
25263330	16653	Platt RJ	CRISPR-Cas9 knockin mice for genome editing and cancer modeling.	Cell	2014	179
25339352	16653	Tao S	Oncogenic KRAS confers chemoresistance by upregulating NRF2.	Cancer research	2014	34
25363767	16653	Westcott PM	The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.	Nature	2015	48
25601637	16653	Kong B	A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.	Gut	2016	10
25734337	16653	Grabner B	Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.	Nature communications	2015	18
25843002	16653	von Karstedt S	Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis.	Cancer cell	2015	19
26004068	16653	Whittle MC	RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.	Cell	2015	19
26106858	16653	Melo SA	Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.	Nature	2015	183
26151762	16653	Krah NM	The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma.	eLife	2015	17
26541605	16653	Yun J	Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH.	Science	2015	50
26677984	16653	Choi E	Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.	Gastroenterology	2016	11
26855149	16653	Ambrogio C	Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.	Nature medicine	2016	13
26872698	16653	Pfirschke C	Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.	Immunity	2016	25
27089513	16653	Laklai H	Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.	Nature medicine	2016	25
27821490	16653	Wang X	Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.	Cancer research	2017	9
8182121	16835	Ishibashi S	Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.	The Journal of clinical investigation	1994	135
9734366	16835	Gu L	Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.	Molecular cell	1998	269
10922059	16835	Hajra L	The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation.	Proceedings of the National Academy of Sciences of the United States of America	2000	133
12032330	16835	Joseph SB	Synthetic LXR ligand inhibits the development of atherosclerosis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	187
12740573	16835	Binder CJ	Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.	Nature medicine	2003	165
15665085	16835	Buono C	T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses.	Proceedings of the National Academy of Sciences of the United States of America	2005	68
16127462	16835	Vikramadithyan RK	Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.	The Journal of clinical investigation	2005	66
17932314	16835	Al-Aly Z	Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice.	Arteriosclerosis, thrombosis, and vascular biology	2007	88
18239153	16835	Subramanian S	Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2008	62
18666236	16835	Wouters K	Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.	Hepatology	2008	118
19478200	16835	Verschuren L	MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.	Circulation research	2009	46
19520913	16835	Zelcer N	LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.	Science	2009	189
19893012	16835	Paulson KE	Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis.	Circulation research	2010	69
21252156	16835	Rateri DL	Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice.	Circulation research	2011	48
21690266	16835	Subramanian S	Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.	Journal of lipid research	2011	50
21690490	16835	Maganto-García E	Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.	Circulation	2011	38
21703998	16835	Van Rooyen DM	Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis.	Gastroenterology	2011	49
22152303	16835	Pols TW	TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading.	Cell metabolism	2011	53
22223731	16835	Derwall M	Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2012	47
23257360	16835	Subramanian M	Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.	The Journal of clinical investigation	2013	43
23288159	16835	Marquart TJ	Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2013	46
23333278	16835	Lin J	A role of RIP3-mediated macrophage necrosis in atherosclerosis development.	Cell reports	2013	52
23426179	16835	Klingenberg R	Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.	The Journal of clinical investigation	2013	61
23584088	16835	Murphy AJ	Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis.	Nature medicine	2013	31
23702658	16835	Rotllan N	Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report.	Arteriosclerosis, thrombosis, and vascular biology	2013	45
26903003	16835	Seldin MM	Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB.	Journal of the American Heart Association	2016	19
27659679	16835	Fredman G	An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques.	Nature communications	2016	13
11242118	17257	Chen RZ	Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.	Nature genetics	2001	392
12160743	17257	Shahbazian M	Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3.	Neuron	2002	256
15351775	17257	Collins AL	Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.	Human molecular genetics	2004	158
16199017	17257	Gemelli T	Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.	Biological psychiatry	2006	70
17383101	17257	Stearns NA	Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.	Neuroscience	2007	67
17532643	17257	Smrt RD	Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons.	Neurobiology of disease	2007	85
19234456	17257	Ballas N	Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology.	Nature neuroscience	2009	158
19296534	17257	Belichenko PV	Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.	The Journal of comparative neurology	2009	81
19339616	17257	Adachi M	MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome.	The Journal of neuroscience 	2009	50
19386901	17257	Maezawa I	Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions.	The Journal of neuroscience 	2009	105
19394452	17257	Katz DM	Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth.	Respiratory physiology and neurobiology	2009	54
19741133	17257	Dani VS	Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome.	The Journal of neuroscience 	2009	51
21068835	17257	Chao HT	Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.	Nature	2010	304
21482354	17257	Noutel J	Experience-dependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice.	Neuron	2011	39
21716289	17257	Lioy DT	A role for glia in the progression of Rett's syndrome.	Nature	2011	150
21966470	17257	Ananiev G	Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model.	PloS one	2011	66
22525157	17257	Robinson L	Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome.	Brain 	2012	33
23770565	17257	Lyst MJ	Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.	Nature neuroscience	2013	69
23892605	17257	Buchovecky CM	A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome.	Nature genetics	2013	40
23966684	17257	Garg SK	Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome.	The Journal of neuroscience 	2013	46
26237041	17257	Lombardi LM	MECP2 disorders: from the clinic to mice and back.	The Journal of clinical investigation	2015	28
9500469	17390	Itoh T	Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.	Cancer research	1998	156
11025665	17390	Bergers G	Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.	Nature cell biology	2000	570
15711638	17390	Matsumura S	Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.	The Journal of clinical investigation	2005	74
16585265	17390	Agrawal S	Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis.	The Journal of experimental medicine	2006	115
17363557	17390	Mabuchi S	RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer.	Cancer research	2007	58
18340378	17390	Kenny HA	The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.	The Journal of clinical investigation	2008	92
19147652	17390	Roy S	MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue.	Cardiovascular research	2009	165
19591227	17390	Mias C	Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.	Stem cells	2009	59
19995958	17390	Muñoz M	Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.	The Journal of experimental medicine	2009	101
20215503	17390	Littlepage LE	Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.	Cancer research	2010	45
20505729	17390	Lam CK	Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization.	Nature	2010	46
23322905	17390	auf dem Keller U	Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation.	Science signaling	2013	25
9590175	17395	Vu TH	MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.	Cell	1998	350
10880048	17395	Ducharme A	Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.	The Journal of clinical investigation	2000	179
11081634	17395	Coussens LM	MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.	Cell	2000	287
11129784	17395	Asahi M	Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.	Journal of cerebral blood flow and metabolism 	2000	144
11485970	17395	Creemers EE	Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?	Circulation research	2001	102
11567062	17395	Asahi M	Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.	The Journal of neuroscience 	2001	225
12196576	17395	Noble LJ	Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.	The Journal of neuroscience 	2002	107
15565662	17395	Sakaida I	Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.	Hepatology	2004	107
15632000	17395	Pflugfelder SC	Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye.	The American journal of pathology	2005	76
15764676	17395	Gidday JM	Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.	American journal of physiology. Heart and circulatory physiology	2005	123
16000631	17395	Gu Z	A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.	The Journal of neuroscience 	2005	116
16126817	17395	Lindsey ML	Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction.	American journal of physiology. Heart and circulatory physiology	2006	78
16481424	17395	Nagy V	Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory.	The Journal of neuroscience 	2006	124
16571756	17395	Lee SR	Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke.	The Journal of neuroscience 	2006	81
16788715	17395	Tejima E	Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage.	Journal of cerebral blood flow and metabolism 	2007	57
16891410	17395	Nozawa H	Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2006	207
17202364	17395	Malik M	Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis.	Journal of immunology	2007	63
17301159	17395	Svedin P	Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia.	The Journal of neuroscience 	2007	70
18056472	17395	Melani C	Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma.	Cancer research	2007	82
18328424	17395	Ahn GO	Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells.	Cancer cell	2008	129
18332222	17395	Wilczynski GM	Important role of matrix metalloproteinase 9 in epileptogenesis.	The Journal of cell biology	2008	67
19401296	17395	Li H	Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.	Human molecular genetics	2009	47
19997118	17395	Bauer AT	Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement.	Journal of cerebral blood flow and metabolism 	2010	56
20534467	17395	Jujo K	CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction.	Proceedings of the National Academy of Sciences of the United States of America	2010	59
21895523	17395	Yu F	Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury.	Journal of neurotrauma	2012	32
21933988	17395	Kowluru RA	Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.	Diabetes	2011	40
22918978	17395	Chiao YA	Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice.	Cardiovascular research	2012	36
23281396	17395	Seo JH	Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury.	The Journal of clinical investigation	2013	29
24462097	17395	Kaplan A	Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration.	Neuron	2014	38
24561613	17395	Ehling J	CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.	Gut	2014	35
24570026	17395	Carmona-Rivera C	Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2.	Annals of the rheumatic diseases	2015	40
25379015	17395	Deryugina EI	Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.	Neoplasia	2014	25
12244184	17874	Edelson BT	MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity.	Journal of immunology	2002	87
14563635	17874	Krug A	Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.	Blood	2004	173
15004134	17874	Skerrett SJ	Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus.	Journal of immunology	2004	77
15265935	17874	Bolz DD	MyD88 plays a unique role in host defense but not arthritis development in Lyme disease.	Journal of immunology	2004	74
15599404	17874	Fremond CM	Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.	The Journal of clinical investigation	2004	96
15615857	17874	Pull SL	Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury.	Proceedings of the National Academy of Sciences of the United States of America	2005	174
15661931	17874	Hapfelmeier S	The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms.	Journal of immunology	2005	121
16413925	17874	Miller LS	MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus.	Immunity	2006	108
16440059	17874	Prinz M	Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis.	The Journal of clinical investigation	2006	81
16492804	17874	Ehlers M	TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.	The Journal of experimental medicine	2006	93
16886064	17874	Chen CJ	MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals.	The Journal of clinical investigation	2006	105
16936244	17874	Skerrett SJ	Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa.	American journal of physiology. Lung cellular and molecular physiology	2007	58
17200722	17874	Brown SL	Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury.	The Journal of clinical investigation	2007	86
17408640	17874	Cario E	Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function.	Gastroenterology	2007	149
17495130	17874	Phipps S	Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus.	Blood	2007	65
17579078	17874	Lebeis SL	TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium.	Journal of immunology	2007	69
17615359	17874	Rakoff-Nahoum S	Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88.	Science	2007	184
17853945	17874	Wu H	TLR4 activation mediates kidney ischemia/reperfusion injury.	The Journal of clinical investigation	2007	247
17979981	17874	Gibson DL	MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis.	Cellular microbiology	2008	52
18003835	17874	Boivin A	Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury.	The Journal of neuroscience 	2007	57
18523294	17874	Vijay-Kumar M	Flagellin treatment protects against chemicals, bacteria, viruses, and radiation.	Journal of immunology	2008	81
18792393	17874	Hritz I	The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.	Hepatology	2008	130
18806780	17874	Wen L	Innate immunity and intestinal microbiota in the development of Type 1 diabetes.	Nature	2008	519
18974879	17874	Pulskens WP	Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury.	PloS one	2008	63
19181857	17874	Roger T	Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4.	Proceedings of the National Academy of Sciences of the United States of America	2009	76
19666548	17874	Ehses JA	IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat.	Proceedings of the National Academy of Sciences of the United States of America	2009	82
19846873	17874	Cai S	Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection.	Journal of immunology	2009	47
20124098	17874	Chen L	Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection.	Journal of immunology	2010	43
20526283	17874	Mittal D	TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.	The EMBO journal	2010	46
20639251	17874	Heimesaat MM	MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease.	Gut	2010	68
21206087	17874	Wüthrich M	Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice.	The Journal of clinical investigation	2011	94
21257968	17874	Guarda G	Differential expression of NLRP3 among hematopoietic cells.	Journal of immunology	2011	63
22019834	17874	Hammer GE	Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis.	Nature immunology	2011	72
22236996	17874	Conrady CD	Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16.	Mucosal immunology	2012	46
22465073	17874	Eguchi K	Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation.	Cell metabolism	2012	81
22677551	17874	Allam R	Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4.	Journal of the American Society of Nephrology 	2012	70
22689818	17874	Jarchum I	Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis.	Infection and immunity	2012	45
23047678	17874	Hoshi N	MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice.	Nature communications	2012	43
24448240	17874	Hakim F	Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling.	Cancer research	2014	21
24807222	17874	Nagareddy PR	Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity.	Cell metabolism	2014	48
24990886	17874	Boettcher S	Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis.	Blood	2014	32
25362351	17874	Scheeren FA	A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis.	Nature cell biology	2014	21
25532804	17874	Carmody RN	Diet dominates host genotype in shaping the murine gut microbiota.	Cell host and microbe	2015	115
25620548	17874	Kubinak JL	MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health.	Cell host and microbe	2015	25
26936504	17874	Garg AD	Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.	Science translational medicine	2016	16
9214616	18015	Weiss WA	Targeted expression of MYCN causes neuroblastoma in transgenic mice.	The EMBO journal	1997	195
10591652	18015	Cichowski K	Mouse models of tumor development in neurofibromatosis type 1.	Science	1999	113
10591653	18015	Vogel KS	Mouse tumor model for neurofibromatosis type 1.	Science	1999	98
10973261	18015	Reilly KM	Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.	Nature genetics	2000	94
11297510	18015	Zhu Y	Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.	Genes and development	2001	178
11988578	18015	Zhu Y	Neurofibromas in NF1: Schwann cell origin and role of tumor environment.	Science	2002	158
14695164	18015	Bajenaru ML	Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.	Cancer research	2003	94
16098465	18015	Zhu Y	Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.	Cancer cell	2005	152
17105749	18015	Ferner RE	Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.	Journal of medical genetics	2007	93
17362838	18015	Ferner RE	Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.	The Lancet. Neurology	2007	64
17400655	18015	Daginakatte GC	Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.	Human molecular genetics	2007	69
18242513	18015	Joseph NM	The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.	Cancer cell	2008	52
18451155	18015	Kwon CH	Pten haploinsufficiency accelerates formation of high-grade astrocytomas.	Cancer research	2008	91
21737130	18015	Liu C	Mosaic analysis with double markers reveals tumor cell of origin in glioma.	Cell	2011	158
22789544	18015	Lee DY	Innate neural stem cell heterogeneity determines the patterning of glioma formation in children.	Cancer cell	2012	36
23221341	18015	Jessen WJ	MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.	The Journal of clinical investigation	2013	66
23434321	18015	Mo W	CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.	Cell	2013	48
24535670	18015	de Bruin EC	Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer.	Cancer discovery	2014	33
25119042	18015	De Raedt T	PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies.	Nature	2014	63
26067104	18015	Zuckermann M	Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling.	Nature communications	2015	31
11134556	18024	Enomoto A	High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes.	Toxicological sciences 	2001	164
11287661	18024	Chan K	An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen.	Proceedings of the National Academy of Sciences of the United States of America	2001	191
12968018	18024	Leung L	Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress.	The Journal of biological chemistry	2003	82
15208274	18024	Cho HY	The transcription factor NRF2 protects against pulmonary fibrosis.	FASEB journal 	2004	93
15520857	18024	Rangasamy T	Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.	The Journal of clinical investigation	2004	296
15998787	18024	Rangasamy T	Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice.	The Journal of experimental medicine	2005	187
16324149	18024	Iizuka T	Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema.	Genes to cells 	2005	82
16912211	18024	Xu C	Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2.	Cancer research	2006	103
17178849	18024	Khor TO	Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis.	Cancer research	2006	112
17562481	18024	Aleksunes LM	Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.	Toxicologic pathology	2007	84
17602956	18024	Wang J	Role of Nrf2 in protection against intracerebral hemorrhage injury in mice.	Free radical biology and medicine	2007	66
17631644	18024	Osburn WO	Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment.	International journal of cancer	2007	62
17962605	18024	Zhao X	Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage.	Stroke	2007	62
18059474	18024	Beyer TA	Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance.	The EMBO journal	2008	68
18316592	18024	Ohta T	Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.	Cancer research	2008	158
18372916	18024	Frohlich DA	The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis.	Oncogene	2008	56
18566336	18024	Suzuki M	Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease.	American journal of respiratory cell and molecular biology	2008	73
19028565	18024	Harvey CJ	Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress.	Free radical biology and medicine	2009	64
19074031	18024	Vargas MR	Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.	The Journal of neuroscience 	2008	123
19104057	18024	Sussan TE	Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	114
19196989	18024	Chen PC	Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte.	Proceedings of the National Academy of Sciences of the United States of America	2009	142
19286929	18024	Rangasamy T	Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression.	American journal of physiology. Lung cellular and molecular physiology	2009	45
19454723	18024	Reddy NM	Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice.	Journal of immunology	2009	48
19484125	18024	Yang L	Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.	PloS one	2009	49
19592468	18024	Li J	Nrf2 protects against maladaptive cardiac responses to hemodynamic stress.	Arteriosclerosis, thrombosis, and vascular biology	2009	58
19665035	18024	Biswas M	Role of Nrf1 in antioxidant response element-mediated gene expression and beyond.	Toxicology and applied pharmacology	2010	53
19908287	18024	Rojo AI	Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.	Glia	2010	59
19914374	18024	Chowdhry S	Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis.	Free radical biology and medicine	2010	51
20089859	18024	Pi J	Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity.	The Journal of biological chemistry	2010	63
20338236	18024	Stack C	Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease.	Free radical biology and medicine	2010	49
20350562	18024	Zhang YK	Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.	Toxicology and applied pharmacology	2010	42
20418481	18024	Ungvari Z	Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.	American journal of physiology. Heart and circulatory physiology	2010	94
20511556	18024	Kong X	NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice.	Journal of immunology	2010	43
21173018	18024	Wruck CJ	Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice.	Annals of the rheumatic diseases	2011	49
21482715	18024	Inami Y	Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.	The Journal of cell biology	2011	131
21559389	18024	Zhao Z	Age-related retinopathy in NRF2-deficient mice.	PloS one	2011	73
21734707	18024	DeNicola GM	Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.	Nature	2011	376
22025779	18024	Zheng H	Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy.	Diabetes	2011	80
22226832	18024	Wang B	Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage.	Free radical biology and medicine	2012	31
22267202	18024	Scannevin RH	Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway.	The Journal of pharmacology and experimental therapeutics	2012	88
22383093	18024	Schäfer M	Nrf2 links epidermal barrier function with antioxidant defense.	EMBO molecular medicine	2012	30
22513881	18024	Lastres-Becker I	α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.	Human molecular genetics	2012	33
22751928	18024	Rada P	Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis.	Molecular and cellular biology	2012	49
23041058	18024	Lee JH	Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.	Pharmacology and therapeutics	2013	33
23610445	18024	Satoh H	Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.	Cancer research	2013	43
23875776	18024	Mo C	The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice.	Antioxidants and redox signaling	2014	31
24025640	18024	Jiang T	Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.	Kidney international	2014	21
24186494	18024	Xu Z	NRF2 plays a protective role in diabetic retinopathy in mice.	Diabetologia	2014	26
24637114	18024	Pekovic-Vaughan V	The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis.	Genes and development	2014	37
24718857	18024	Hecker L	Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance.	Science translational medicine	2014	90
24958099	18024	Meakin PJ	Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance.	Molecular and cellular biology	2014	22
25049227	18024	Kageyama S	Proteasome dysfunction activates autophagy and the Keap1-Nrf2 pathway.	The Journal of biological chemistry	2014	22
27251288	18024	Tao G	Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury.	Nature	2016	14
14557547	18587	Hsu T	The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.	Proceedings of the National Academy of Sciences of the United States of America	2003	228
15372100	18587	Otani A	Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells.	The Journal of clinical investigation	2004	84
16849425	18587	Komeima K	Antioxidants reduce cone cell death in a model of retinitis pigmentosa.	Proceedings of the National Academy of Sciences of the United States of America	2006	108
17111372	18587	Gargini C	Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: a morphological and ERG study.	The Journal of comparative neurology	2007	134
17267005	18587	Chang B	Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene.	Vision research	2007	91
17520694	18587	Komeima K	Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa.	Journal of cellular physiology	2007	70
18216234	18587	Stasheff SF	Emergence of sustained spontaneous hyperactivity and temporary preservation of OFF responses in ganglion cells of the retinal degeneration (rd1) mouse.	Journal of neurophysiology	2008	82
18432197	18587	Lagali PS	Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration.	Nature neuroscience	2008	149
18586879	18587	Pang JJ	AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation.	Investigative ophthalmology and visual science	2008	57
18639614	18587	Barhoum R	Functional and structural modifications during retinal degeneration in the rd10 mouse.	Neuroscience	2008	53
19109509	18587	Mazzoni F	Retinal ganglion cells survive and maintain normal dendritic morphology in a mouse model of inherited photoreceptor degeneration.	The Journal of neuroscience 	2008	65
19661229	18587	Huber G	Spectral domain optical coherence tomography in mouse models of retinal degeneration.	Investigative ophthalmology and visual science	2009	64
20592196	18587	Thyagarajan S	Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells.	The Journal of neuroscience 	2010	41
21139570	18587	Pang JJ	Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa.	Molecular therapy 	2011	68
21307264	18587	Menzler J	Network oscillations in rod-degenerated mouse retinas.	The Journal of neuroscience 	2011	41
21451038	18587	Borowska J	An intrinsic neural oscillator in the degenerating mouse retina.	The Journal of neuroscience 	2011	46
22908283	18587	Murakami Y	Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2012	39
22986110	18587	Yoshida N	Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa.	Ophthalmology	2013	34
24936453	18587	Assawachananont J	Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice.	Stem cell reports	2014	33
25793273	18587	Hippert C	Müller glia activation in response to inherited retinal degeneration is highly varied and disease-specific.	PloS one	2015	19
26139610	18587	Zhao L	Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration.	EMBO molecular medicine	2015	29
1680859	19122	Caughey B	The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive.	The Journal of biological chemistry	1991	156
1977523	19122	Prusiner SB	Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.	Cell	1990	211
8100741	19122	Büeler H	Mice devoid of PrP are resistant to scrapie.	Cell	1993	438
8552188	19122	Brandner S	Normal host prion protein necessary for scrapie-induced neurotoxicity.	Nature	1996	167
8953038	19122	Telling GC	Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.	Science	1996	228
9452375	19122	Hegde RS	A transmembrane form of the prion protein in neurodegenerative disease.	Science	1998	146
9568713	19122	Shmerling D	Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions.	Cell	1998	150
10525406	19122	Moore RC	Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel.	Journal of molecular biology	1999	114
11470893	19122	Enari M	Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.	Proceedings of the National Academy of Sciences of the United States of America	2001	103
11823413	19122	Mallucci GR	Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration.	The EMBO journal	2002	88
12086640	19122	Peretz D	A change in the conformation of prions accompanies the emergence of a new prion strain.	Neuron	2002	83
12386337	19122	Ma J	Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.	Science	2002	99
14522852	19122	Bruce ME	TSE strain variation.	British medical bulletin	2003	82
14593181	19122	Mallucci G	Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.	Science	2003	185
15286374	19122	Legname G	Synthetic mammalian prions.	Science	2004	286
15542685	19122	Browning SR	Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP.	Journal of virology	2004	73
15671162	19122	Legname G	Strain-specified characteristics of mouse synthetic prions.	Proceedings of the National Academy of Sciences of the United States of America	2005	74
15933194	19122	Chesebro B	Anchorless prion protein results in infectious amyloid disease without clinical scrapie.	Science	2005	218
16239348	19122	Le Dur A	A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes.	Proceedings of the National Academy of Sciences of the United States of America	2005	77
16940522	19122	Tamgüney G	Transmission of elk and deer prions to transgenic mice.	Journal of virology	2006	63
17142317	19122	Legname G	Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.	Proceedings of the National Academy of Sciences of the United States of America	2006	95
17245437	19122	Li A	Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125.	The EMBO journal	2007	81
17270731	19122	Mallucci GR	Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.	Neuron	2007	77
17466621	19122	Kristiansen M	Disease-associated prion protein oligomers inhibit the 26S proteasome.	Molecular cell	2007	75
18233951	19122	Aguzzi A	Molecular mechanisms of prion pathogenesis.	Annual review of pathology	2008	111
18443219	19122	Khosravani H	Prion protein attenuates excitotoxicity by inhibiting NMDA receptors.	The Journal of cell biology	2008	80
18775309	19122	Castilla J	Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.	Cell	2008	76
18800058	19122	Castilla J	Cell-free propagation of prion strains.	The EMBO journal	2008	68
19073920	19122	Sigurdson CJ	De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.	Proceedings of the National Academy of Sciences of the United States of America	2009	82
19198598	19122	Gousset K	Prions hijack tunnelling nanotubes for intercellular spread.	Nature cell biology	2009	155
19242475	19122	Laurén J	Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.	Nature	2009	403
19293928	19122	Haley NJ	Detection of CWD prions in urine and saliva of deer by transgenic mouse bioassay.	PloS one	2009	77
19308092	19122	Hwang D	A systems approach to prion disease.	Molecular systems biology	2009	98
19915150	19122	Colby DW	Design and construction of diverse mammalian prion strains.	Proceedings of the National Academy of Sciences of the United States of America	2009	94
20098419	19122	Bremer J	Axonal prion protein is required for peripheral myelin maintenance.	Nature neuroscience	2010	107
20107515	19122	Colby DW	Protease-sensitive synthetic prions.	PLoS pathogens	2010	80
20110469	19122	Wang F	Generating a prion with bacterially expressed recombinant prion protein.	Science	2010	257
20221436	19122	Chesebro B	Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.	PLoS pathogens	2010	51
20445063	19122	Gimbel DA	Memory impairment in transgenic Alzheimer mice requires cellular prion protein.	The Journal of neuroscience 	2010	135
20466881	19122	Angers RC	Prion strain mutation determined by prion protein conformational compatibility and primary structure.	Science	2010	62
20551516	19122	Sigurdson CJ	A molecular switch controls interspecies prion disease transmission in mice.	The Journal of clinical investigation	2010	44
20946660	19122	Chung E	Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.	BMC neuroscience	2010	60
22100763	19122	Kudo W	Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.	Human molecular genetics	2012	45
22586108	19122	Deleault NR	Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids.	Proceedings of the National Academy of Sciences of the United States of America	2012	86
23072804	19122	Watt NT	Prion protein facilitates uptake of zinc into neuronal cells.	Nature communications	2012	33
23208281	19122	Ashe KH	Prions, prionoids and pathogenic proteins in Alzheimer disease.	Prion	2013	27
23604588	19122	Wagner J	Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.	Acta neuropathologica	2013	36
26926995	19122	Nuvolone M	Strictly co-isogenic C57BL/6J-Prnp-/- mice: A rigorous resource for prion science.	The Journal of experimental medicine	2016	10
15549107	19126	Singh SK	Identification of human brain tumour initiating cells.	Nature	2004	1811
15681837	19126	Bussolati B	Isolation of renal progenitor cells from adult human kidney.	The American journal of pathology	2005	129
17084552	19126	Blazek ER	Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.	International journal of radiation oncology, biology, physics	2007	57
17122771	19126	Ricci-Vitiani L	Identification and expansion of human colon-cancer-initiating cells.	Nature	2007	1050
17483311	19126	Beier D	CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.	Cancer research	2007	313
18049477	19126	Eramo A	Identification and expansion of the tumorigenic lung cancer stem cell population.	Cell death and differentiation	2008	420
18535669	19126	Khan ZA	Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.	The Journal of clinical investigation	2008	73
18663533	19126	Haraguchi N	CD133+CD44+ population efficiently enriches colon cancer initiating cells.	Annals of surgical oncology	2008	63
19243384	19126	Tchoghandjian A	A2B5 cells from human glioblastoma have cancer stem cell properties.	Brain pathology	2010	44
20620237	19126	Wang CH	Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody.	Nanomedicine 	2011	40
21112564	19126	Ma S	miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.	Cell stem cell	2010	103
23307586	19126	Brescia P	CD133 is essential for glioblastoma stem cell maintenance.	Stem cells	2013	37
25200065	19126	Zhang D	Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.	Molecular cancer	2014	22
8938131	19164	Borchelt DR	Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.	Neuron	1996	274
8986743	19164	Citron M	Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.	Nature medicine	1997	178
10623648	19164	Gouras GK	Intraneuronal Abeta42 accumulation in human brain.	The American journal of pathology	2000	208
11279122	19164	Chishti MA	Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.	The Journal of biological chemistry	2001	221
11738035	19164	Feng R	Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces.	Neuron	2001	96
14645205	19164	Jankowsky JL	Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.	Human molecular genetics	2004	295
14724250	19164	Stutzmann GE	Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer's-linked mutation in presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability.	The Journal of neuroscience 	2004	74
15466394	19164	Casas C	Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.	The American journal of pathology	2004	111
15649704	19164	Malm TM	Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.	Neurobiology of disease	2005	91
15748777	19164	Patel NV	Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models.	Neurobiology of aging	2005	71
15755686	19164	Savonenko A	Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.	Neurobiology of disease	2005	105
16906128	19164	Radde R	Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.	EMBO reports	2006	145
17070803	19164	Zhang C	Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.	Experimental neurology	2007	62
17442823	19164	Green KN	Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels.	The Journal of neuroscience 	2007	64
18667150	19164	Kuchibhotla KV	Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks.	Neuron	2008	165
18698410	19164	Rodríguez JJ	Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease.	PloS one	2008	80
19710322	19164	Yan P	Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice.	The Journal of neuroscience 	2009	77
19837759	19164	Choi SR	Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.	Journal of nuclear medicine 	2009	93
20541250	19164	Lee JH	Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations.	Cell	2010	260
20550967	19164	Koronyo-Hamaoui M	Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.	NeuroImage	2011	65
20573903	19164	Zhang H	Role of presenilins in neuronal calcium homeostasis.	The Journal of neuroscience 	2010	52
21296668	19164	Nixon RA	Autophagy failure in Alzheimer's disease--locating the primary defect.	Neurobiology of disease	2011	109
22306812	19164	Mouton-Liger F	Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway.	Biochimica et biophysica acta	2012	30
22457485	19164	Bero AW	Bidirectional relationship between functional connectivity and amyloid-β deposition in mouse brain.	The Journal of neuroscience 	2012	31
22836255	19164	Bachstetter AD	Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathology.	The Journal of neuroscience 	2012	32
23152608	19164	Lauritzen I	The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus.	The Journal of neuroscience 	2012	35
23332170	19164	Nash KR	Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy.	Neurobiology of aging	2013	26
24795750	19164	Webster SJ	Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models.	Frontiers in genetics	2014	69
25741723	19164	Xia D	Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease.	Neuron	2015	38
25756590	19164	López-González I	Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species.	Journal of neuropathology and experimental neurology	2015	18
26299959	19164	Lee JH	Presenilin 1 Maintains Lysosomal Ca(2+) Homeostasis via TRPML1 by Regulating vATPase-Mediated Lysosome Acidification.	Cell reports	2015	26
26338325	19164	Xiao Q	Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.	The Journal of neuroscience 	2015	18
26888450	19164	Graham LC	Chronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer's disease.	Scientific reports	2016	10
9697695	19211	Di Cristofano A	Pten is essential for embryonic development and tumour suppression.	Nature genetics	1998	421
9990064	19211	Podsypanina K	Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.	Proceedings of the National Academy of Sciences of the United States of America	1999	267
10497129	19211	Di Cristofano A	Impaired Fas response and autoimmunity in Pten+/- mice.	Science	1999	114
10910075	19211	Stambolic V	High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.	Cancer research	2000	114
11504907	19211	Podsypanina K	An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.	Proceedings of the National Academy of Sciences of the United States of America	2001	127
11726926	19211	Backman SA	Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease.	Nature genetics	2001	132
11726927	19211	Kwon CH	Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease.	Nature genetics	2001	137
14522255	19211	Wang S	Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.	Cancer cell	2003	337
14534328	19211	Kwon CH	mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	92
14668450	19211	Li Y	Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.	Proceedings of the National Academy of Sciences of the United States of America	2003	184
14769918	19211	Stiles B	Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity corrected.	Proceedings of the National Academy of Sciences of the United States of America	2004	119
15199412	19211	Horie Y	Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.	The Journal of clinical investigation	2004	153
15261145	19211	Shaw RJ	The LKB1 tumor suppressor negatively regulates mTOR signaling.	Cancer cell	2004	295
15520182	19211	Fraser MM	Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo.	Cancer research	2004	83
15657439	19211	Wijesekara N	Muscle-specific Pten deletion protects against insulin resistance and diabetes.	Molecular and cellular biology	2005	66
16079851	19211	Chen Z	Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.	Nature	2005	592
16169464	19211	Stanger BZ	Pten constrains centroacinar cell expansion and malignant transformation in the pancreas.	Cancer cell	2005	107
16432235	19211	Wang S	Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.	Proceedings of the National Academy of Sciences of the United States of America	2006	116
16598206	19211	Yilmaz OH	Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.	Nature	2006	453
16633340	19211	Zhang J	PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.	Nature	2006	295
16675393	19211	Kwon CH	Pten regulates neuronal arborization and social interaction in mice.	Neuron	2006	304
17418409	19211	Wu R	Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.	Cancer cell	2007	122
17496901	19211	Hernando E	The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.	Nature medicine	2007	76
17607361	19211	Berquin IM	Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids.	The Journal of clinical investigation	2007	88
17616663	19211	Jiao J	Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.	Cancer research	2007	56
17909629	19211	Yanagi S	Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.	The Journal of clinical investigation	2007	62
18082964	19211	Fraser MM	Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities.	Neuroscience	2008	60
18258752	19211	de la Iglesia N	Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway.	Genes and development	2008	110
18322014	19211	Hui ST	Txnip balances metabolic and growth signaling via PTEN disulfide reduction.	Proceedings of the National Academy of Sciences of the United States of America	2008	72
18327259	19211	Xiao C	Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.	Nature immunology	2008	417
18387000	19211	Huang X	Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.	The Biochemical journal	2008	121
18463637	19211	Guo W	Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation.	Nature	2008	83
18541712	19211	Xia H	Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis.	The Journal of experimental medicine	2008	76
18632614	19211	Daikoku T	Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice.	Cancer research	2008	79
18948956	19211	Zheng H	p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.	Nature	2008	237
19185849	19211	Guertin DA	mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.	Cancer cell	2009	143
19211884	19211	Zhou J	Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice.	The Journal of neuroscience 	2009	136
19261747	19211	Puzio-Kuter AM	Inactivation of p53 and Pten promotes invasive bladder cancer.	Genes and development	2009	89
19326431	19211	Narayanan NK	Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.	International journal of cancer	2009	57
19470613	19211	Ljungberg MC	Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia.	Disease models and mechanisms	2009	64
19487573	19211	Huse JT	The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo.	Genes and development	2009	172
19847259	19211	Trimboli AJ	Pten in stromal fibroblasts suppresses mammary epithelial tumours.	Nature	2009	178
19887604	19211	Mulholland DJ	Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model.	Cancer research	2009	80
20197621	19211	Alimonti A	A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.	The Journal of clinical investigation	2010	98
20853437	19211	Harrington EP	Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.	Annals of neurology	2010	52
21236500	19211	Leslie NR	Non-genomic loss of PTEN function in cancer: not in my genes.	Trends in pharmacological sciences	2011	47
21266353	19211	Carracedo A	PTEN level in tumor suppression: how much is too little?	Cancer research	2011	67
21430697	19211	Hollander MC	PTEN loss in the continuum of common cancers, rare syndromes and mouse models.	Nature reviews. Cancer	2011	216
21572435	19211	Vitari AC	COP1 is a tumour suppressor that causes degradation of ETS transcription factors.	Nature	2011	49
21575859	19211	Carver BS	Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.	Cancer cell	2011	296
21642975	19211	Klöckener T	High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons.	Nature neuroscience	2011	63
22037217	19211	Bian Y	Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.	Oncogene	2012	46
22331912	19211	Kim J	High-grade serous ovarian cancer arises from fallopian tube in a mouse model.	Proceedings of the National Academy of Sciences of the United States of America	2012	90
22340597	19211	Choi N	Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation.	Cancer cell	2012	108
22350410	19211	Mulholland DJ	Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.	Cancer research	2012	123
22488882	19211	Goebbels S	Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.	EMBO molecular medicine	2012	39
22544933	19211	Liu Y	MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.	Journal of immunology	2012	65
22740087	19211	Tian Z	Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice.	Circulation research	2012	33
22859719	19211	Sun ZJ	Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.	Clinical cancer research 	2012	38
22958933	19211	Magee JA	Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression.	Cell stem cell	2012	59
22958934	19211	Kalaitzidis D	mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis.	Cell stem cell	2012	60
22998871	19211	Pun RY	Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy.	Neuron	2012	64
23313138	19211	Lu TL	Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice.	The American journal of pathology	2013	40
23487788	19211	Takeuchi K	Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism.	Proceedings of the National Academy of Sciences of the United States of America	2013	25
23727860	19211	Lunardi A	A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.	Nature genetics	2013	39
23902739	19211	Conley-LaComb MK	PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.	Molecular cancer	2013	28
24068802	19211	Zukor K	Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury.	The Journal of neuroscience 	2013	45
24630729	19211	McFadden DG	Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.	Cell	2014	56
24670665	19211	Signer RA	Haematopoietic stem cells require a highly regulated protein synthesis rate.	Nature	2014	64
24766807	19211	Papa A	Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function.	Cell	2014	46
24794706	19211	Xu C	Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.	Cancer cell	2014	56
24899687	19211	Guan B	Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis.	Journal of the National Cancer Institute	2014	25
25069841	19211	Polito VA	Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB.	EMBO molecular medicine	2014	42
25119044	19211	Xue W	CRISPR-mediated direct mutation of cancer genes in the mouse liver.	Nature	2014	111
25446664	19211	Lengyel E	Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.	American journal of obstetrics and gynecology	2015	17
26479035	19211	Zhang L	Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.	Nature	2015	94
9275227	20595	Schrank B	Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.	Proceedings of the National Academy of Sciences of the United States of America	1997	181
10615130	20595	Hsieh-Li HM	A mouse model for spinal muscular atrophy.	Nature genetics	2000	183
10655541	20595	Monani UR	The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.	Human molecular genetics	2000	222
17895963	20595	Gabanella F	Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs.	PloS one	2007	123
18065780	20595	Murray LM	Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.	Human molecular genetics	2008	137
18178576	20595	Gavrilina TO	Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.	Human molecular genetics	2008	82
19074460	20595	Rose FF Jr	Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.	Human molecular genetics	2009	45
20019802	20595	Bäumer D	Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.	PLoS genetics	2009	82
20234094	20595	Passini MA	CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.	The Journal of clinical investigation	2010	108
20538619	20595	Valori CF	Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy.	Science translational medicine	2010	80
20639395	20595	Bevan AK	Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery.	Human molecular genetics	2010	77
20826664	20595	Park GH	Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.	The Journal of neuroscience 	2010	58
21118896	20595	Dominguez E	Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.	Human molecular genetics	2011	88
21979052	20595	Hua Y	Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.	Nature	2011	180
22071333	20595	Bowerman M	A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.	Neuromuscular disorders 	2012	38
22723710	20595	Martinez TL	Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.	The Journal of neuroscience 	2012	55
23263861	20595	Ackermann B	Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality.	Human molecular genetics	2013	29
23295949	20595	Benkhelifa-Ziyyat S	Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice.	Molecular therapy 	2013	33
23839956	20595	McGivern JV	Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production.	Glia	2013	29
24617515	20595	Passini MA	Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.	Human gene therapy	2014	21
10878819	20617	Goldberg MS	Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?	Nature cell biology	2000	94
11707429	20617	Manning-Bog AB	The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein.	The Journal of biological chemistry	2002	112
12111846	20617	Rockenstein E	Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.	Journal of neuroscience research	2002	138
15026254	20617	Song DD	Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.	Experimental neurology	2004	79
16260631	20617	Ellis CE	Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein.	Molecular and cellular biology	2005	71
17456777	20617	Dufty BM	Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.	The American journal of pathology	2007	66
18172548	20617	Martinez-Vicente M	Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.	The Journal of clinical investigation	2008	161
19864570	20617	Spencer B	Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.	The Journal of neuroscience 	2009	162
20098733	20617	Pan-Montojo F	Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.	PloS one	2010	60
20106867	20617	Kuo YM	Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.	Human molecular genetics	2010	56
20118279	20617	Reynolds AD	Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.	Journal of immunology	2010	73
23205266	20617	Pan-Montojo F	Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice.	Scientific reports	2012	49
24082145	20617	Janezic S	Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.	Proceedings of the National Academy of Sciences of the United States of America	2013	41
24931606	20617	Tran HT	Α-synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration.	Cell reports	2014	41
25095794	20617	Masuda-Suzukake M	Pathological alpha-synuclein propagates through neural networks.	Acta neuropathologica communications	2014	35
25484190	20617	Poehler AM	Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.	Autophagy	2014	22
25732816	20617	Osterberg VR	Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism.	Cell reports	2015	26
26093169	20617	Paumier KL	Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.	Neurobiology of disease	2015	26
7605627	20655	Wong PC	An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.	Neuron	1995	276
8673102	20655	Reaume AG	Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury.	Nature genetics	1996	217
9547233	20655	Kong J	Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1.	The Journal of neuroscience 	1998	132
9633809	20655	Hall ED	Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.	Glia	1998	119
9743498	20655	Bruijn LI	Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.	Science	1998	232
12966034	20655	Wang J	Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature.	Human molecular genetics	2003	98
14526083	20655	Clement AM	Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.	Science	2003	249
14736504	20655	Fischer LR	Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.	Experimental neurology	2004	322
15034571	20655	Kieran D	Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice.	Nature medicine	2004	95
15164063	20655	Azzouz M	VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.	Nature	2004	129
15531919	20655	Elchuri S	CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life.	Oncogene	2005	158
15911875	20655	Kieran D	A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice.	The Journal of cell biology	2005	78
16082680	20655	Schaefer AM	A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis.	The Journal of comparative neurology	2005	79
16369483	20655	Urushitani M	Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis.	Nature neuroscience	2006	115
16595634	20655	Kikuchi H	Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
16716900	20655	Muller FL	Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy.	Free radical biology and medicine	2006	116
16844785	20655	Imamura Y	Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2006	118
16847061	20655	Atkin JD	Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1.	The Journal of biological chemistry	2006	87
17043238	20655	Beers DR	Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2006	178
17486090	20655	Rakhit R	An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS.	Nature medicine	2007	80
17496168	20655	Bordet T	Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.	The Journal of pharmacology and experimental therapeutics	2007	61
17584954	20655	Muller FL	Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.	American journal of physiology. Regulatory, integrative and comparative physiology	2007	74
17715356	20655	Ferraiuolo L	Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS.	The Journal of neuroscience 	2007	66
17725983	20655	De Vos KJ	Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content.	Human molecular genetics	2007	123
17766128	20655	Hegedus J	Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.	Neurobiology of disease	2007	81
18305242	20655	Jaarsma D	Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice.	The Journal of neuroscience 	2008	70
18492803	20655	Yamanaka K	Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	82
18519638	20655	Nishitoh H	ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.	Genes and development	2008	117
19046573	20655	Dobrowolny G	Skeletal muscle is a primary target of SOD1G93A-mediated toxicity.	Cell metabolism	2008	121
19251638	20655	Lobsiger CS	Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	48
19272377	20655	Martin LJ	The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.	Experimental neurology	2009	65
19416874	20655	Karch CM	Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS.	Proceedings of the National Academy of Sciences of the United States of America	2009	67
19715760	20655	Shi P	Mitochondrial dysfunction in amyotrophic lateral sclerosis.	Biochimica et biophysica acta	2010	50
19731042	20655	Henkel JS	Microglia in ALS: the good, the bad, and the resting.	Journal of neuroimmune pharmacology 	2009	91
19779023	20655	Magrané J	Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.	Human molecular genetics	2009	47
20040516	20655	Jang YC	Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration.	FASEB journal 	2010	83
20962037	20655	Wang L	Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.	Human molecular genetics	2011	41
21057983	20655	Dadon-Nachum M	The "dying-back" phenomenon of motor neurons in ALS.	Journal of molecular neuroscience 	2011	59
21059924	20655	Bilsland LG	Deficits in axonal transport precede ALS symptoms in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2010	77
22072713	20655	Murakami K	SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.	The Journal of biological chemistry	2011	40
23542689	20655	Kang SH	Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis.	Nature neuroscience	2013	93
23602540	20655	Yang YM	A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.	Cell stem cell	2013	63
23850290	20655	Chiu IM	A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model.	Cell reports	2013	80
23978556	20655	Kalmar B	The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.	Pharmacology and therapeutics	2014	21
24094105	20655	Saxena S	Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.	Neuron	2013	40
24108104	20655	Wang H	Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.	Human molecular genetics	2014	22
24154542	20655	Magrané J	Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.	Human molecular genetics	2014	50
24378874	20655	Sakellariou GK	Neuron-specific expression of CuZnSOD prevents the loss of muscle mass and function that occurs in homozygous CuZnSOD-knockout mice.	FASEB journal 	2014	20
24591593	20655	Winkler EA	Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice.	Proceedings of the National Academy of Sciences of the United States of America	2014	32
25559081	20655	Filézac de L'Etang A	Marinesco-Sjögren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS.	Nature neuroscience	2015	22
26650262	20655	Ayers JI	Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways.	Acta neuropathologica	2016	14
27572073	20655	Klein D	Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression.	Antioxidants and redox signaling	2017	5
1436033	21803	Shull MM	Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.	Nature	1992	619
7708687	21803	Sanderson N	Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.	Proceedings of the National Academy of Sciences of the United States of America	1995	130
8421714	21803	Kulkarni AB	Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.	Proceedings of the National Academy of Sciences of the United States of America	1993	416
9657149	21803	Crawford SE	Thrombospondin-1 is a major activator of TGF-beta1 in vivo.	Cell	1998	277
10978901	21803	Lawler J	The functions of thrombospondin-1 and-2.	Current opinion in cell biology	2000	102
11329064	21803	Wyss-Coray T	TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.	Nature medicine	2001	150
11413161	21803	Pittet JF	TGF-beta is a critical mediator of acute lung injury.	The Journal of clinical investigation	2001	127
11901187	21803	Schultz Jel J	TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.	The Journal of clinical investigation	2002	100
12070308	21803	Yang YA	Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.	The Journal of clinical investigation	2002	110
12119423	21803	Wyss-Coray T	Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	109
14687548	21803	Brionne TC	Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain.	Neuron	2003	83
14707053	21803	Nakamura K	TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice.	Journal of immunology	2004	143
14764882	21803	Bhowmick NA	TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.	Science	2004	407
15117823	21803	Verheule S	Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.	Circulation research	2004	104
15520202	21803	Uhl M	SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.	Cancer research	2004	89
15843580	21803	McMillan SJ	Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway.	Journal of immunology	2005	90
15937546	21803	Han G	Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.	The Journal of clinical investigation	2005	69
16998492	21803	Veldhoen M	Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.	Nature immunology	2006	134
17080199	21803	Tesseur I	Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.	The Journal of clinical investigation	2006	83
17353357	21803	Yang Z	Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice.	The Journal of cell biology	2007	110
17597062	21803	Zhu J	Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis.	The Journal of biological chemistry	2007	75
17694047	21803	Travis MA	Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice.	Nature	2007	175
17724470	21803	Gal A	Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.	Oncogene	2008	74
18032576	21803	Kollias HD	Transforming growth factor-beta and myostatin signaling in skeletal muscle.	Journal of applied physiology	2008	79
18310502	21803	Oka M	Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis.	Blood	2008	59
18387441	21803	Bujak M	Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction.	Journal of the American College of Cardiology	2008	54
18471524	21803	Jung Y	Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans.	Gastroenterology	2008	53
18593877	21803	Vidal B	Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway.	Genes and development	2008	68
18669656	21803	Laouar Y	TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis.	Proceedings of the National Academy of Sciences of the United States of America	2008	50
18849330	21803	Clavin NW	TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair.	American journal of physiology. Heart and circulatory physiology	2008	61
19002105	21803	Kawai T	PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta.	Laboratory investigation; a journal of technical methods and pathology	2009	55
19109155	21803	Li H	Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.	Journal of immunology	2009	165
19340291	21803	Walshe TE	TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature.	PloS one	2009	45
19584867	21803	Tang Y	TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation.	Nature medicine	2009	220
20130650	21803	Naka K	TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.	Nature	2010	141
20227040	21803	Reimann M	Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.	Cancer cell	2010	42
20231466	21803	Nemeth K	Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma.	Proceedings of the National Academy of Sciences of the United States of America	2010	97
20442777	21803	Bandyopadhyay A	Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models.	PloS one	2010	47
20616344	21803	Koesters R	Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells.	The American journal of pathology	2010	77
20811150	21803	Teekakirikul P	Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.	The Journal of clinical investigation	2010	120
21056998	21803	Avraham T	Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair.	The American journal of pathology	2010	57
21059352	21803	Dobaczewski M	Transforming growth factor (TGF)-β signaling in cardiac remodeling.	Journal of molecular and cellular cardiology	2011	119
21099117	21803	Melton AC	Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice.	The Journal of clinical investigation	2010	51
21370225	21803	Wei J	Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?	Arthritis and rheumatism	2011	40
21389977	21803	Kato M	A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells.	Kidney international	2011	58
21537080	21803	Koitabashi N	Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload.	The Journal of clinical investigation	2011	80
21646718	21803	Kitamura H	Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β.	The Journal of clinical investigation	2011	44
21742730	21803	Loureiro J	Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.	Journal of the American Society of Nephrology 	2011	39
21832980	21803	Wang D	Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.	Kidney international	2011	36
21987723	21803	Schliekelman MJ	Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.	Cancer research	2011	48
22028490	21803	Bouquet F	TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.	Clinical cancer research 	2011	36
22182843	21803	Podowski M	Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice.	The Journal of clinical investigation	2012	30
22238361	21803	Leight JL	Matrix rigidity regulates a switch between TGF-β1-induced apoptosis and epithelial-mesenchymal transition.	Molecular biology of the cell	2012	84
22539597	21803	Kassan M	Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice.	Arteriosclerosis, thrombosis, and vascular biology	2012	44
22664874	21803	Ye XZ	Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway.	Journal of immunology	2012	63
22693253	21803	Hardee ME	Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.	Cancer research	2012	42
22711826	21803	Lorts A	Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-β pathway.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
22904198	21803	Green DE	The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.	American journal of respiratory cell and molecular biology	2012	45
23142380	21803	Wu CF	Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.	The American journal of pathology	2013	45
23153532	21803	Calon A	Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.	Cancer cell	2012	132
23349081	21803	Kundu J	An additive manufacturing-based PCL-alginate-chondrocyte bioprinted scaffold for cartilage tissue engineering.	Journal of tissue engineering and regenerative medicine	2015	17
23391818	21803	Yang L	Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.	Gastroenterology	2013	27
23685840	21803	Zhen G	Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis.	Nature medicine	2013	103
23741506	21803	Mendel TA	Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy.	PloS one	2013	27
23868260	21803	Wang X	LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.	Nature	2013	39
23996730	21803	Yang L	Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice.	Hepatology	2014	24
24700192	21803	Lee KM	TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance.	European journal of immunology	2014	28
24892648	21803	Fan QM	Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.	Cancer letters	2014	51
25180292	21803	Zerr P	Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.	Annals of the rheumatic diseases	2016	14
25233132	21803	Blum B	Reversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathway.	eLife	2014	22
25365224	21803	Rahaman SO	TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice.	The Journal of clinical investigation	2014	25
25605728	21803	Richards EJ	Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.	The Journal of biological chemistry	2015	25
25644060	21803	Raimondo S	Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism.	Cell communication and signaling 	2015	19
25739764	21803	Hatfield SM	Immunological mechanisms of the antitumor effects of supplemental oxygenation.	Science translational medicine	2015	37
25785991	21803	Patel AS	Epithelial cell mitochondrial dysfunction and PINK1 are induced by transforming growth factor-beta1 in pulmonary fibrosis.	PloS one	2015	18
25858148	21803	Vanpouille-Box C	TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity.	Cancer research	2015	25
25939064	21803	Dalmas E	Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity.	Nature medicine	2015	18
25986930	21803	Lan YW	Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.	Stem cell research and therapy	2015	17
26053624	21803	Lemos DR	Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors.	Nature medicine	2015	37
26109568	21803	Bravi L	Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
26884601	21803	Viel S	TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.	Science signaling	2016	13
11179315	21898	Hirschfeld M	Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.	Infection and immunity	2001	141
11431739	21898	Uesugi T	Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice.	Hepatology	2001	125
11602714	21898	Haynes LM	Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus.	Journal of virology	2001	123
11923412	21898	Lehnardt S	The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS.	The Journal of neuroscience 	2002	173
12218133	21898	Abel B	Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.	Journal of immunology	2002	81
12486107	21898	Eisenbarth SC	Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen.	The Journal of experimental medicine	2002	300
12671050	21898	Andonegui G	Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs.	The Journal of clinical investigation	2003	105
12682225	21898	Ortega-Cava CF	Strategic compartmentalization of Toll-like receptor 4 in the mouse gut.	Journal of immunology	2003	75
12824464	21898	Lehnardt S	Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway.	Proceedings of the National Academy of Sciences of the United States of America	2003	270
14634135	21898	Darville T	Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.	Journal of immunology	2003	89
14970116	21898	Oyama J	Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.	Circulation	2004	152
15585830	21898	Zhai Y	Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.	Journal of immunology	2004	129
15716415	21898	Chakravarty S	Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines.	The Journal of neuroscience 	2005	110
15809417	21898	Tanga FY	The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy.	Proceedings of the National Academy of Sciences of the United States of America	2005	165
16301676	21898	Tsung A	Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells.	Journal of immunology	2005	110
16391018	21898	Peyssonnaux C	TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens.	Blood	2006	66
16622187	21898	Khan MA	Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.	Infection and immunity	2006	63
16820585	21898	Shimamoto A	Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury.	Circulation	2006	71
16920968	21898	Jilling T	The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis.	Journal of immunology	2006	107
17053835	21898	Zhang X	Toll-like receptor 4 deficiency causes pulmonary emphysema.	The Journal of clinical investigation	2006	80
17188246	21898	Cao CX	Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice.	Biochemical and biophysical research communications	2007	80
17277152	21898	Hashimoto Y	Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice.	Journal of immunology	2007	62
17372179	21898	Caso JR	Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke.	Circulation	2007	155
17403033	21898	Kigerl KA	Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury.	Journal of neurochemistry	2007	76
17478729	21898	Kim F	Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity.	Circulation research	2007	161
17519423	21898	Tsukumo DM	Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance.	Diabetes	2007	260
17644211	21898	Rivera CA	Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.	Journal of hepatology	2007	138
17653282	21898	Heimesaat MM	Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4.	PloS one	2007	70
17707128	21898	Kim HS	Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes.	Immunity	2007	69
17878380	21898	Leaphart CL	A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair.	Journal of immunology	2007	107
17884182	21898	Hua F	Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion.	Journal of neuroimmunology	2007	71
17952090	21898	Seki E	TLR4 enhances TGF-beta signaling and hepatic fibrosis.	Nature medicine	2007	435
17982277	21898	Walter S	Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.	Cellular physiology and biochemistry 	2007	100
18008007	21898	Vijay-Kumar M	Deletion of TLR5 results in spontaneous colitis in mice.	The Journal of clinical investigation	2007	142
18256356	21898	Zhang B	TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.	Journal of the American Society of Nephrology 	2008	73
18309167	21898	Caso JR	Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke.	Stroke	2008	51
18322079	21898	Lehnardt S	A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS.	The Journal of neuroscience 	2008	80
18486483	21898	Kilic U	TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration.	Neurobiology of disease	2008	61
18586243	21898	Tang SC	Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal.	Experimental neurology	2008	59
19229991	21898	Fukata M	Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors.	Inflammatory bowel diseases	2009	50
19265037	21898	Stoletov K	Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish.	Circulation research	2009	64
19461045	21898	Choi SH	Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake.	Circulation research	2009	62
19637282	21898	Spruss A	Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.	Hepatology	2009	111
19752239	21898	Fernandez-Lizarbe S	Critical role of TLR4 response in the activation of microglia induced by ethanol.	Journal of immunology	2009	80
19883619	21898	Saberi M	Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice.	Cell metabolism	2009	126
20007931	21898	Garantziotis S	TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation.	American journal of respiratory and critical care medicine	2010	43
20554880	21898	Alfonso-Loeches S	Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage.	The Journal of neuroscience 	2010	104
20595685	21898	Pulskens WP	TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury.	Journal of the American Society of Nephrology 	2010	42
20811584	21898	Hannan TJ	Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.	PLoS pathogens	2010	72
21224055	21898	Allen K	Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.	The American journal of pathology	2011	76
21352907	21898	Pascual M	Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage.	Brain, behavior, and immunity	2011	49
21674704	21898	Fukata M	Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis.	Inflammatory bowel diseases	2011	47
21784973	21898	Xu J	Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury.	Journal of immunology	2011	87
21827663	21898	Song M	TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease.	Journal of neuroinflammation	2011	51
21999375	21898	Vartanian KB	LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.	Journal of neuroinflammation	2011	44
22019135	21898	Christianson CA	Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis.	Pain	2011	37
22031891	21898	Sorge RE	Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice.	The Journal of neuroscience 	2011	66
22751700	21898	Orr JS	Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages.	Diabetes	2012	33
22796522	21898	Sodhi CP	Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice.	Gastroenterology	2012	61
22911652	21898	Scheffel J	Toll-like receptor activation reveals developmental reorganization and unmasks responder subsets of microglia.	Glia	2012	31
22915113	21898	Chen Z	Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.	The Journal of neuroscience 	2012	65
22983353	21898	An CH	TLR4 deficiency promotes autophagy during cigarette smoke-induced pulmonary emphysema.	American journal of physiology. Lung cellular and molecular physiology	2012	31
23033474	21898	Lin L	Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.	mBio	2012	37
23091640	21898	Kim KA	High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway.	PloS one	2012	115
23141927	21898	Bhattacharyya S	Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.	The American journal of pathology	2013	30
23455503	21898	Neal MD	A critical role for TLR4 induction of autophagy in the regulation of enterocyte migration and the pathogenesis of necrotizing enterocolitis.	Journal of immunology	2013	26
23572532	21898	Kohno H	Photoreceptor proteins initiate microglial activation via Toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal.	The Journal of biological chemistry	2013	35
23600947	21898	Fernandez-Lizarbe S	Ethanol induces TLR4/TLR2 association, triggering an inflammatory response in microglial cells.	Journal of neurochemistry	2013	34
24459235	21898	Kulkarni OP	Toll-like receptor 4-induced IL-22 accelerates kidney regeneration.	Journal of the American Society of Nephrology 	2014	23
24739758	21898	Bhattacharyya S	FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling.	Science translational medicine	2014	22
24815961	21898	Jia L	Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance.	Nature communications	2014	30
25765328	21898	Bedner P	Astrocyte uncoupling as a cause of human temporal lobe epilepsy.	Brain 	2015	24
26686767	21898	Montesinos J	Involvement of TLR4 in the long-term epigenetic changes, rewarding and anxiety effects induced by intermittent ethanol treatment in adolescence.	Brain, behavior, and immunity	2016	18
8602242	22339	Ferrara N	Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.	Nature	1996	639
9665379	22339	Detmar M	Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice.	The Journal of investigative dermatology	1998	106
10021335	22339	Gerber HP	VEGF is required for growth and survival in neonatal mice.	Development	1999	223
10416597	22339	Gorski DH	Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.	Cancer research	1999	169
10952892	22339	Miquerol L	Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression.	Development	2000	119
11507045	22339	Fukumura D	Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo.	Cancer research	2001	87
11839630	22339	Iwaguro H	Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration.	Circulation	2002	86
12086877	22339	Inoue M	VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.	Cancer cell	2002	83
12461084	22339	Nagy JA	Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis.	The Journal of experimental medicine	2002	117
12618525	22339	Eremina V	Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.	The Journal of clinical investigation	2003	268
12651605	22339	Wendt TM	RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.	The American journal of pathology	2003	90
12847526	22339	Lambrechts D	VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.	Nature genetics	2003	141
15037527	22339	Heeschen C	Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.	Circulation	2004	128
15100155	22339	Kunstfeld R	Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia.	Blood	2004	87
15339668	22339	Chang CP	A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis.	Cell	2004	117
16049343	22339	Al-Shabrawey M	Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.	The American journal of pathology	2005	74
16251428	22339	Marneros AG	Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function.	The American journal of pathology	2005	73
16567591	22339	Izumiya Y	Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload.	Hypertension	2006	80
17016557	22339	Mancuso MR	Rapid vascular regrowth in tumors after reversal of VEGF inhibition.	The Journal of clinical investigation	2006	206
17191092	22339	Chen RR	Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation.	Pharmaceutical research	2007	83
17202420	22339	Nakagawa T	Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.	Journal of the American Society of Nephrology 	2007	102
17322368	22339	van Amerongen MJ	Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice.	The American journal of pathology	2007	118
17606728	22339	Dickson PV	Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.	Clinical cancer research 	2007	116
17625067	22339	Halin C	VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes.	Blood	2007	63
18293091	22339	Nagy JA	Vascular permeability, vascular hyperpermeability and angiogenesis.	Angiogenesis	2008	125
18337603	22339	Eremina V	VEGF inhibition and renal thrombotic microangiopathy.	The New England journal of medicine	2008	294
18495668	22339	Guo X	Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer.	The Journal of biological chemistry	2008	54
18650835	22339	Bergers G	Modes of resistance to anti-angiogenic therapy.	Nature reviews. Cancer	2008	725
19013462	22339	Scaldaferri F	VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.	Gastroenterology	2009	67
19036702	22339	Klement GL	Platelets actively sequester angiogenesis regulators.	Blood	2009	64
19249680	22339	Pàez-Ribes M	Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.	Cancer cell	2009	665
19249681	22339	Ebos JM	Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.	Cancer cell	2009	483
19768732	22339	Bai Y	Müller cell-derived VEGF is a significant contributor to retinal neovascularization.	The Journal of pathology	2009	61
19841260	22339	Saint-Geniez M	An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris.	Proceedings of the National Academy of Sciences of the United States of America	2009	98
20023634	22339	Kienast Y	Real-time imaging reveals the single steps of brain metastasis formation.	Nature medicine	2010	188
20026662	22339	Wuest TR	VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.	The Journal of experimental medicine	2010	65
20068579	22339	Thau-Zuchman O	Vascular endothelial growth factor increases neurogenesis after traumatic brain injury.	Journal of cerebral blood flow and metabolism 	2010	45
20167811	22339	de Groot JF	Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.	Neuro-oncology	2010	156
20490982	22339	Nagy JA	Heterogeneity of the tumor vasculature.	Seminars in thrombosis and hemostasis	2010	58
20501654	22339	Long J	Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.	The Journal of biological chemistry	2010	82
20530741	22339	Wang J	Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage.	Diabetes	2010	65
20953557	22339	Meister J	miR-126 and miR-126*: new players in cancer.	TheScientificWorldJournal	2010	56
21102434	22339	Ricci-Vitiani L	Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.	Nature	2010	321
21784979	22339	Oladipupo S	VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting.	Proceedings of the National Academy of Sciences of the United States of America	2011	40
22012397	22339	Beck B	A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours.	Nature	2011	107
22110210	22339	Zhang T	Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.	Anticancer research	2011	37
22262122	22339	Linde N	Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages.	The Journal of pathology	2012	31
22451920	22339	Sun K	Dichotomous effects of VEGF-A on adipose tissue dysfunction.	Proceedings of the National Academy of Sciences of the United States of America	2012	88
22508695	22339	Sitohy B	Anti-VEGF/VEGFR therapy for cancer: reassessing the target.	Cancer research	2012	77
22653056	22339	Argaw AT	Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.	The Journal of clinical investigation	2012	97
22886301	22339	Liu Y	Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation.	The Journal of clinical investigation	2012	68
23093773	22339	Kurihara T	Targeted deletion of Vegfa in adult mice induces vision loss.	The Journal of clinical investigation	2012	72
23312284	22339	Sung HK	Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis.	Cell metabolism	2013	48
23804423	22339	Piao Y	Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition.	Clinical cancer research 	2013	45
24203759	22339	Liu Y	Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development.	Protein and cell	2013	30
24503129	22339	Yang L	Vascular endothelial growth factor promotes fibrosis resolution and repair in mice.	Gastroenterology	2014	41
24713652	22339	Shimizu I	Vascular rarefaction mediates whitening of brown fat in obesity.	The Journal of clinical investigation	2014	37
25331846	22339	Cifuentes D	Hypertension accelerates the progression of Alzheimer-like pathology in a mouse model of the disease.	Hypertension	2015	15
26336827	22339	Yan JJ	MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.	Oncotarget	2015	16
15800626	105675	Nakagawa T	Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.	Nature	2005	418
15800627	105675	Baines CP	Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death.	Nature	2005	589
16497286	105675	Di Lisa F	Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole.	Cardiovascular research	2006	69
17463082	105675	Forte M	Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2007	74
17512507	105675	Lim SY	Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.	Cardiovascular research	2007	60
17694179	105675	Nakayama H	Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure.	The Journal of clinical investigation	2007	126
18345011	105675	Millay DP	Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy.	Nature medicine	2008	101
19244535	105675	Wang X	Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury.	The Journal of neuroscience 	2009	48
19362755	105675	Du H	Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model.	Neurobiology of aging	2011	61
20463406	105675	Manczak M	Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.	Journal of Alzheimer's disease 	2010	100
20668412	105675	Quinsay MN	Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore.	Autophagy	2010	47
21212461	105675	Hafner AV	Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy.	Aging	2010	130
21248121	105675	Barrientos SA	Axonal degeneration is mediated by the mitochondrial permeability transition pore.	The Journal of neuroscience 	2011	71
22726440	105675	Vaseva AV	p53 opens the mitochondrial permeability transition pore to trigger necrosis.	Cell	2012	145
23486940	105675	Parone PA	Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.	The Journal of neuroscience 	2013	47
23507145	105675	Du H	Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration.	Biochimica et biophysica acta	2014	22
23788623	105675	Thomas RL	Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure.	Genes and development	2013	41
23818611	105675	Linkermann A	Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury.	Proceedings of the National Academy of Sciences of the United States of America	2013	88
24768964	105675	Gutiérrez-Aguilar M	Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition.	Journal of molecular and cellular cardiology	2014	22
15899815	109880	Knauf JA	Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.	Cancer research	2005	82
17299132	109880	Dankort D	A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors.	Genes and development	2007	140
19282848	109880	Dankort D	Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.	Nature genetics	2009	299
19345328	109880	Dhomen N	Oncogenic Braf induces melanocyte senescence and melanoma in mice.	Cancer cell	2009	168
19492075	109880	Jaiswal BS	Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors.	PloS one	2009	50
21220306	109880	Franco AT	Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.	Proceedings of the National Academy of Sciences of the United States of America	2011	48
21383698	109880	Knauf JA	Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.	Oncogene	2011	41
21388974	109880	Cantwell-Dorris ER	BRAFV600E: implications for carcinogenesis and molecular therapy.	Molecular cancer therapeutics	2011	52
21514245	109880	Blasco RB	c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.	Cancer cell	2011	77
21638088	109880	Capper D	Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.	Acta neuropathologica	2011	74
22000016	109880	Karreth FA	In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma.	Cell	2011	180
22172720	109880	Damsky WE	β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.	Cancer cell	2011	90
22392911	109880	Migliardi G	Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas.	Clinical cancer research 	2012	43
22576211	109880	Martin MJ	Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A.	Cancer discovery	2012	31
22693252	109880	Koya RC	BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.	Cancer research	2012	60
22891351	109880	Couto JP	STAT3 negatively regulates thyroid tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2012	37
23171796	109880	Maertens O	Elucidating distinct roles for NF1 in melanomagenesis.	Cancer discovery	2013	50
23249624	109880	Mittapalli RK	Mechanisms limiting distribution of the threonine-protein kinase B-RaF(V600E) inhibitor dabrafenib to the brain: implications for the treatment of melanoma brain metastases.	The Journal of pharmacology and experimental therapeutics	2013	25
23454771	109880	Knight DA	Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.	The Journal of clinical investigation	2013	68
23563312	109880	Hanna SC	HIF1α and HIF2α independently activate SRC to promote melanoma metastases.	The Journal of clinical investigation	2013	40
23583981	109880	Zhang J	Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.	Nature genetics	2013	126
24095280	109880	Shen CH	Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation.	Molecular cell	2013	26
24247719	109880	Mok S	Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.	Cancer research	2014	54
24362353	109880	Strohecker AM	Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism.	Autophagy	2014	21
24477002	109880	Sayin VI	Antioxidants accelerate lung cancer progression in mice.	Science translational medicine	2014	115
24711431	109880	McFadden DG	p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.	Proceedings of the National Academy of Sciences of the United States of America	2014	23
24717435	109880	Brady DC	Copper is required for oncogenic BRAF signalling and tumorigenesis.	Nature	2014	47
24746818	109880	Luo X	Isolation and molecular characterization of circulating melanoma cells.	Cell reports	2014	24
24903021	109880	Cooper ZA	Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade.	Cancer immunology research	2014	47
24919155	109880	Viros A	Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.	Nature	2014	25
25624498	109880	Perna D	BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model.	Proceedings of the National Academy of Sciences of the United States of America	2015	22
25843629	109880	Karreth FA	The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo.	Cell	2015	30
27135738	109880	Souroullas GP	An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.	Nature medicine	2016	13
14745443	142980	Heikenwalder M	Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration.	Nature medicine	2004	90
16027240	142980	Christensen SR	Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.	The Journal of experimental medicine	2005	150
16424225	142980	Rudd BD	Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection.	Journal of immunology	2006	63
16714379	142980	Gitlin L	Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus.	Proceedings of the National Academy of Sciences of the United States of America	2006	347
16789835	142980	Le Goffic R	Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.	PLoS pathogens	2006	147
17572686	142980	Chen CJ	Identification of a key pathway required for the sterile inflammatory response triggered by dying cells.	Nature medicine	2007	235
17929296	142980	Wu J	Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.	Hepatology	2007	62
18032677	142980	Cameron JS	Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals.	The Journal of neuroscience 	2007	61
18636103	142980	McCartney SA	MDA-5 recognition of a murine norovirus.	PLoS pathogens	2008	64
18838547	142980	Cavassani KA	TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events.	The Journal of experimental medicine	2008	147
19451267	142980	Fukui R	Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing.	The Journal of experimental medicine	2009	50
19995959	142980	McCartney S	Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells.	The Journal of experimental medicine	2009	57
20628601	142980	Aumeunier A	Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice.	PloS one	2010	42
20804821	142980	Hyakkoku K	Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia.	Neuroscience	2010	58
21220319	142980	Cole JE	Unexpected protective role for Toll-like receptor 3 in the arterial wall.	Proceedings of the National Academy of Sciences of the United States of America	2011	37
21311023	142980	Ives A	Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.	Science	2011	65
22565312	142980	Liu T	TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice.	The Journal of clinical investigation	2012	41
24070541	142980	O'Dwyer DN	The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.	American journal of respiratory and critical care medicine	2013	31
24836575	142980	Schwab L	Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.	Nature medicine	2014	26
27505671	142980	Liu Y	Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils.	Cancer cell	2016	16
20040602	230908	Sephton CF	TDP-43 is a developmentally regulated protein essential for early embryonic development.	The Journal of biological chemistry	2010	107
20198480	230908	Kraemer BC	Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis.	Acta neuropathologica	2010	90
20660618	230908	Tsai KJ	Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.	The Journal of experimental medicine	2010	70
20660762	230908	Chiang PM	Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2010	84
20736350	230908	Shan X	Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2010	99
21206091	230908	Igaz LM	Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.	The Journal of clinical investigation	2011	127
21358643	230908	Polymenidou M	Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43.	Nature neuroscience	2011	293
21752789	230908	Swarup V	Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.	Brain 	2011	52
21783422	230908	Cohen TJ	TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.	Trends in molecular medicine	2011	38
22084410	230908	Swarup V	Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways.	The Journal of experimental medicine	2011	54
22485182	230908	Valdez G	Shared resistance to aging and ALS in neuromuscular junctions of specific muscles.	PloS one	2012	49
23023293	230908	Lagier-Tourenne C	Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.	Nature neuroscience	2012	163
23449777	230908	Iguchi Y	Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.	Brain 	2013	28
24616503	230908	Yang C	Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2014	35
24974230	230908	Barmada SJ	Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.	Nature chemical biology	2014	56
25977373	230908	Chew J	Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits.	Science	2015	48
26044557	230908	Koppers M	C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits.	Annals of neurology	2015	38
26197969	230908	Walker AK	Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.	Acta neuropathologica	2015	18
